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ABSTRACT 
The term cystatin refers to proteins that specifically inhibit the activity 
of papain like lysosomal cysteine proteinases. Their function is to protect 
the cells from unwanted proteolysis. These endogenous thiol proteinase 
inhibitors are widely distributed in animals, plants and microorganisms. 
These are non covalent and tight binding inhibitors. Cystatins have been 
found to be evolutionary, structurally and functionally related forming the 
"Cystatin Superfamily". Members of this family may be divided into three 
groups of proteins known as family 1, 2 and 3. This classification is based 
on differences in amino acid sequence, molecular mass, number of 
disulphide bonds, carbohydrate content and sub cellular localization. Type 1 
cystatins or stefins are intracellular inhibitors, type 2 cystatins are 
extracellular inhibitors found mainly in body fluids such as saliva, tears and 
seminal plasma whereas type 3 cystatins or kininogens are present only in 
the blood. 
Cystatins have been purified from a number of mammalian sources 
like muscle, spleen, skin and liver. In this study a low molecular weight 
thiol proteinase inhibitor (12500) has been purified and characterized from 
human placenta in terms of its biochemical and biophysical properties. The 
purification has been achieved by a simple two step procedure involving 
ammonium sulphate fractionation and gel filtration chromatography on 
Sephadex G50-80. The preparation was found to be homogenous on the basis 
of molecular weight and charge. The inhibitor was obtained with 14.8% 
yield and 8913 fold purification. Human placental cystatin (HPC) consists of 
single polypeptide chain as determined by gel filtration and SDS-PAGE. The 
stoke's radius of the inhibitor was found to be 14.5 A. It is devoid of 
disulphide bonds and carbohydrate content. The inhibitor was found to have 
inhibitory activity in the pH range 3.0-9.0 and temperature stability was 
between 40-100°C. 
There was no cross reaction between anti HPC serum and other 
purified cystatins-like HMW kininogens isolated from sheep plasma and 
phytocystatins-isolated from a plant source Phaseolns mvngo. Purified HPC 
strongly inhibited activities of papain, ficin and bromelain but not of trypsin 
and chymotrypsin. 
The inhibition kinetics studies revealed that HPC is competitive tight 
binding inhibitor. The respective ki values obtained for papain ficin and 
bromelain were 5.5 xiO"*M, 8.4x10'^M and 9.5xlO'^M. The values of 
association constants Kass for the three proteases papain, ficin and bromelain 
were 3.4 xio"*, 2.9x10^ and 8.6x10^ M"'S'' and the respecfive dissociation 
constant values for the three proteinases were 2.3xlO"^ 2.6x10'^ and 
2.1x10"^ S'', respectively. These kinetic parameters taken together along 
with ti/2 values (for papain, ficin and bromelain values were 3.01x10 S, 
2.6x10" S and 3.3x10"$ respectively) and IC50 values (for the three 
proteinases papain, ficin and bromelain values were 0.051 ^M, 0.09 l|aM and 
0.13 l^M respectively) imply that HPC binds more effectively to papain, 
then ficin and least with bromelain. 
The partial amino acid sequence analysis showed that HPC has 
highest sequence homology with chicken cystatin, the Gly residue is present 
at position 11 rather than conserved position 9 which has also been reported 
for Human stefin A structure. The hydropathy plot of this 30 residue stretch 
showed that most of these N-terminal 30 residues are present inside the 
hydrophobic core of the protein as observed from their respective 
hydrophobic indices. 
Secondary structural composition showed presence of 21.08% a-
helical content and significant amount of p structure. Near UV-CD spectra 
of HPC showed peak at 280 nm indicating presence of sufficient amount of 
tertiary structure whereas absence of peak at 250 nm depicts that disulphide 
bonds are not present in HPC. Owing to low molecular weight, absence of 
disulphide bonds and carbohydrate content HPC can be placed in type 1 
cystatin family with some resemblance to chicken cystatin (type 2) as shown 
by CD studies and amino acid analysis. The binding of HPC to activated 
papain was accompanied by pronounced changes in secondary and tertiary 
structure as shown by UV absorption difference spectra, fluorescence and 
CD spectra of papain-inhibitor complex. The changes suggest perturbation 
of environment of aromatic residues of the proteins during binding which 
leads to the change in the native structure and conformation of these 
proteins. 
The structural changes of HPC were studied under various conditions 
of denaturation which includes the use of GdnHCl, urea and acid induced 
denaturation with subsequent refolding studies. In the presence of increasing 
GdnHCl and urea concentration inactivation and unfolding of HPC was 
significantly enhanced. HPC was 50% inactivated at 1.5M GdnHCl or 3M 
urea. Fluorescence studies showed that up to 1.5M GdnHCl there was 
quenching of fluorescence intensity compared to native form. At 2M 
GdnHCl intensity increased with 5nm red shift and complete unfolding was 
observed in 4-6M GdnHCl concentration range with mid point of transition 
in the region of 1.5-2M. In case of urea denaturation the fluorescence 
intensity increased with increase in urea concentration and HPC was 
completely unfolded in 6-8M concentration range with mid point of 
transition at 3M. Up to 1.5M GdnHCl the ellipticity in the far UV-CD region 
increased compared to native state where as from 2-5M GdnHCl there was 
gradual decrease in ellipticity and at 6M GdnHCl HPC showed random coil 
conformation. The increasing concentration of urea led to gradual decrease 
in ellipticity of HPC showing a sigmoidal shaped transition curve. HPC 
loses its structure at 6M urea and represents random coil conformation at 8M 
urea concentration. The urea induced denaturation of HPC follows two state 
rule where Native —*• Denatured state transition takes place in a single step 
whereas in GdnHCl induced denaturation intermediate or non-native states 
are observed in 0.5-1.5M GdnHCl concentration range. Intermediate states 
were also observed in the refolding pattern of HPC as determined by 
fluorescence measurements. 
Acid induced denaturation showed decrease in ellipticity value of 
HPC in far UV-CD region and increase in ANS fluorescence bound to HPC 
was observed ( due to exposure of hydrophobic clusters) as the pH was 
decreased from pH 6.0 (native state value) to pH 2.0. HPC at pH 2.0 
represents molten globule state with the following characteristic features -
significant amount of secondary structure, tertiary structural resemblance to 
native state, decreased fluorescence with 10 nm blue shift indicating that the 
micro environment of aromatic amino acids is more non-polar compared to 
native state, and maximum ANS fluorescence. 
Refolding of acid denatured state of HPC was studied in the presence 
of TFE and methanol. TFE induced formation of a-helical structure in acid 
denatured HPC which was evident by increase in ellipticity values at 222nm 
as concentration of TFE increased from 0-80%. At 40% TFE the spectral 
features in far UV-CD region were similar to native state (pH 6.0). Near 
UV-CD studies also supported resemblance of 40% TFE induced state to 
native state as the respective spectra of acid denatured HPC in the presence 
of 40% TFE was close to native state spectra, however at the highest 
concentration of TFE (80%) used there was loss of tertiary structure 
although having significant helical secondary structural features. The ability 
of TFE (40%) to refold acid denatured HPC close to native state 
conformation is also supported by intrinsic fluorescence and ANS 
fluorescence measurements. Methanol was not found to be as effective as 
TFE in inducing a-helical conformation in acid denatured HPC. The 
enhanced ability of TFE to form alcohol induced stable state at pH 2.0 has 
been attributed to presence of fluorine atoms which being bulkier have more 
stearic effects on protein and helps in forming open helical structures at 
higher concentration of alcohol (80%) with reduced tertiary structure. 
Polyols (glycerol and sorbitol) and Salts (MgS04, Na7.S04 and MgCb) 
were also used to study the refolding of acid denatured HPC. The helical 
content of acid denatured HPC increased with increase in glycerol 
concentration (0-80%). At 80% glycerol concentration the secondary 
structural features observed in the far UV-CD region are similar to that of 
native state (pH 6.0). The intrinsic fluorescence and near UV-CD studies 
showed that this 80% glycerol induced state has significant amount of 
tertiary structure with decreased ANS binding compared to acid denatured 
state suggesting a decrease in hydrophobic clusters and ordering of tertiary 
structure. It was found that glycerol is more effective in stabilizing acid 
denatured state of HPC compared to sorbitol which had similar but less 
pronounced stabilizing effects. 
Among the salts, stability effect was more for MgCb as compared to 
MgS04 and Na2S04. The CD and fluorescence spectra of acid denatured 
HPC in presence of MgCb showed secondary and tertiary structural 
resemblance close to that of the native state and showed overall spectral 
features in between native state and acid denatured state. This MgCla (3M) 
induced state also showed decreased ANS fluorescence as compared to acid 
denatured state but more than that of native state. The stabilizing effects of 
salts in addition to preferential hydration effect as observed in case of 
polyols, also seem to involve ion binding effects at high salt concentration 
which explains differential effects of salts used in this study and the system 
under particular set of conditions, that is a particular pH and presence of co 
solvents (polyols and salts) favours a specific protein conformation. The 
results taken together suggest that acid denatured state of HPC in presence 
of 80% glycerol or 3M MgCb has a conformation in between that of native 
state (pH 6.0) and molten globule state (at pH 2.0). 
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ABSTRACT 
The term cystatin refers to proteins that specifically inhibit the activity 
of papain like lysosomal cysteine proteinases. Their function is to protect 
the cells from unwanted proteolysis. These endogenous thiol proteinase 
inhibitors are widely distributed in animals, plants and microorganisms. 
These are non covalent and tight binding inhibitors. Cystatins have been 
found to be evolutionary, structurally and functionally related forming the 
"Cystatin Superfamily". Members of this family may be divided into three 
groups of proteins known as family 1, 2 and 3. This classification is based 
on differences in amino acid sequence, molecular mass, number of 
disulphide bonds, carbohydrate content and sub cellular localization. Type 1 
cystatins or stefins are intracellular inhibitors, type 2 cystatins are 
extracellular inhibitors found mainly in body fluids such as saliva, tears and 
seminal plasma whereas type 3 cystatins or kininogens are present only in 
the blood. 
Cystatins have been purified from a number of mammalian sources 
like muscle, spleen, skin and liver. In this study a low molecular weight 
thiol proteinase inhibitor (12500) has been purified and characterized from 
human placenta in terms of its biochemical and biophysical properties. The 
purification has been achieved by a simple two step procedure involving 
ammonium sulphate fractionation and gel filtration chromatography on 
Sephadex Gso-go. The preparation was found to be homogenous on the basis 
of molecular weight and charge. The inhibitor was obtained with 14.8% 
yield and 8913 fold purification. Human placental cystatin (HPC) consists of 
single polypeptide chain as determined by gel filtration and SDS-PAGE. The 
stoke's radius of the inhibitor was found to be 14.5 A. It is devoid of 
disulphide bonds and carbohydrate content. The inhibitor was found to have 
inhibitory activity in the pH range 3.0-9.0 and temperature stability was 
between 40-100°C. 
There was no cross reaction between anti HPC serum and other 
purified cystatins-like HMW kininogens isolated from sheep plasma and 
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phytocystatins-isolated from a plant source Phaseolus mungo. Purified HPC 
strongly inhibited activities of papain, ficin and bromelain but not of trypsin 
and chymotrypsin. 
The inhibition kinetics studies revealed that HPC is competitive tight 
binding inhibitor. The respective ki values obtained for papain ficin and 
bromelain were 5.5 xlO"*M, 8.4X10"''M and 9.5X10' ' 'M. The values of 
association constants Ka$$ for the three proteases papain, ficin and bromelain 
were 3.4 xlO\ 2.9x10^ and 8.6x10^ M''S'' and the respective dissociation 
constant values for the three proteinases were 2.3x10'^, 2.6x10'^ and 
2.1x10*^ S"', respectively. These kinetic parameters taken together along 
with ti/2 values (for papain, ficin and bromelain values were 3.01x10^ S, 
2.6x10^ S and 3.3xlO^S respectively) and IC50 values (for the three 
proteinases papain, ficin and bromelain values were 0.051 ^M, 0.09 l^M and 
O.nijiM respectively) imply that HPC binds more effectively to papain, 
then ficin and least with bromelain. 
The partial amino acid sequence analysis showed that HPC has 
highest sequence homology with chicken cystatin, the Gly residue is present 
at position 11 rather than conserved position 9 which has also been reported 
for Human stefin A structure. The hydropathy plot of this 30 residue stretch 
showed that most of these N-terminal 30 residues are present inside the 
hydrophobic core of the protein as observed from their respective 
hydrophobic indices. 
Secondary structural composition showed presence of 21.08% a-
helical content and significant amount of P structure. Near UV-CD spectra 
of HPC showed peak at 280 nm indicating presence of sufficient amount of 
tertiary structure whereas absence of peak at 250 nm depicts that disulphide 
bonds are not present in HPC. Owing to low molecular weight, absence of 
disulphide bonds and carbohydrate content HPC can be placed in type 1 
cystatin family with some resemblance to chicken cystatin (type 2) as shown 
by CD studies and amino acid analysis. The binding of HPC to activated 
papain was accompanied by pronounced changes in secondary and tertiary 
structure as shown by UV absorption difference spectra, fluorescence and 
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CD spectra of papain-inhibitor complex. The changes suggest perturbation 
of environment of aromatic residues of the proteins during binding which 
leads to the change in the native structure and conformation of these 
proteins. 
The structural changes of HPC were studied under various conditions 
of denaturation which includes the use of GdnHCl, urea and acid induced 
denaturation with subsequent refolding studies. In the presence of increasing 
GdnHCl and urea concentration inactivation and unfolding of HPC was 
significantly enhanced. HPC was 50% inactivated at 1.5M GdnHCl or 3M 
urea. Fluorescence studies showed that up to 1.5M GdnHCl there was 
quenching of fluorescence intensity compared to native form. At 2M 
GdnHCl intensity increased with 5nm red shift and complete unfolding was 
observed in 4-6M GdnHCl concentration range with mid point of transition 
in the region of 1.5-2M. In case of urea denaturation the fluorescence 
intensity increased with increase in urea concentration and HPC was 
completely unfolded in 6-8M concentration range with mid point of 
transition at 3M. Up to 1.5M GdnHCl the ellipticity in the far UV-CD region 
increased compared to native state where as from 2-5M GdnHCl there was 
gradual decrease in ellipticity and at 6M GdnHCl HPC showed random coil 
conformation. The increasing concentration of urea led to gradual decrease 
in ellipticity of HPC showing a sigmoidal shaped transition curve. HPC 
loses its structure at 6M urea and represents random coil conformation at 8M 
urea concentration. The urea induced denaturation of HPC follows two state 
rule where Native —^ Denatured state transition takes place in a single step 
whereas in GdnHCl induced denaturation intermediate or non-native states 
are observed in 0.5-1.5M GdnHCl concentration range. Intermediate states 
were also observed in the refolding pattern of HPC as determined by 
fluorescence measurements. 
Acid induced denaturation showed decrease in ellipticity value of 
HPC in far UV-CD region and increase in ANS fluorescence bound to HPC 
was observed ( due to exposure of hydrophobic clusters) as the pH was 
decreased fiom pH 6.0 (native state value) to pH 2.0. HPC at pH 2.0 
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represents molten globule state with the following characteristic features -
significant amount of secondary structure, tertiary structural resemblance to 
native state, decreased fluorescence with 10 nm blue shift indicating that the 
micro environment of aromatic amino acids is more non-polar compared to 
native state, and maximum ANS fluorescence. 
Refolding of acid denatured state of HPC was studied in the presence 
of TFE and methanol. TFE induced formation of a-helical structure in acid 
denatured HPC which was evident by increase in ellipticity values at 222nm 
as concentration of TFE increased from 0-80%. At 40% TFE the spectral 
features in far UV-CD region were similar to native state (pH 6.0). Near 
UV-CD studies also supported resemblance of 40% TFE induced state to 
native state as the respective spectra of acid denatured HPC in the presence 
of 40% TFE was close to native state spectra, however at the highest 
concentration of TFE (80%) used there was loss of tertiary structure 
although having significant helical secondary structural features. The ability 
of TFE (40%) to refold acid denatured HPC close to native state 
conformation is also supported by intrinsic fluorescence and ANS 
fluorescence measurements. Methanol was not found to be as effective as 
TFE in inducing a-helical conformation in acid denatured HPC. The 
enhanced ability of TFE tc form alcohol induced stable state at pH 2.0 has 
been attributed to presence of fluorine atoms which being bulkier have more 
stearic effects on protein and helps in forming open helical structures at 
higher concentration of alcohol (80%) with reduced tertiary structure. 
Polyols (glycerol and sorbitol) and Salts (MgS04, Na2S04 and MgCh) 
were also used to study the refolding of acid denatured HPC. The helical 
content of acid denatured HPC increased with increase in glycerol 
concentration (0-80%). At 80% glycerol concentration the secondary 
structural features observed in the far UV-CD region are similar to that of 
native state (pH 6.0). The intrinsic fluorescence and near UV-CD studies 
showed that this 80% glycerol induced state has significant amount of 
tertiary structure with decreased ANS binding compared to acid denatured 
state suggesting a decrease in hydrophobic clusters and ordering of tertiary 
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structure. It was found that glycerol is more effective in stabilizing acid 
denatured state of HPC compared to sorbitol which had similar but less 
pronounced stabilizing effects. 
Among the salts, stability effect was more for MgCb as compared to 
MgS04 and Na2S04. The CD and fluorescence spectra of acid denatured 
HPC in presence of MgCla showed secondary and tertiary structural 
resemblance close to that of the native state and showed overall spectral 
features in between native state and acid denatured state. This MgCla (3M) 
induced state also showed decreased ANS fluorescence as compared to acid 
denatured state but more than that of native state. The stabilizing effects of 
salts in addition to preferential hydration effect as observed in case of 
polyols, also seem to involve ion binding effects at high salt concentration 
which explains differential effects of salts used in this study and the system 
under particular set of conditions, that is a particular pH and presence of co 
solvents (polyols and salts) favours a specific protein conformation. The 
results taken together suggest that acid denatured state of HPC in presence 
of 80% glycerol or 3M MgCb has a conformation in between that of native 
state (pH 6.0) and molten globule state (at pH 2.0). 

1. INTRODUCTION 
GENERAL 
Proteinase inhibitors constitute a powerful regulatory system for 
endogenous proteinases, which may otherwise cause unlimited proteolysis 
and tissue damage. The term proteinase is considered to be a general term, it 
is applied equally to both exopeptidases and endopeptidases. A protease is 
classified as a proteinase if it exhibits a significant degree of endopeptidase 
activity regardless of whether it exhibits exopeptidase activity. However, 
protease and proteinases are synonymously used in literature. Proteinases 
have been grouped into four classes, these are metalloproteinases, acid 
proteinases, serine proteinases and thiol proteinases. Metalloproteinases 
require metal ions for their full activity, acid proteinases require low pH 
conditions for activity and serine proteinases require presence of serine 
residue at their active sites where as thiol proteinases have cysteine residue 
at their active sites. 
The present knowledge of serine proteinases and their endogenous 
inhibitors at the molecular level is much more detailed than is our 
understanding of the structure and physiological functions of thiol 
proteinases. The discovery of thiol proteinases offered a new insight into the 
process in which they participate. Thiol or cysteine proteinases are widely 
distributed among living organisms (Barrett et al., 1986a). These are 
proteins of molecular mass of about 25-35 KDa, they play important role in 
the control mechanism responsible for intracellular or extracellular 
proteolysis such as catabolism of proteins and peptides, processing of 
prohormones, precursor proteins and in antigen processing and presentation 
(Turk et al.,1997; 2000;2001; Stoka 2001). 
Thiol proteinases are synthesized in a precursor form in order to 
prevent unwanted proteolysis, and are later subjected to co-translational and 
post translational modifications to convert them into catalytically active 
mature enzymes (Turk et al., 2000). These proteinases contain two principal 
catalytic amino acid residues, cysteine and histidine which are involved in 
the cleavage of peptide bonds connecting the amino acid residues of a 
protein or peptide substrate (Stennicke and Salvesen, 1999). 
Nearly half of the known families of cysteine proteinases are present 
only in viruses, some occur in bacteria, whereas others exist in eukaryotic 
organisms (Rawlings and Barrett, 1994). About forty different families of 
thiol proteinases have so far been identified (Barrett et al., 1998). The first 
clearly recognized and extensively studied cysteine proteinase is papain, 
isolated from the latex of plant Carica papaya. Current evidence suggest 
that all eleven lysosomal cathepsins known to date (B, H, L, S, C, K, O, F, 
V, X and W) are members of papain family (Kotyza and Krepela, 2002) 
Mammalian thiol proteinases have been classified in to four different types: 
1. Cathepsins 2. Legumain 3. Calpains 4. Caspases. 
Cathepsins are relatively small proteins with the exception of 
cathepsin C which is an oligomeric enzyme of molecular weight of about 
200 KDa. Cathepsins are present in the lysosomes of cells and are involved 
in intracellular protein turnover, proteolytic degradation and cleavage of a 
number of precursor proteins and hormones. These are present in high 
concentrations in spleen (McDonald and Elis, 1975), kidney, liver (Knight, 
1980; Quinn and Judah 1978), lungs (Singh and Kalnitsky, 1978), brain 
(Suhar and Marks, 1979) and breast (Mort et al., 1984). 
Legumain is an asparaginyl endopeptidase also present in lysosomes. 
These are involved in MHC class 11- restricted antigen presentation (Manoury 
ei al., 1998) and local negative regulation of osteoclasts formation and activity 
(Choi etal., 1994). 
Calpains and Caspases are cytoplasmic thiol proteinases. Calpains 
participate in many intracellular processes such as turnover of cytoskeletal 
proteins, cell differentiation and regulation of signal peptides. Mammalian 
calpains have molecular mass of about 110 KDa (Yajima and Kawashima, 
2001). Caspases are the cysteine dependent aspartate specific proteinases. 
The central component of cell apoptosis consists of proteolytic systems 
involving caspases (Nicholson, 1999; Stennicke and Salvesen, 2000). 
Cathepsins play very important role in inflammatory processes and in 
pathogenesis of diseases such as rheumatoid arthritis (Trabandt et al., 1991), 
pulmonary emphysema, cancer (Koppel et al., 1994) and renal failure 
(Kabanda et al., 1995). Pulmonary emphysema occurs due to proteolysis of 
lung structural proteins by cathepsin G, a proteinase released from 
polymorphonuclear leucocytes (Gabrijeleic et al., 1990). In arthritis and 
joint inflammation, there is breakdown of extracellular proteoglycans. The 
core protein of proteoglycans is susceptible to the action of cathepsin B that 
produces peptide fragments containing one to several polypeptide chains. 
Inflammatory reactions of whatever origin are accompanied by an increase 
of lysosomal membrane permeability, which provokes the release of 
lysosomal enzymes, cathepsins. The enzyme may come from injured 
connective tissue or from polymorphonuclear cells. In some pathological 
conditions like ischemia, hypervitaminosis and on exposure to UV radiations 
lysosomal enzymes are released in extracellular space and produce extensive 
damage to the extracellular matrix. 
Regulation of Lysosomal Thiol Proteinase Activity 
The process of proteolysis in cells is under biological control acting 
at the level of protein biosynthesis or mediated through protein inhibitors. 
There are several processes which lead to increase in proteinase levels like 
starvation in animals increases the rate of protein degradation in liver (Dice 
et al., 1978) and muscles (Li and Glodberg, 1976) and causes about two fold 
increase of cathepsin D and A level in the liver (Katunuma et al., 1982). 
Similarly, several hormones are known to regulate the average rates of 
protein degradation. Various pathological conditions have been associated 
with thiol proteinase activities like metastasizing cancer (Koppel et al., 
1994), renal failure (Kabanda et al., 1995), rheumatoid arthritis (Trabandt et 
al., 1991), muscular dystrophy (Noda et al., 1981), purulent bronchiectasis 
(Buttle et al., 1990), peridontitis (Cox and Eley, 1989). Hence the wide 
implications of thiol proteinases in various biological functions need to be 
effectively regulated by opposing effects of the activators and inhibitors. 
Members of cystatin superfamily include stefins, cystatins and kininogens. 
All the cysteine proteinase inhibitors studied so far have been found to be 
the members of cystatin superfamily. These cystatins constitute a powerful 
regulatory system for endogenous cysteine proteinases which may otherwise 
cause uncontrolled proteolysis and tissue damage. 
Discovery of Cystatin Superfamily 
Protein inhibitors of cysteine proteinases in mammalian tissues were 
first reported by Finkelstadt (1957), who reported a heat stable inhibitor of 
cathepsin B and dipeptidyl peptidase I in rat liver cytosol. Later on Whitaker 
and coworkers discovered and partially characterized a protein from chicken 
egg white that inhibits ficin and papain (Fosum amd Whitaker, 1968; Sen 
and Whitaker 1973). Keilova and Tomasek (1975) reported that this protein 
also inhibits cathepsin B and dipeptidyl peptidase I. The term cystatin was 
originally given by Barrett (1981) for this protein because of its unique 
property of arresting the activity of cysteine proteinases (CPs). Later, the 
name cystatin was given to the superfamily of evolutionary, structurally and 
functionally related proteins involved in the inhibition of cysteine proteinase 
activities. Subsequently, cysteine proteinase inhibitors (CPIs) from various 
mammalian tissues were isolated and characterized. These inhibitors 
resembled cysteine proteinase inhibitors isolated from chicken egg white, in 
relative molecular mass and physicochemical properties. Susequently, 
Machleidt et al (1983) reported that the sequence of stefin also called 
'cystatin A' and chicken cystatin are homologous. Stefins, however differed 
in lacking cysteine residues and hence, were placed in a different family 
with in the cystatin superfamily (Green et al., 1984, Barrett, 1985). 
All cystatins fall in to a single superfamily i.e. a group within which 
all the members can be shown to have a statistically significant relation with 
each other or with papain but they do not resemble members of other 
superfamilies of proteinase inhibitors (Dayhoff et al., 1979a). Cystatin 
superfamily contains atleast three distinct families as given below, the 
members of these families have atleast half of their amino acid residues in 
common (Dayhoff et al., 1979b). Cystatins have also been reported to be 
present in plants and are referred to as Phytocystatins. First cystatin in plant 
kingdom was reported from rice known as Oryza cystatin (Ryan et al., 1998) 
CLASSIFICATION OF CYSTATIN SUERFAMILY 
The first international symposium on 'Cysteine proteinases and their 
inhibitors' in 1985 divided the proteins of cystatin superfamily into three 
families 1, 2 and 3 on the basis of sequence homology, molecular structure 
and the number of amino acids (Barrett et al., 1986a, Rawlings and Barrett, 
1990; Turk et al., 1997) Fig 1.0. 
Family I (Type I Cystatins): Stefins 
The name stefins has been assigned to the family 1 of cystatin 
superfamily to emphasize the structural difference between these proteinases 
and other cystatins. The proteins of this family are the smallest among the 
members of cystatin superfamily, lacking disulphide bonds and carbohydrate 
moieties. Stefins are single chain proteins, without signal peptide consisting 
of about 100 amino acid residues (Mr llKDa). They occur both 
intracellularly and extracellularly. The important members of this family are 
cystatin A and B isolated from human tissues and stefin C from bovine 
tissue. Cystatin a and p are considered to be simply the rat species variant of 
cystatin A and B. The amino acid sequence of these proteins closely 
resembles each other (Barrett et al., 1986a). 
Cystatin A 
It is an inhibitor of cathepsin B present in human skin discovered by 
Fraki (1976). Later on Jarvinen (1978) studied it as 'acid cysteine proteinase 
inhibitor' (ACPI). Brzin et al (1983) purified this inhibitor from blood 
leucocytes and named it as stefin. The amino acid sequence of this inhibitor 
was determined by Machleidt et al (1983). Green et al (1984) characterized 
same type of CPI from human liver and later renamed it as cystatin A. 
Fig 1.0 Diagrammatic representation of the chain structure 
of proteins in the cystatin super family 
The structure indicated for kininogens is that of L-
kininogens, H-kininogens have a longer carboxyl terminal 
extension. The symbol j, marks potential sites for the 
attachment of the carbohydrate side chains. 
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Cystatin A occurs in multiple isoelectric forms with predominantly 
acidic pi values in the range 4.5-5.0 (Hopsu-Havu et al., 1983a). Rinnie et al 
(1978) detected cystatin A in extracts of squamous epithelia from esophagus. 
It was also found in the dendritic reticulum cells of the lymph nodes (Rinnie 
et al., 1983), seminal plasma (Minakata and Asano, 1985), saliva, human 
nails (Tsushima, 1993) and in a number of epidermoid carcinomas (Rinnie et 
al., 1984) as well as in bovine skin (Turk et al., 1995). Physiological 
concentration of human cystatin A was found to be 10-15 [ig/ml in serum, 
65-200 fig/g in epidermis of tongue and 8 ftg/g in bone marrow. However its 
concentration varies between 0.3-8 jig/g in lungs, liver and spleen (Hopsu-
Havu et al., 1983b). 
Cystatin a is assumed to be a species variant of cystatin A found in 
rats. This protein was characterized by Jarvinen (1979) as specific inhibitor 
of cysteine proteinases from rat skin having Mr of 13 KDa. Cystatin a is 
generally found on the epidermal layer (Jarvinen et al., 1978) and in various 
other squamous epithelia (Rinnie et al., 1978). Kominami et al (1984) and 
Katunuma and Kominami (1985) quantified the concentration in skin and 
small intestine as 2800 ng/mg protein and 820 ng/g protein, respectively. 
The serum level of cystatin a in rat liver was 2.5 ng/ml. The N-terminal 
sequence of bovine stefin A was identified as a truncated form of bovine 
cystatin C (Turk et al., 1985). The sequence identity of stefin A with N and 
C terminal parts of human cystatin A was 86% and 88%. 
Cystatin B 
Cystatin B was detected as an inhibitor of cathepsin B and H in 
human tissues by Lenney et al (1979). Jarvinen and Rinnie (1982) purified 
cystatin B from human spleen. Green et al (1984) purified cystatin B from 
human spleen and liver with separation of multiple forms. Cystatin B is a 
relatively basic protein with pi value of 6.25 and 6.35 for the two forms of 
cystatin B (Green et al., 1984). Human cystatin B forms dimmers (Green et 
al., 1984) which shows no inhibitory activity. Cystatin B is ubiquitously 
distributed in various cells and tissues like epithelial cells, lymphocytes 
(Davies and Barrett, 1984), monocytes (Hopsu-Havu et al., 1985b) and to 
much lesser extent in seminal plasma (Brzin, 1982). Jarvinen et al (1983) 
have shown cystatin B in cells of the upper layers of epithelium of the oral 
mucosa. Cystatin B is more abundant in all cells than cystatin A with the 
exception of PMNs (polymorphonucleocytes). 
Cystatin p, a species variant of cystatin B was isolated from rat liver 
(Finkelstadt, 1957; Lenney, 1979) with pi values ranging from 5.04 to 5.6 
(Kominami et al., 1981). Cystatin B has an even distribution in the tissues 
and is more abundant than cystatin a in all tissues except skin. This 
characteristic of cystatin P resembles cystatin B of human variant. 
Stefin C 
Stefin C is unique among the inhibitors from stefin family which was 
found in multiple forms resulting from the cleavage of Asn 5 - Leu 6 bond 
of the inhibitor (Turk et al., 1993). This property is common in stefins and 
other low molecular weight CPI's (Barrett et al., 1986a; Brzin et al., 1982). 
Stefin C consists of 101 amino acids and its Mr is calculated to be 11,546. 
The inhibitor was found to be acidic with pi values ranging from 4.5 and 5.6 
(Turk et al., 1993). It exhibits considerable sequence homology with other 
inhibitors from stefin family with maximum homology of 84.7% with bovine 
stefin B, 72.4% with human cystatin B and 47.9% with human stefin A. It 
was identified as the first tryptophan containing stefin at position 2 (Turk et 
al., 1993). 
Family 2 (Type II): Cystatins 
Family 2 cystatins are also low molecular weight thiol proteinase 
inhibitors. These are composed of 115-120 amino acid residues having Mr of 
about 13,000. Cystatins contain two disulphide bonds and lack carbohydrate 
content. They are synthesized with the signal peptide and are found at 
relatively higher concentrations in secretions like chicken egg white, 
seminal plasma and saliva (Colle et al., 1976). They originate in cells and 
may also function intracellularly. The known members of this family are 
chicken cystatin, human cystatin C, D, S, SN, SA, E, F and M. 
Determination of the concentration of cystatins in human biological fluids 
reveal that all such fluids contain inhibitors, but the total molar ratio of 
different inhibitors vary markedly. Cystatins are found in both cells and 
tissues (Lofberg et al., 1982). The general pattern shows that secretions 
contain the highest concentration of family 2 cystatins (Abrahamson, 1994). 
Family 2 cystatin genes are clustered in a multigene locus on chromosome 
20 together with two pseudogenes (Schnittger et al., 1993). The best known 
representatives of this class of cystatins are human cystatin C and chicken 
cystatin. The pi values range from 4.4 to 9.3. 
Cystatin C 
Originally cystatin C was termed as Y-trace or post y-globulin isolated 
from human CSF (cerebro spinal fluid) because of its basic nature and y-
electrophoretic mobility (Barrett et al., 1984; Brzin, 1984). It was also found 
in the urine from patients with renal failure (Butler and Flynn, 1961) and 
ascitic and pleural fluids (Hochwald and Thornbecke, 1962). Later cystatin 
C was also detected in saliva, normal serum (Cejka and Fleischmann, 1973) 
and in seminal plasma (Colle et al., 1976). Lofberg and Grubb (1979) 
determined cystatin C concentration of 5.8 \iglml in CSF, 1.8 mg/ml in 
saliva, 0.095 ^g/ml in normal urine, 21 ^g/ml in urine from patients with 
renal tubular disorders and 1.1 i^g/ml in normal plasma. Seminal plasma 
contains 50 fig/ml i.e. 36 fold higher concentration of inhibitor than in 
normal blood plasma (Grubb et al., 1983). The high level of cystatin C in the 
CSF compared with blood plasma suggests the production of cystatin in 
central nervous system (Lofberg and Grubb, 1979). The protein is able to 
cross blood barrier to the vascular space thereby rapidly filtered in the 
glomeruli and catabolised in the renal tubular cells. 
Despite wide spread extracellulair distribution cystatin has also been 
detected intracellularly in brain cortical nerves (Lofberg et al., 1981a), 
normal and neoplastic neuroendocrine cells in the adrenal medulla (Lofberg 
et al., 1982), in A cells of pancreatic islets (Lofberg et al., 1981b), thyroid 
(Lofberg et al., 1983) and pituitary glands (Moller et al., 1985). Homologues 
of human cystatin C have been found in several mammals including mouse, 
rat, cow and dog (Solan et al., 1990; Esnard et al., 1988; Hirado et al., 1985, 
Poulik et al., 1981). One of the best described examples of cystatn C is 
chicken cystatin. It was first isolated from chicken egg white by Fossum 
amd Whitaker (1968) and later by Sen and Whitaker (1973) as low Mr tight 
binding cysteine proteinase inhibitor of ficin, papain, cathepsin B and 
cathepsin C (Keilova and Tomasek, 1975). Chicken cystatin has also been 
detected in the serum of both male and female chicken (Anastasi et al., 
1983) and in chicken muscle cell (Wood et al., 1985). It is present at 
concentration of about 80 ng/ml in egg white and 1 i^g/ml in the serum 
(Anasatasi et al., 1983). A molecular weight of about 13 KDa has been 
determined from the amino acid composition of this protein (Lindahl et al., 
1988). 
Cystatin D 
Cystatin D is a member of human cystatin multigene family and was 
cloned from a genomic library using cystatin C cDNA probe (Freije et al., 
1991). The inhibitor consists of 122 amino acid residues having a molecular 
mass of 13,885 kDa. The deduced amino acid sequence includes a putative 
signal peptide and has 51-55% homology with either cystatin C or secretory 
gland cystatins S, SA and SN. Cystatin D is a relatively neutral protein with 
pi values in the range 6.8 to 7.0 (Freije et al., 1991). Cystatin D is expressed 
in parotid gland, saliva and tears (Balbin et al., 1994). This tissue restricted 
expression of cystatin D is in marked contrast with a wider distribution of 
all other family 2 cystatins. 
Cystatin S 
Human saliva contains several low Mr acidic proteins which include 
CPI also (Isemura et al., 1984b). The first salivary inhibitor was purified and 
sequenced by Isemura et al (1984a) and named as cystatin S. It was found to 
have 54 and 41% sequence homology with cystatin C and chicken cystatin, 
respectively (Isemura 1984a, b). Cystatin S contains no phosphate, in 
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contrast to other salivary proteins (Isemura et al., 1984b). This inhibitor has 
also been isolated from human submaxillary, submandibular and sublingual 
glands and found to be present in the serous cells of parotid and 
submaxillary glands (Isemura 1984b). It is assumed that these cells are 
responsible for its synthesis. The protein has also been found in tears, 
serum, urine, bile, pancreas and bronchus (Isemura et al., 1986). 
Variants of cystatin S 
Several molecular variants of cystatin S have been studied by Isemura 
et al (1986). They differ in their N-terminal sequence and pi value (Isemura, 
1986). Differences in pl values result from phosphorylation of residues ser 3 
or ser 1 in salivary cystatin (Isemura et al., 1991). 
Cystatin SN: Originally known as cystatin SV or SA-1 
(Abrahamson et al., 1986). The protein consists of 121 amino acid residues 
and Mr of 14,316. The pl value is in the range of 6.6-6.8. Rat SN cystatin 
has also been purified from the submandibular glands of rats subjected to 
chronic IPR (Isoproterenol) treatment (Bedi, 1989a) and its amino acid 
sequence has been determined by Bedi (1989b). 
Cystatin SA: The protein consists of 121 amino acid residues and 
Mr (14,351) is slightly higher than cystatin SN. It has acidic pi value of 4.6 
(Isemura et al., 1991). Cystatin SA isolated from saliva had N-terminal 
residue Glu (Isemura et al., 1986). 
Cystatin E 
Ni et al (1997) found this type of cystatin by expression of the 
amniotic cell and fetal epithelial cell cDNA libraries. The mature protein is 
a polypeptide of 121 amino acid residues with 28 residue signal peptide 
having a Mr of 15,000. Cystatin E resembles family 2 cystatins structurally 
in having two protective disulphide bridges and by being a secreted protein. 
The inhibitor has unusual characteristic of being a glycoprotein, carrying an 
N-linked oligosaccharide at Asn 108. The amino acid sequence similarities 
of cystatin E with other cystatins are 26-34% with human family 2 cystatins 
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(C, D, S, SN and SA), 18 and 23% with family 1 cystatin A and B and less 
than 30% with domain 2 and 3 of family 3 cystatins (kininogens) (Ni et al., 
1997). The protein has Pro-Trp pair towards the C-terminal like that of 
family 2 and 3 cystatins. The gene of this inhibitor has been localized on 
chromosome 11 (Stenmann et al., 1997). 
Cystatin E has been detected in variety of specialized tissues and 
organs (Ni et al., 1997). High concentration has been found in uterus, liver, 
pancreas, heart, spleen, small intestine and peripleural blood leucocytes. 
Low cystatin E content is found in brain, testis and kidney (Ni et al., 1997). 
Cystatin F 
Another described human member of the cystatin superfamily was 
identified as cystatin F by Ni et al (1998). The whole sequence contained 
signal peptide and a mature protein of 126 amino acid residues with two 
disulphide bonds which resembles family 2 cystatins. Unlike other members, 
cystatin F has two additional cys residues indicating the presence of an extra 
disulphide bridge which stabilizes the N-terminal segment of the molecule. 
The protein has an extended N-terminal segment being 6-10 residues longer 
than the other single domain cystatins. Cystatin F has a Mr of 14,543 as 
determined by sequence analysis (Ni et al., 1998). Cystatin F has two N-
linked carbohydrate chains at position 36 and 88. It has 30-34% sequence 
homology with human family 2 cystatins and 29% homology with cystatin E, 
even lower 22-20% identity to cystatin A and B and 24% homology with 
domain 3 of kininogens. The distribution pattern of cystatin F is very 
different from that of cystatin C or E. Blood contains low levels of the 
inhibitor (0.9 ^g/ml). The highest concentration is present in the spleen and 
peripheral blood leucocytes, moderate levels in thymus and small intestine. 
Cystatin F is found mostly in the immune cells (Ni et al., 1998). 
Cystatin M 
Cystatin M was discovered in the primary tumor cell line. It is 
synthesized and secreted as a precursor protein (Von Heinjie, 1985). The 
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predicted molecular mass is approximately 14.3 KDa and pi of 7.8 was 
found for the mature protein. A single disulphide bond is present 
(Sotirpoulou et al., 1997). An N-glycosilated form of cystatin M of 20-22 
KDa was co-immunoprecipitated and accounted for about 30-40% of total 
cystatin M protein. Both forms of native cystatin M occurred intracellularly. 
Cystatin M resembles other members of the family in having the three 
conserved domains. It has 40% homology with human family 2 cystatins 
(Sotirpoulou et al., 1997). The overall homology between cystatin M and 
other cystatins range from 30-40% for conserved amino acid residues and 
25-33% for identical amino acids. It shows closest homology to cystatin C, 
they share 33% identical and 38% conserved amino acid residues. Cystatin 
M is expressed by normal mammary epithelial cells and a variety of human 
tissues but is not expressed in many metastatic mammary tumor cell lines. 
High levels of cystatin M are present in lung, skeletal muscle, kidney and 
pancreas. Low level was observed in heart tissue. 
Various mammalian and non-mammalian sources from where low Mr 
CPI has been isolated are summarized in Table 1.0. 
FAMILY 3 (TYPE III): KININOGENS 
In mammals, three types of kininogens have been found differing in 
size, structure and function. The largest kinin precursor, commonly referred 
to as high molecular weight (HMW) kininogen has Mr of 88,000-120,000 
depending on its species origin (Kato et al., 1981). Among the smaller 
kininogens, a low Mr kininogen with Mr of 50,000-68,000 is found 
throughout the mammalian lineage (Muller-Esterl et al., 1986). The third 
type T- kininogen of Mr 68,000 seems to be unique to the rat (Okamoto and 
Greenbaum, 1983). The various types of kininogen have the same basic 
structure, a heavy chain of 50-60 KDa at the amino terminus, the kinin 
segment in the core part of the molecules and the light chain of variable 
length at the carboxy-terminal (Lottspeich et al., 1985). The primary 
structure of the heavy chain, kinin section and a segment of 12 amino acids 
are identical in HMW and LMW kininogens, but the structure of their light 
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TABLE 1.0: 
Source 
African puff 
(Bitis arietus) 
Beef 
Bombyx mori 
Bovine 
Dog 
Guinea pig 
Horse shoe Crab 
Hog 
Human 
Litomosoides 
sigmodotis 
Paramecium 
caudatum 
Rabbit 
Rat 
Tetrahymena 
pyriformis 
Trypanosoma 
cruz 
Carp 
Cat 
Chum Salmon 
Low Mr CPI F 
Tissue 
Adder 
Nasal & 
articular 
cartilage 
spleen 
Hemolymph 
Brain 
Brain 
Hoof 
Nyscke 
Colostrums 
Colostrum 
Parotid 
gland & 
Kidney 
Skin 
Hemocytes 
Kidney 
Liver 
Squamous 
cell 
carcinomata 
Spleen 
-
-
Liver 
Skin 
Brain 
-
-
Ovary 
Skin 
Egg 
ROMOT 
Mr 
13,000 
13,000 
-
25,000 
11,000 
11,406 
14,000 
14,300 
12,787 
-
-
12,600 
-
12,400 
11,400 
12,000 
14,000 
-
5000-
10,000 
12,5000 
12,500 
-
-
11,000 
12,000 
-
• 
HER SOI 
Pl 
6.5 
4.8-7.0 
-
4.7 
5.23 
-
6.2 
10.0-10.3 
-
Acidic 
-
-
-
4.7-50 
6.0-6.5 
-
-
6.6 
-
-
-
acidic 
-
-
JRCES 
Reference 
Evans and Barrett, 1987 
Roughly et al., 1978 
Brzinetal., 1982 
Yamamoto et al., 1999 
Aghajanyan et al., 1996 
Tsushima et al., 1996 
Bigeetal., 1985 
Zabarietal., 1993 
Hiradoetal., 1984 
Pouliketal., 1981 
Sekineand Poulik, 1982 
Jarvinen, 1976 
Agarwala et al., 1996 
Lenney et al., 1979 
Green et al., 1984 
Rinnieetal., 1980 
Jarvinen and Rinnie, 1982 
Plaffetal., 2002 
Lenney etal., 1979 
Pontremoli etal., 1983 
Udaka«& Hayashi, 1965 
Hayashi,1975;Tokaji,1971 
Kopitar et al., 1983 
Lenney etal., 1979 
Monteiro et al., 2001 
Tsaietal., 1996 
Jarvinen, 1976 
Yamashita and 
Konagawa, 1996 
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chains diverge considerably. HMW kininogen has a light chain of 45-58 
KDa which harbors a unique histidine rich region (Sugo et al., 1980). The 
HMW light chain contains the binding site for prekallikrein and factor XI. 
The structure of T-kininogen closely resembles that of LMW kininogen in 
its light and heavy chain portions (Cole et al., 1985) but differs at the amino 
terminal flanking region of the kinin segment. 
The primary site of kininogen synthesis is the liver with only minor 
expression in other tissues. The kininogens are secretory proteins synthesized 
with a signal peptide and undergo glycosylation. Important functions of 
kininogens are the release of vasoactive peptide bradykinin, by acting as 
substrate for kallikrein, intrinsic blood coagulation, acute phase reactions and 
inhibition of cysteine proteinases (Muller-Esterl et al., 1986). pi values reported 
for the multiple isoelectric forms of L and H kininogens fall in the range 4.0-4.9 
(Muller-Esterl et al., 1982). The proteins are stable to temperature in the range 
50-90''C (Taniguchi et al., 1981). 
Plasma concentrations of kininogens have been determined by radio 
immuno assay to be 109-272 ng/ml (L-kininogens) and 69-116 ng/ml (H-
kininogens) (Adam et al., 1985). Plasma concentration of a CPI has been 
reported to be 425 ^ig/ml (Ryley, 1979) and 359 ^g/ml (Gounaris et al., 
1984). Kitamura et al (1985) and Salvesen et al (1985) found that three 
cystatin like segments are present, although the first lacks the conserved 
sequence Gln-Val-Val-Ala-Gly. It is known that the LMW-kininogens 
contain no free thiol groups (Salvesen et al., 1985). Kininogens inhibit 
papain, ficin, cathepsin B, H and L (Pagano and Engler, 1982; Gounaris et 
al., 1984). 
EVOLUTIONARY RELATIONSHIP 
Statistical analysis of the similarities between aligned sequences 
suggests that they have evolved from a single primitive sequence (Barker 
and Dayhoff, 1972). Difference matrix of the sequence of the members of 
superfamily revealed that the type 1 forms one family and the type 2 forms a 
second family whereas kininogens also forms a single family. However, 
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members of cystatin superfamily are closely related to each other. Fig 1.1 
demonstrates the relationship between all known human cystatin domains 
according to their sequence homology and physicochemical properties. 
The structure of cystatins indicates that the members of the family 
involved at least six duplications of genetic material from a single 
primordial sequence to produce the cystatins A, B, C, S and 3 segments of 
kininogens. Gene structure of kininogens (Kitamura et al., 1985) shows that 
each of the three cystatin like segments of kininogens is coded for by three 
exons for which, the cystatin gene was the precursor. Some workers reported 
that only the first two of the three exons of the primitive family 2 genes 
were represented in family 1 cystatin gene, the third segment is acquired 
during the evolution of family 2 cystatins (Keil-Dlouha, 1986). Analysis of 
amino acid sequence data led to the conclusion that the differences in the 
length of polypeptides are accounted for by insertion and deletion of the 
genetic material in small blocks (Salvesen et al., 1986). Since disulphide 
bonds are often acquired in the evolution of protein but rarely lost 
(Williams, 1982), it is assumed that the primitive precursor of the cystatin 
was not unlike a modern type 1 cystatin. 
The evolutionary relationship among the various cysteine proteinase 
inhibitors remain largely obscure until Muller-Esterl et al (1985) suggested a 
common evolutionary origin of stefms, cystatins and kininogens. Their 
model has been constructed on the basis of sequence homology. Muller-
Esterl (1985) proposed that the diversity of CPI has evolved from two 
ancestral building blocks 'A' and 'B' . The stefin progenitor represents the 
whole superfamily comprising a single 'A' unit. Cystatin acquired a second 
element B, possibly by gene fusion thus forming 'AB' unit. Gene triplication 
of the archetype inhibitor generated the kininogen heavy chain which 
contains three cystatin like copies (AB)3. Hence, the superfamily of 
mammalian CPI is constituted by atleast three distinct families with stefin, 
cystatin and kininogens as their prototypes. 
The phylogenetic dendogram depicts the divergence between the 
chicken cystatin and human cystatin C and S occurred 300 million years ago. 
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- Cystatin A 
. Cystatin B 
> Cystatin S 
, Cystatin SA 
, Cystatin SN 
Cystatin C 
Cystatin D 
Cystatin E/M 
Cystatin F 
Kininogen D3 
Kinitiogen D2 
Type I 
Type II 
Type III 
Fig 1.1 Schematic illustration of evolutionary relationship 
The evolutionary relationship between all known inhibitory 
active human cystatin families. 
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members of cystatin superfamily are closely related to each other. Fig 1.1 
demonstrates the relationship between all known human cystatin domains 
according to their sequence homology and physicochemical properties. 
The structure of cystatins indicates that the members of the family 
involved at least six duplications of genetic material from a single 
primordial sequence to produce the cystatins A, B, C, S and 3 segments of 
kininogens. Gene structure of kininogens (Kitamura et al., 1985) shows that 
each of the three cystatin like segments of kininogens is coded for by three 
exons for which, the cystatin gene was the precursor. Some workers reported 
that only the first two of the three exons of the primitive family 2 genes 
were represented in family 1 cystatin gene, the third segment is acquired 
during the evolution of family 2 cystatins (Keil-Dlouha, 1986). Analysis of 
amino acid sequence data led to the conclusion that the differences in the 
length of polypeptides are accounted for by insertion and deletion of the 
genetic material in small blocks (Salvesen et al., 1986). Since disulphide 
bonds are often acquired in the evolution of protein but rarely lost 
(Williams, 1982), it is assumed that the primitive precursor of the cystatin 
was not unlike a modern type 1 cystatin. 
The evolutionary relationship among the various cysteine proteinase 
inhibitors remain largely obscure until Muller-Esterl et al (1985) suggested a 
common evolutionary origin of stefins, cystatins and kininogens. Their 
model has been constructed on the basis of sequence homology. Muller-
Esterl (1985) proposed that the diversity of CPI has evolved from two 
ancestral building blocks 'A' and 'B' . The stefin progenitor represents the 
whole superfamily comprising a single 'A' unit. Cystatin acquired a second 
element B, possibly by gene fusion thus forming 'AB' unit. Gene triplication 
of the archetype inhibitor generated the kininogen heavy chain which 
contains three cystatin like copies (AB)3. Hence, the superfamily of 
mammalian CPI is constituted by atleast three distinct families with stefin, 
cystatin and kininogens as their prototypes. 
The phylogenetic dendogram depicts the divergence between the 
chicken cystatin and human cystatin C and S occurred 300 million years ago. 
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Cystatin A 
Cystatin B 
Type I 
Cystatin S 
Cystatin SA 
Cystatin SN 
Cystatin C 
Cystatin D 
Cystatin E/M 
Cystatin F 
Kininogen D3 
Kininogen D2 
Type li 
Type III 
the time of appearance of first reptile. The appearance of the first mammals 
about 90 million years ago coincides with the divergence of human cystatin A 
and rat cystatin a and cystatin C and S. The divergence of human and rat 
cystatin B (p) corresponds to the time of the oldest known placental mammals 
about 80 million years ago. The divergence of cystatin A and B appears to be 
about 230 million years ago, before the appearance of true mammals (MuUer-
Esterl 1985). 
STRUCTURE 
Amino acid composition of cystatins 
Most of the members of the cystatin superfamily are polypeptides of 
98-126 amino acid residues with Mr values falling in the range 11,000-
14,000 (Table 1.1). It can be seen that cystatin A and a are devoid of 
cysteine residues where as cystatin B and P contain one and two residues, 
respectively. Cystatin F is reported to have two more cysteine residues apart 
from the usual four cysteine residues. Although tryptophan is absent from 
type 1 cystatins it is reported to be present in stefin C. An interesting feature 
of the stefin B is the conserved QVVAG region in the stefins of mammalian 
origin. Val 54 is replaced with Leu 54. Grubb et al (1984) identified the 
disulphide linked peptides from human cystatin C and chicken cystatin 
between Cys 71- Cys 81 and Cys 95- Cys 115. Anastasi et al (1983) found 
that cystatin type 1 contains no free thiol group. Cystatin E apart from other 
usual conserved sequences characteristic of family 2 cystatins has a five 
residue insertion between amino acid 76 and 77 and a deletion of residue 91 
(cystatin C numbering). Ni et al (1998) deciphered the presence of a second 
trp residue, in addition to the conserved trp-106 in cystatin F. 
Secondary Structure 
The structure of chicken cystatin and human cystatin C has 
been studied extensively. Based on lines of evidences from analysis of 
amino acid sequence for the distribution of hydrophilic and hydrophobic 
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TABLE 1.1: AMINO ACID COMPOSITION OF CYSTATINS 
Data are calculated from published amino acid sequences for type 1 and 
type2 cystatins. 
AA 
Cys 
Ser 
Thr 
Pro 
Ala 
Gly 
An 
Asp 
Glu 
Gin 
His 
Arg 
Lys 
Met 
He 
Leu 
Val 
Phe 
Tyr 
Trp 
Total 
Human 
cyst A 
-
2 
7 
5 
5 
8 
5 
6 
9 
6 
1 
1 
12 
2 
4 
8 
9 
2 
6 
-
98 
TYPE-I 
Human 
cystB 
1 
6 
7 
5 
8 
3 
5 
4 
6 
7 
5 
2 
9 
2 
2 
6 
9 
4 
4 
-
98 
Bovine 
stefin 
C 
-
5 
5 
4 
7 
4 
5 
7 
8 
7 
5 
3 
9 
2 
4 
6 
12 
3 
3 
1 
101 
CystC 
4 
9 
7 
8 
10 
8 
5 
7 
5 
7 
5 
8 
7 
3 
2 
8 
10 
4 
4 
-
122 
TYPE-II 
Cysts 
4 
5 
5 
5 
7 
5 
4 
8 
12 
8 
2 
8 
4 
1 
6 
8 
7 
6 
6 
2 
113 
Chicken 
cyst 
4 
12 
5 
5 
7 
5 
4 
6 
9 
7 
1 
8 
7 
2 
6 
10 
9 
5 
5 
1 
116 
CystF 
s 
6 
6 
9 
5 
3 
4 
7 
5 
6 
6 
4 
7 
10 
2 
4 
12 
11 
3 
3 
2 
118 
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residues, the predicted hydrophilic residues are considered to be on the 
surface where as hydrophobic regions are internal. Each sequence possesses 
a large N-terminal hydrophilic region (55-70) followed by another large 
hydrophilic region at C-terminus. The secondary structure of human cystatin 
C in solution is very similar to that reported for chicken cystatin 
(Dieckmann et al., 1992). The crystalline form of chicken cystatin has been 
reported by Bode et al (1988). Both human cystatin C and chicken cystatin 
as well as family 1 cystatins A and B (Martin et al., 1994; 1995; Stubbs et 
al., 1990) consist of five stranded anti-parallel P-pleated sheets which is 
wrapped around a straight five turn a-helix (Fig 1.2). An appending segment 
of partial a-helical geometry is present in chicken cystatin (Saxena and 
Tayyab, 1997) which was not found in human cystatin C by X-ray 
diffraction (Bode et al., 1988). The conformation of this region seems to be 
closer to that found for chicken cystatin in solution which consists of two 
loops (Dieckmann et al., 1993). The N-terminal segment up to Val 10 is 
flexible, similar to that of other cystatins (Dieckmann et al., 1993; Martin et 
al., 1995). Trp was found only in the second hairpin loop of cystatins (Bode 
etal., 1988). 
The three dimensional structure of stefin A and B is shown in Fig 1.3 
A and B. Stefins have a well defined globular fold consisting of five 
antiparallel p strands wrapped around a central five turn a helix. There is 
considerable similarity between the structural features of stefins A and B, 
but there are also some important differences in the regions which are 
fundamental to proteinase binding. The difference consist primarily of two 
regions of high conformational heterogeneity in free stefin A which 
correspond in stefin B to two of the components of the tripartite wedge that 
docks in to the active site of target proteinases. These regions which are 
mobile in solutions are the five N-terminal residues and the second binding 
loop. In the bound conformation of stefin B they form a turn and a short 
helix, respectively 
Circular Dichroism and computer prediction of secondary structure 
from the sequence indicates that the chicken cystatin has about 20% a-helix. 
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Fig 1.2 3D structure of typical type 2 cystatins and its 
secondary structural elements 
The structure contains a large proportion of p-strands, which 
form a p-pleated sheet that is wrapped around a central a 
helix. N-terminal is exposed to the surface. Letters represent 
the conserved amino acid residues in the binding surface. 
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Fig 1.3 Three dimensional structure of stefins 
Ribbon representation of the minimized average structure of 
stefins , illustrating the 5-stranded antiparallel P sheet 
wrapped around the central a helix with the C-terminal loop 
running along the convex face of the sheet. 
(A) Sructure of stefin A 
(B) Structure of stefin B 
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42% p-structure and 24% p-turn and 12% random coil (Schwabe et al., 
1984). Janowski et al (2001) proposed that human cystatin C undergoes 
dimerization under mild denaturating conditions. NMR studies revealed that 
the majority of the proteins are not affected by dimerization, however, the 
CP binding site is significantly affected (Ekiel et al., 1997) which accounts 
for the activity loss (Abrahamson, 2001). Hence, it is concluded that 
hydrophobic CP binding site is involved in the monomer-monomer contact. 
The dimerization may be relevant to regulation of cystatin C inhibitory 
activity in vivo (Abrahamson, 2001). Three dimensional swapping studies 
indicate the dimerization of human cystatin C to be a step towards protein 
oligomerization (Janowski et al., 2001). 
INHIBITION OF PROTEASES 
Specificity 
Cystatins inhibit proteinases which have cysteine at their active sites. 
No example of serine, aspartic or metalloproteinase or non-proteolytic 
enzymes being inhibited by cystatins is available. Tests that have been 
reported include those of cystatin A and B with trypsin, chmotrypsin, 
pancreatic elastase, cathepsin G and thermolysin (Green et al., 1984). The 
available data indicates that all cystatins inhibit CP of papain superfamily 
including papain, chymopapain, papaya proteinase III, ficin, actinidin and 
the lysosomal CP, cathepsin B, H and L. 
Among type 2 cystatins, chicken cystatin has been shown to inhibit 
papain, ficin, chymopapain, papaya proteinase III, actinidin and cathepsin B, 
H, L and N (Fossum and Whitaker, 1968; Barrett 1985; Etherington, 1976), 
cystatin S inhibits papain and ficin (Isemura et al., 1984b). Cystatin M 
inhibits papain (Sotiropoulou et al., 1997). Papain and cathepsin B are 
inhibited by cystatin E (Ni et al., 1997). Cystatin F inhibits papain and 
cathepsin L but not cathepsin B (Ni et al., 1998). Cystatin D inhibits 
cathepsin L, H and S but not cathepsin B (Balbin et al., 1994). The low 
molecular weight cystatins- cystatin B (Kominami et al., 1982b), chicken 
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cystatin (Johnson et al., 1984), human amniotic fluid cystatin (Rohrlich et 
al., 1985) do not inhibit the calpains. 
Partial inhibition of colstripain by human cystatin A and chicken 
cystatin but no inhibition of streptococcal cysteine proteinase were reported 
by Green et al (1984). Clostripain was not inhibited by cystatin S (Isemura 
et al, 1984b). Cystatins also inhibit exopeptidases. Keilova and Tomasek 
(1975) showed that chicken cystatin inhibits dipeptidyl peptidase I. This 
proteinase is also known to be inhibited by human cystatin A, B, C and S 
(Green et al., 1984; Barrett et al., 1984a; Isemura et al., 1986), cystatin a 
(Jarvinen and Hopsu-Havu, 1975) and cystatin P (Kominami et al., 1982a). 
Inhibition of lysosomal carboxypeptidase B by cystatin P was reported by 
Kominami et al (1982a). 
Kinetic Behaviour 
The cystatins are the first group of protein inhibitors of C? for which 
the mechanism of inhibition was investigated. Cystatins are a group of 
potent, non covalent, tight binding and reversible inhibitors of CP of papain 
superfamily (Barrett, 1987; Ekiel et al., 1997). Some of the reported values 
of Ki are presented in Table 1.2a. It can be seen that the inhibition constants 
extend down at least as far as 5x10''^ M. Inhibition of cathepsin B tends to 
be weaker than that of papain and cathepsin H and L, except with cystatin C 
which is a strong inhibitor of cathepsin B. Some estimates of individual 
association and dissociation rate constants are given in Table 1.2b. 
Reactive site 
The reactive site of the folded, native cystatin molecule could 
obviously involve parts of the molecule well separated in primary sequence. 
The elucidation of the crystallographic structure of cystatin/enzyme 
complexes classified the precise location of the reactive site. The central 
region of the sequence contains the highly conserved block, usually Gin— 
Val-Val-Ala-Gly at 53-57, Gin 53 and Gly 57 is common to all the cystatins. 
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TABLE-1.2 a: Ki VALUES FOR INHIBITION OF CYSTEINE 
PROTEINASES BY LOW Mr CYSTATINS 
Enzymes 
Papain 
Cath.B 
Cath.H 
Cath.L 
Dipeptdyl 
Peptidase I 
Cath.S 
A' 
0.019 
8.2 
0.31 
1.3 
33 
nd 
B* 
0.12 
73 
0.58 
0.23 
0.23 
nd 
C* 
0.005 
0.25 
0.28 
0.005 
3.5 
nd 
D" 
0.9 
1000 
8.5 
25 
nd 
0.24 
F* 
1.1 
-
-
0.31 
nd 
nd 
E" 
0.39 
32 
0.064 
nd 
nd 
nd 
Chicken 
cyst 
0.005 
1.7 
nd 
0.019 
nd 
0.35 
Bovine 
Stefin 
0.18 
>100 
nd 
0.0065 
nd 
nd 
Puff 
adder 
0.1 
2.7 
0.23 
nd 
0.23 
nd 
TABLE-L2 b: RATE CONSTANTS FOR THE INTERACTION 
OF CYSTATINS WITH THIOL PROTEINASES 
Enzymes 
Papain 
Cath. B 
Ficin 
Dipeptidyl 
Peptidase I 
Inhibitor 
Chickien cystatin 
Bovine cystatin B 
Bovine stefin C 
Chicken cystatin 
Chicken cystatin 
Chicken cystatin 
K»ss 
IxlO' 
6.3x10* 
1.8x10** 
1.4x10** 
4.3x10* 
l.OxlO' 
Kdiss 
<5.0xlO"^ 
7.7x10"* 
-
2.3x10* 
nd 
2.2x10"^ 
Reference 
Nicklin & Barrett, 1984 
Nicklin& Barrett, 1984 
Nicklin & Barrett, 1984 
Niclin& Barrett, 1984 
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The inhibitory kininogen segments and the neighboring residues also show 
strong tendency to conserve this type of sequence. In chicken cystatin this 
type of sequence is QLVSG instead of QVAAG (Barrett et al., 1986a; 
Barrett 1987). Residues 60-62 are all uncharged generally with large 
hydrophobic side chains in the small cystatins. 
The C-terminal part of the sequence tends to be very varied, although 
Cys 71 and Tyr 100 are conserved in the large majority of sequences. There 
also appear to be deletions and insertions in the C-terminal segment that 
suggest variability in structure but the disulphide bonds presumably stabilize 
the folding of these segments in cystatins of type 2 and 3. Chicken cystatin 
has Trp 104 as the reactive group during the interaction with CP. All other 
type 2 cystatins also contain the conserved second hairpin loop around Trp 
104. Estrada et al (1998) emphasized the role of Gly 4 of human stefin A 
(cystatin A) in the binding of target proteins. Even the smallest replacement 
by the site directed mutagenesis by Ala resulted in approximately 1000, 10 
and 6000-fold decreased affmities for papain, cathepsin L and cathepsin B, 
respectively. As the side chain of substituted amino acid residue become 
more bulky, the inhibitory activity of the variant markedly decreased. 
The single residue, Cys 3 of human and bovine cystatin B has 
appreciable importance for inhibition of CP in particular, cathepsin B (Pol 
and Bjork, 2001). The contact residue in the second hairpin loop, Leu 73 and 
His 75 were replaced by Gly and resulted in appreciably reduced affinities 
for papain and cathepsin H and B. These two residues contribute 20-30% of 
the free energy of binding of cystatin B (Pol and Bjork, 2001). Replacement 
of the contact residue in the C-terminal end, Tyr 97, with Ala resulted in 
loss of affinity for papain and cathepsin H and L. All affinity decreases were 
due to increased dissociation rate constants (Pol and Bjork, 2001). 
Cystatins form tight equimolar complexes with CP (Anastasi et a!., 
1983; Nicklin and Barrett, 1984). Kominami et al (1982b) concluded that the 
binding ratio between cystatin p and rat cystatin H is 1:1 on the basis of the 
titration of the active site of proteinases. Nicklin and Barrett (1984) found 
that the dipeptidyl peptidase I and papain competed for binding to single 
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binding site of cystatin, contrary to a previous report (Bjork et al., 1989). In 
a separate experiment cathepsin B was also shown to compete for binding to 
the same site too (Nicklin and Barrett, 1984). 
MECHANISM OF INTERACTION OF CYSTATINS WITH 
PROTEINASES 
It has been established that no disulphide bond is formed between the 
active site cysteine residue and the inhibitor because complexes dissociate 
when denatured with out reduction as was found in chicken cystatin (Nicklin 
and Barrett, 1984) and Kininogens (Gounaris et al., 1984). Carboxymethylation 
of enzyme and inhibitor does not prevent complex formation (Anastasi et al., 
1983). It became clear that complex formation is reversible, competitive and 
non-covalent with substrate. The nature of interaction resembles the 
standard mechanism of inhibition described by Laskowski and kato (1980). 
The active site of papain in complex with chicken cystatin is unreactive with 
5, 5'-dithio-bis-(2-nitrobenzoic acid) at pH 8.0, 2, 2'-dipyridyl disulphite and 
iodo["'C] acetate at pH 4.0 (Nicklin and Barrett, 1984). The complex 
formation is accompanied by pronounced spectroscopic changes (Bjork et 
al., 1989). 
The mechanism of inhibition of papain by chicken egg white cystatin 
has been extensively studied. Bode et al (1988) proposed a model for the 
interaction of cystatin with CP based on X-ray crystal structure of chicken 
cystatin and subsequent studies based on docking experiment. Three parts of 
the inhibitor are in close contact with the active site cleft of papain, the 
amino terminus with conserved Gly-9, a first hairpin loop (53-57) containing 
the prototype sequence, QVVAG (Barrett et al., 1986; Barrett, 1987) and a 
second hairpin loop (residues 102-107) containing conserved trp 104. Bode 
et al (1988) demonstrated that the major contribution is from the first hairpin 
loop containing the QVVAG sequence (Turk, 1985). According to the model 
the N-terminal segment of cystatin which is more flexible bridges over the 
active site Cys 25 residue of papain without completely burying it and 
additionally the side chain of Leu 8 binds to S2 sub site of papain which 
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determines the substrate specificity of papain (Asboth et al., 1988). The side 
chain groups of QLVSG segment of chicken cystatin make the most intimate 
contacts with putative Si subsite of papain (Fig 1.4). This explains the 
presence of Gly 9 in close vicinity of but not in direct contact with Cys 25 of 
papain. Removal of Leu 7 and Leu 8 leads to an approximately 5000 fold 
lower affinity for papain (Asboth et al., 1988). 
This was supported by Brzin et al (1984) who demonstrated that the 
truncated form of human cystatin C starting with Leu-Val before Gly-11 
(corresponding to Gly-9 of chicken cystatin) has virtually the same affinity 
for papain as the full length form whereas the truncated form starting with 
Gly-12 has been reported to show 1000 fold weaker inhibition (Abrahamson 
et al., 1987). However, Nycander and Bjork (1990) emphasized the role of 
Trp-104 in the inhibition of CP. According to their model, Trp-104 of 
cystatin interacts primarily with two tryptophan side chains in the active site 
cleft of papain, Trp 177 and trp 181, in such a manner that the indole ring of 
Trp-104 stacks on the side chain of Trp 177 and the edge lies on the indole 
ring of trp 181. 
A two step mechanism of inhibition of the lysosomal CP cathepsin B 
by its endogenous inhibitor cystatin C was observed by Nycander et al 
(1998). An initial weak interaction in which N-terminal of the inhibitor 
binds to the proteinase is followed by a conformational change. 
Subsequently, the occluding loop of the proteinase that partially obscures 
the active site is displaced by the inhibitor bringing about another 
conformational change. The presence of occluding loop of cathepsin B 
renders it much less susceptible to inhibition by cystatin than other 
proteinases. A similar two step binding of cystatin A to the CP was 
suggested by Estrada and Bjork (2000). The flexible N-terminal region of 
the cystatin binds independently to the target proteinases after the binding of 
hairpin loops. 
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Fig 1.4 Scheme of proposed model for the interaction of chicken 
cystatin with papain 
Interaction of chicken cystatin with papain has been 
illustrated. 
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BIOLOGICAL ROLE OF CYSTATINS 
Cystatins constitute a powerful regulatory system for endogenous 
cysteine proteinases which are often secreted or leaking from the lysosomes 
of dying or diseased cells (Ekiel et al., 1997). These proteinases may 
otherwise cause uncontrolled proteolysis and tissue damage. It is established 
that imbalance between these endogenous inhibitors and thiol proteinases 
have been associated with different diseases. Thiol proteinase activity is not 
normally measured in body fluids however, it has been detected 
extracellularly in conditions like endotoxin induced sepsis (Abrahamson, 
1994), metastasizing cancer (Koppel et al., 1994) and local inflammatory 
processes such as rheumatoid arthritis (Gabrijeleic et al., 1990; Trabandt et 
al., 1991), purulent broncheictasis (Buttle et al., 1990), periondontitis (Lah 
et al., 1993) renal failure (Kabanda et al., 1995), Alzheimer's disease 
(Nakamura et al., 1991), multiple sclerosis (Bever et al., 1995) and in 
muscular dystrophy (Sohar et al., 1988) which indicates that a tight enzyme 
regulation by cystatin is a necessity in the normal state. 
Cystatins are amyloid forming proteins and form highly stable, 
domain swapped dimmers at physiological protein concentration (Staniforth 
et al., 2001). Domain swapping is a means of generating very strong 
intermolecular interactions and is a good candidate for the connections 
between protofilaments in a fibril. The cystatin folded units with in domain 
swapped dimmers have the appropriate dimensions to constitute the electron 
dense region of protofilaments, and would represent p rich surface for 
propagation into a continuous P structure proposed in fibers. Both stefins A 
and B are also reported to form amyloid fibers. The amyloid fibrils of both 
stefins share common structural features characteristic of other amyloid 
fibrils (Jenko et al., 2004). 
The abundance of cystatin A selectively in squamous epithelial cells 
and PMN leucocytes contrasts strongly with the general distribution of 
cystatin B and suggests a specific function connected with these types of 
cells. These cells are in the front line of defense against invading pathogens 
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and parasites, many of which use CP in entering the body (North, 1982). 
Hibino et al (1980) demonstrated production of cystatin a in the upper 
spinous or granular cells that become keratinized. Fukuyama et al (1982) 
have also suggested that cystatin o is involved in the differentiation of 
epidermis on the basis of electron microscope immunolocalization work. 
Hopsu-Havu et al (1981) demonstrated auto antibodies to cystatin A in 
patients with a variety of dermatological conditions like dermatitis and 
psoriasis. Auto antibodies may be produced when the inhibitor leaks in the 
blood serum following damage to the epidermis and dermis. Cystatins have 
also been implicated in other inflammatory reactions in the skin (Hayashi et 
al., 1975). Alaviakko et al (1985) reported that one or two cases of AIDS 
showed profound alterations of dendritic reticulum cells revealed by 
localization of cystatin A. 
A role of type I cystatins have also been considered in connection 
with the control of turnover of myofibrils in the cytoplasm of muscle fibers. 
The degradation of myofibrils in the cytoplasm of muscle cells is probably 
mediated by CP and can be modified by low Mr inhibitors. Spanier and Bird 
(1982) indicated that the levels of cystatin decreases in the guinea pig with a 
nutritional muscular dystrophy induced by vitamin E deficiency. Cystatin A 
level increases in patients with cardiovascular diseases, sarcoidosis and 
hepatic cirrhosis (Hopsu-Havu et al., 1983b). The concentration of cystatin 
B increases in patients suffering from inflammatory diseases and kidney 
failure (Hopsu-Havu et al., 1982; 1985a). 
Human stefin A is expressed predominantly in epithelial tissues and 
in leucocytes, while stefin B is more equally distributed. Selective 
distributions of stefin A in tissues that form the first line of defense against 
pathogens suggest its possible protective function (Barrett et al., 1986a). 
Both inhibitors have important role in certain disease states. Lower 
expression of stefin A may play a key role in tumor invasion, whereas stefin 
B concentration increases above normal in the macrophages of lung cancer 
patients (Lah et al., 1990). Recently a defect in the stefin B (cystatin B) gene 
was found to be directly correlated to myoclonus epilepsy (Pennacchio et al., 
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1996; Lalioti et al., 1997) which points to the important role of this inhibitor 
in the central nervous system (CNS). 
Some reports tend to implicate lysosomal CP in the malignancy 
suggesting that they may contribute to the nutrition of tumor cells, to the 
destruction of connective tissue elements, in invasion and sloughing off of 
the metastatic cells in to the circulation (Strauli et al., 1980; Sloane and 
Honn, 1984). Fvuthermore, the role of cathepsins and their inhibitors in 
various types of cancers has been investigated (Sloane et al,, 1994). Nishida 
et al (1984) have reported that cells of human malignant melanoma cell line 
released cystatin like inhibitor in to their culture medium 
Recent observations indicate that some pathogens produce proteins 
homologous to cystatin that are capable of suppressing the host immune 
response against the pathogen through interference with the MHC class II 
restricted antigen processing in the antigen presenting cells of infected host. 
This type of pathogen induced immunosupression is exemplified by Bm-CPI-2 
protein, a cystatin homologue secreated by the filarial parasite Brugia malayi, 
which inhibits the MHC class II restricted antigen processing via direct 
inhibition of multiple lysosomal cysteine proteases including cathepsins S, L 
and B and legumain (Manoury et al., 2001). The concentration of cystatin C 
may be elevated in the serum of patients suffering fi-om autoimmune diseases, 
lupus erythematosus and glomerulonephritis (Brzin et al., 1984). 
Certain genetic disorders are linked to mutation in cystatin gene. In 
Icelandic hereditary cystatin C amyloid angiopathy, a mutation in the cystatin C 
gene (CSTC) causing a single substitution (L68Q) in cystatin C gene is coupled 
to decreased concentration of this major CPI in CSF, and leads to amyloid 
deposition in almost all tissues including the cerebral arteries (Pennacchio et 
al., 1998; Grubb, 1990). This deposition results in fatal cerebral hemorrhage in 
young non hypertensive adults. Another pathological condition has been 
implicated due to the decrease in CSF cystatin level i.e, Guillain-Barr 
syndrome, chronic inflammatory demyelinating polyneuropathy and multiple 
sclerosis. In these groups of patients, high cathepsin B activity was observed in 
CSF (Nagai et al., 2000). Kos et al (1997) pointed out that the cystatin C level 
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in the sera of advanced melanoma patients increases owing to higher levels of 
cathepsins B and H in these patients. Differently truncated forms of cyststin C 
are found in the urine of patients with nephrological disorders (Popovic et al., 
1990). 
Moreover, cystatins play additional role in human defense by being 
the members of non-immune defense system of the body against microbial 
invasion (North et al., 1990). Cell culture shows that the chicken cystatin, 
human cystatin C and D inhibit the replication of polio (Korant et al., 1985) 
and coma virus (Collins and Grubb, 1991), respectively. Antibacterial 
activity of peptidyl derivative, cyclopeptides structurally based upon the 
inhibitory sequence of human cystatin C was reported by Kasprzykowski et 
al (2000). It was active against Streptococcus pyrogens and Staphylococcus 
aureus. 
Different reports suggest possible clinical applications of these 
proteins for prediction of prognosis (Duffy et al., 1996). Serum cystatin C 
can be used as a marker of GFR in patients with various renal diseases 
(Newmann et al., 1995). 
UNFOLDING AND REFOLDING STUDIES 
Biological activity of the proteins is strictly related to the three 
dimensional structure which is assumed to depend in principle, only on the 
primary structure of protein. The transformation of a newly synthesized 
protein on ribosomes to a functionally active form, involves complex and 
intricate process of folding. The information for the folding of a disordered 
structure of protein lies in its amino acid sequence (Anfinsen 1973). The 
identification and characterization of intermediates during the folding 
process is central to understand the process of protein folding. These studies 
provide an insight to the mechanism of how and when different forces come 
into play in directing the protein folding (Wulthrich 1994; Ballery et al. 
1993). The mechanism by which proteins fold from a denatured structure 
less state to their biologically active form is an intricate process (Nolting et 
al., 1995; Plaxo and Dobson 1996). Recent technological progress especially 
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in the field of biophysical studies has helped to show the presence of 
intermediate states during folding and unfolding pathway (Ptitsyn 1994; 
Radford and Dobson 1995). These intermediate states or partially unfolded 
states have been studied for several proteins (Christensen and Pain 1991). 
Characterization of these conformational transitions has helped in 
understanding the phenomenon of protein folding (Kim and Baldwin 1990; 
Redfield et al., 1994). 
It has been shown that the amount of tertiary structure and the 
compactness of intermediate state vary form one protein to another 
(Kuwajima 1989). These intermediate states have structures either close to 
the native state or unfolded state depending upon the protein being studied 
and experimental conditions used. Therefore besides presence of molten 
globule states from N *-• D folding/unfolding transition, there exist 
transition states between native and molten globule states or between molten 
globule and unfolded state (Redfield et al., 1994; Ptitsyn 1995). 
Characterization of such states can be of utmost importance in further 
understanding the protein folding phenomenon. There are various ways of 
studying protein stabilization, for example, denaturation by GdnHCl, urea 
and Acid denaturation. Protein folding is based on the interaction of 
relatively short stretches of the peptide back bone to form complex 
structures. Much of what is currently known about protein folding and 
stability has been observed from theoretical and experimental investigation 
in small, monomeric proteins and protein domains ranging from 50-150 
amino acids in size. Unfolding and refolding studies using chaotropic agents 
have given a wealth of information on the structure and biogenesis of 
proteins (Tanford, 1968). Solvent denaturation studies on monomeric 
proteins have been extremely rewarding in understanding protein structure. 
Studies on a number of monomeric proteins have helped in elucidating 
many important factors in protein folding reactions. It has been established 
that electrostatic interactions, the hydrophobic effect (Schreiber and Fersht, 
1995) hydrogen bonding (Koh et al., 1997), folding nuclei (Mirny and 
Shakhnovich, 1999) and partially folded intermediates (Chamberlain and 
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Marqusee, 2000) play important role in the process by whicli a single 
polypeptide chain acquires its secondary and tertiary structure. 
Denaturant induced structural studies 
It is well known that proteins unfold under the action of denaturants 
like GdnHCl and urea. Analysis of solvent denaturation curves using these 
reagents can provide a measure of the conformational stability of a protein 
(Pace, 1986; Yao and Bolen, 1995). Despite the wide spread work in this 
front, description of the interaction of GdnHCl and urea with proteins is not 
complete owing to the complex structures of folded proteins. Our current 
understanding of the protein folding/unfolding mechanism is the result of 
intense studies on denaturation of proteins using both theoretical and 
biophysical methods (Wuthrich, 1994; Ballery et al., 1993). Study of 
denatured states provides an insight to understand the mechanism of 
unfolding. The development of broad range of techniques has led to the 
characterization of stable intermediates in several proteins (Barrick et al., 
1994). 
Unfolding of small compact proteins is defmed well by a simple two 
state transition, however, it has been pointed out that the two state model is 
often too simplified version of a more complex unfolding pathway which 
includes the formation of a metastable intermediates (Kuwajima, 1989). It is 
now accepted that unfolding/refolding of a number of proteins involves 
different steps, that is under different conditions different states have been 
observed that do not appear to be native or completely unfolded (Tanford, 
1968). When transitions were analyzed by different spectroscopic probes, 
intermediate states have been found for several proteins like bovine and 
human carbonic anhydrase p (Wong and Tanford, 1973; Jagannadham and 
Balasubramanian, 1985), P-lactamase (Mitchinson and Pain, 1985), bovine 
growth hormone (Brems et al., 1985) and a chemically modified form of 
human growth hormone (Brems et al., 1990). There are various reports 
available which have shown different effects of GdnHCl and urea on protein 
unfolding like Mushroom Tyrosinase which shows different behavior towards 
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GdnHCl, urea and SDS in terms of different transition processes for these 
denaturants (Park et al., 2003). Kinetic parameters in these cases have shown 
different unfolding pathways. In case of RNase from Rhizopus stolonifer it 
has been shown that at pH 5.0 urea has a D (1/2) (D-represents concentration 
at mid point of transition) value of 5.7M where as GdnHCl has a D (1/2) value 
of 3.1 M (Deshpande et al., 2003). For methanol dehydrogenase, inactivation 
is observed at IM GdnHCl or 6M urea and fluorescence maximum is observed 
at 5M GdnHCl or 8M urea (Wang et al., 2000). 
Though the partially folded forms of various proteins have been 
characterized, it has not yet been possible to generalize the concept of 
'intermediate states' as universal equilibrium protein folding intermediates. 
However characterization of protein folding intermediates is helpful in 
identifying and understanding various transition steps and forms located 
between native and denatured states of a protein (Goto et al., 1990; 1993). 
The investigation of presence of intermediate states in HPC in present study 
is important as these states explain the hierarchy of protein folding. 
Acid induced structural studies 
A number of proteins are known to show the presence of intermediate 
states having a compact secondary structure during their equilibrium 
unfolding transitions (Barrick and Baldwin 1993). In case of acid -
denaturation the major intermediate in protein folding has been found to 
represent the 'molten globule' state (Kuwajima 1989; Fink et al. 1994; Goto 
et al. 1990). The characteristic features of molten globule state are (a) it is 
less compact than the native state (b) it is more compact than the unfolded 
state (c) it contains extensive secondary structure and (d) it has loose 
tertiary contacts without tight side chain packing (Kuwajima 1989; Dobson 
1994). Recently increasing evidences support the idea that the molten 
globule may possess well defined tertiary contacts (Song 1998; Wu and Kim 
1998; Shortle and Ackerman 2001). Protein in the molten globule state 
contains high level of secondary structure, as well as rudimentary native like 
topology. Thus the structural similarity between native and molten globule 
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state has significant bearing in understanding the protein folding problem 
(Bai et al. 2001). The molten globule of lysozyme has been shown to be the 
precursor for amyloid formation (Booth et al. 1997) and certain disease 
related mutations have been found to convert native proteins into a molten 
globule like conformation, often associated with a loss of function (Zhang 
and Peng 1996). 
Acid denaturation results in a denatured state that is often less 
unfolded than the completely unfolded form obtained in high concentration 
of urea and GdnHCl (Rashid et al. 2005). In acid denaturation the major 
driving force for unfolding is intramolecular charge repulsion which may 
fail to overcome interactions that favour folding such as hydrophobic forces, 
disulphide bonds, salt bridges and metal ion protein interactions. To 
investigate this effect HPC was acid denatured. 
Effect of Alcohols on the refolding of proteins 
Alcohols exert several distinct effects on proteins and have been 
commonly used to study partially folded states in proteins, thus it helps in 
understanding the protein folding mechanism (Shiraki et al. 1995; 
Schonbrunner et al. 1996). Binary mixtures of water with alcohols like 
methanol, ethanol or 2, 2, 2-trifluoroethanol (TFE) denature the tertiary and 
the quaternary structures of proteins while enhancing their helicity (Radford 
et al. 1995). Alcohols promote local polar interactions and hydrogen bonds 
in proteins, at the same time weakening non-local hydrophobic interactions 
(Dill et al. 1995; Liu and Bolen 1995). 
Molten globule formation in presence of TFE has been reported for 
several proteins (Shiraki et al. 1995). TFE is a preferred choice in protein 
folding studies because of its effectiveness in stabilizing the a-helical 
structures. The secondary structures formed in presence of TFE are assumed 
to reflect conformations that prevail during the early stages of protein 
folding (Hamada et al., 1995). Therefore to identify transition states present 
between N—»^  MG state or MG—»^  D state and characterization of molten 
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globules formed under various conditions holds importance and have been 
investigated for HPC. 
Effect of Polyols and Salts on the refolding of proteins 
The stability of proteins in the salt solutions is the major concern of 
biologists and pharmacologists. The more in depth knowledge of protein 
denaturation and refolding is central in selection of a particular solvent for 
protein stabilization. 
Under conditions of low pH it has been shown that several proteins 
have compact structure with native like secondary structure and largely 
disordered tertiary structure, that is, the characteristics of molten globule 
(MG) state which is considered to be a general intermediate in the protein 
folding pathway of proteins (Kuwajima 1989; Ptitsyn et al., 1990). Polyols 
and Salts have been used for stabilization of proteins in various studies 
(Timasheff et al., 1989). Polyols are one of the groups of osmolytes that are 
able to stabilize proteins (Sola-Penna et al., 1997; Sola-Penna and Meyer 
Fernandes 1998). The effects of various polyols such as ethylene glycol, 
glycerol, erythritol, xylitol, sorbitol and inositol has been studied on the 
structure of acid unfolded horse cytochrome C at pH 2,0 in order to address 
the contribution of hydrophobic interactions to the stability of molten 
globule state of proteins. The importance of charge repulsion to the stability 
of acidic molten globules has been suggested by Goto and Fink (1989). 
Salts effect mainly the electrostatic and hydrophobic interactions in 
the protein molecules. In the presence of salts a conformational transition at 
acidic or alkaline pH from a largely unfolded state to an intermediate 
conformational state has been reported for several small globular proteins 
(Fink et al., 1994; Goto et al., 1990, Babu and Bhakuni 1997). The main 
forces unfolding the protein under extreme pH conitions are the repulsive 
forces between charged groups on the protein molecule. Under these 
conditions the presence of higher salt concentration will have two effects on 
the protein conformation. The Debye-Huckel screening effect, i.e. the 
counter ions presence around the charged groups will weaken the repulsion 
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thus permitting the other forces favoring folding to become relatively 
strengthened and resulting in the folding of the protein. In addition of this 
non-specific effect of salts, specific effects of salts on protein folding will 
also come into play. The stabilizing and destabilizing effects of salts on 
proteins arise either by effects on water surface, and hence hydrophobic 
interactions or by specific interactions with charged groups. 
It is well established that the effect of anions in stabilizing protein 
structure follows the Hofmeinster series (Von Hippie and Wong 1965). The 
representative series is sulphate > phosphate > fiuoride > chloride > bromide 
> iodide > perchlorate > thiocyanate. In this series the ions to the left of 
chloride stabilize the native structure of the protein, whereas anions to the 
right of chloride destabilize the native structure of proteins. Arakawa and 
Timasheff (1982) have shown that preferential hydration of protein occurs in 
the presence of salts such as NaCl, sodium acetate and sodium sulphate and 
that the resulting unfavourable free energy of the unfolded state is related to 
the stabilization effects of these salts on the proteins. Salt dependent 
conformational transition at alkaline or acidic pH may be a general property 
of proteins, however, the concentration of salt required to bring about the 
transition will depend on the particular protein being studied and the 
conditions employed. Therefore, the effects of polyols and salts have been 
studied on refolding of acid denatured HPC. 
Placenta 
In this study cystatin type 1 has been isolated and purified from 
human placenta. Placenta is an independent organ showing the properties of 
an endocrine system. It produces one or more hormones, chorionic 
gonadotropins and progesterone. It is an oval and circular flat cake 
measuring 6-8 inches (15-20 cm) in diameter, Vi -1 inch (2-2.5 cm) in depth 
at the centre, which is the thickest part and weighing about one pound. The 
margin is thinner and firmer than the centre. The fetal surface is covered 
with a thin smooth membrane - the amnion, which can be readily stripped to 
the insertion of the umbilical cord, which join the fetus with placenta. 
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Functions of Placenta 
Placenta performs the function for respiration, food absorption and 
excretion. Waste products are carried to the terminal villi and are then 
passed out to maternal blood stream. Nutrient substances (derived from fats, 
proteins and carbohydrates), minerals, vitamins and oxygen in solution pass 
in the opposite direction from mother to the fetus. The volume of maternal 
blood in the intervillus space has been given as 30-300 ml. The area of the 
placenta in contact with the maternal tissue has been estimated to be 
between 7-13 square meters. The smallest surface area and the sluggish 
circulation of the maternal blood in the placental sinuses accounts for the 
very low oxygen content of the fetal blood; but this is balanced by the 
relatively large amounts of fetal blood, its rapid circulation and the fact that 
the fetal hemoglobin is capable of taking up large volumes of oxygen at low 
partial pressure. The oxygen requirements of the quiescent fetus are low 
(Linetal., 1976a). 
There is of course normally no direct communication between fetal 
blood and the maternal blood, but they come to very close proximity during 
first half of the pregnancy. In the last half of the pregnancy blood streams 
are only separated by a placental membrane 0.002 mm thick. The placental 
membrane has shown to be unusual complex structure in the sense that it 
does not only function as the simple semi permeable membrane but it also 
varies in histological structure at different times during gestation. The 
situation is complicated by the possibility that the membrane permits some 
simple substances to pass more readily than others, it is also engaged in 
protein and carbohydrate metabolism. The thinness of the membrane 
increases as the pregnancy advances. Proteins can cross the placenta as 
unaltered molecules, many antibodies such as antitoxins; agglutinins can 
pass across the membrane. Presence of proteolytic, lipolytic, glycolytic 
oxidizing enzymes has been reported in placenta (Bohn 1976; Obiekwe et 
al., 1978). 
The specific placental proteins e.g. heat stable alkaline phosphatase, 
cysteine amino peptidase (oxytocinase), diamine oxidase (histaminase 
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placental protein 5); with smaller peptides such as ACTH and the 
gonadotrophin releasing hormone (Lin et al., 1976a; Bohn 1976; Obiekwe et 
al., 1978) which ate thoroughly characterized have been found to be 
analogous of proteins present in the normal adult. There is no evidence for 
any difference from the adult product. Excellent examples of the analogues 
are provided by the protein hormones and alkaline phosphatase enzymes. 
The postulated functions of the placental proteins are of three types-
endocrine, metabolic and immunological. The best recognized endocrine 
functions of the placenta are those associated with its production of steroid 
hormones and their role in the maintenance of pregnancy. Function of the 
majority of the placental proteins has not been worked out yet. In general the 
experimental approach to elucidate biological function has concentrated on 
purification of several placental proteins (Lin et al., 1976a; Obiekwe et al., 
1978; Lin et al., 1976b). All placental proteins are synthesized by 
syncytiotrophoblastic cells present in placenta. Lysosomes present in 
cytotrophoblastic and syncytiotrophoblastic cells of placenta take part in 
intracellular degradation of proteins. Cathepsins present in these lysosomes 
constitute an important group of both endo and exopeptidases inhibited by 
cystatins (Swanson et al., 1974). 
Keeping in view the importance of cystatins in human system and 
lack of information regarding the structure and function of cystatin from 
human placenta, a thiol proteinase inhibitor was isolated and purified from 
this source. It has been characterized in detail. The structural properties of 
this protein have been investigated to work out its stability and 
conformation. 
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2. MATERIALS 
Chemicals used for the present study were obtained from the 
following sources. 
Genei Banglore, India 
Molecular weight markers-PMW-L, Fruend's Complete and Incomplete 
Adjuvants. 
Merck-Schereherdt, Germany 
2-Mercaptoethanol, magnesium sulphate, magnesium chloride, sodium 
suphate. 
Pharmacia Fine Chemicals, Sweden 
Blue dextran 
Sigma Chemicals Co. USA 
Anti-rabbit alkaline phosphatase (conjugate). Bromelain, CAPS 
buffer, Chymotrypsin, Cytochrome C, Ficin, Insulin, Papain, p-nitro phenyl 
phosphate, PVDF membrane, Ribonuclease, Sephadex G50-80, Sorbitol, 
Soyabean Trypsin Inhibitor, TFE, Trypsin. 
Qualigens Fine Chemicals, India 
Ammonium persulphate, ammonium sulphate, bromophenol blue, 
disodium hydrogen phosphate, ethyl alcohol, glacial acetic acid, glycerol, 
hydrochloric acid, methanol, isopropanol, mannitol, monosodium 
dihydrogen phosphate, potassium iodide, sodium carbonate, sodium 
chloride, sodium hydroxide, sodiun lauryl sulphate, sodium potassium 
tartarate, sulphuric acid, trichloroacetic acid, TEMED, (Tris (hydroxymethyl 
aminomethane). 
Sisco Research Lab (SRL), India 
Acrylamide, N' N' methylene bis-acrylamide, bovine serum albumin, 
casein, L-cysteine, commassie brilliant blue-R250, cytochrome C, DEAE 
cellulose, EDTA, Folin ciocalteau's phenol reagent, GdnHCl, glycine, 
phenol, Urea. 
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3. METHODS 
3.1 PURIFICATION OF HUMAN PLACENTAL CYSTATIN (HPC) 
Fresh placenta was collected from J.N. Medical College Hospital, 
AMU, Aligarh. The placental tissue (200g) was homogenized in a mixture 
(400ml) of 1% (w/v) NaCl, 2% (v/v) butanol and 3mM EDTA at A^C. The 
supernatant was collected by centrifugation at 3500g for 15 minutes at 4°C 
in a Sigma cooling centrifuge Model 3K30. 
Acid Treatment 
The supernatant was adjusted to pH 3.0 by acetic acid and then 
incubated at 60°C for 10 minutes. After the incubation the solution was 
brought to pH 6.0 with 3M NaOH. The precipitated proteins were removed 
by centrifugation at 3500g at 4°C for 15 minutes. 
Ammonium Sulphate Fractionation 
The supernatant was fractionated with 50% saturation of ammonium 
sulphate with gentle stirring at 4°C. After 4 h the precipitate was removed by 
centrifugation at 3500g for 15 minutes and the supernatant thus collected 
was made 80% saturated with ammonium sulphate. The solution was 
allowed to stand at 4°C for 10 h, the precipitate obtained by centrifugation 
(3500g for 20 minutes at 4°C) was dissolved in 10ml of 20mM sodium 
phosphate buffer, pH 6.0. The fraction was extensively dialyzed to remove 
ammonium sulphate against several changes of the same buffer at 4°C. 
Gel Filtration Chromatography 
A Sephadex G50.80 column was prepared as recommended by Peterson 
and Sober (1962). The gel was allowed to swell in sufficient amount of 
distilled water for 3h in a boiling water bath. The gel fines were removed by 
suspending the gel in two to four fold excess of 20mm sodium phosphate 
buffer, pH 6.0 and the gel was allowed to settle down. The remaining gel in 
the supernatant was rapidly removed by suction. A glass column mounted on 
a sturdy vertical support was filled to one third of its length with operating 
buffer in order to check leaks and to flush air bubbles from the dead space. 
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The deareated gel slurry was then poured with the help of glass rod in to the 
column with care to avoid generating air bubbles. The column was left 
standing' overnight. Flow rate was increased gradually and after 
accomplishing a constant flow rate higher than that required for final 
elution, the column was adjusted to the required flow rate. The packed 
column was thoroughly washed with two bed volumes of operating buffer 
(20mM sodium phosphate buffer, pH 6.0). In order to check uniform packing 
and to determine the void volume of the column, 2% (w/v) solution of blue 
dextran in 20mM sodium phosphate buffer (pH 6.0) was passed through the 
column. The volume of blue dextran and the protein solution applied was not 
more than 2-3% of the total bed volume. Fractions (5ml) were collected and 
assayed for protein and cystatin activity. Homogeneity of the preparation 
was analyzed by 12.5 % PAGE. 
3.2 COLORIMETRIC ANALYSIS 
Determination of protein concentration 
Protein was estimated by the method of Lowry et al (1951). Aliquots of 
protein solution were taken in a set of tubes and final volume was made up 
to 1ml with distilled water. Five ml of alkaline copper reagent (containing 
one part of 1% (w/v) copper sulphate and 2% (w/v) sodium potassium 
tartarate in 1% (w/v) sodium hydroxide and sodium carbonate) was added 
followed after 10 min of incubation at room temperature with 0.5 ml of 1 N 
Folin-Ciocalteu's phenol reagent. The tubes were instantly vortexed. The 
color developed was read after 30 min at 660nm against a reagent blank. A 
standard curve was prepared using BSA. Protein in the column fractions 
were also monitored at 280nm in Camspec Spectrophotometer Model 
M330B. 
Carbohydrate Estimation 
The procedure described by Dubois (1956) was followed. Two 
milliliter aliquots containing 10-70 ^g of protein was pipetted in to a set of 
test tubes and 0.05ml of 80% phenol was added. This was followed by the 
addition of concentrated sulphuric acid. The tubes were allowed to stand for 
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10 min, thoroughly mixed and again incubated for 20 min at 30°C. The color 
intensity was measured at 490 nm for the quantitation of hexose content. 
Glucose was used as standard. 
Thiol Group Estimation 
The procedure described by Ellman (1959) was followed for 
estimating the thiol groups of cystatin. SDS and P-mercaptoethanol induced 
appearance of free thiol group in the cystatin was followed by titration with 
DTNB reagent. Appropriate aliquots of 0.2ml native, SDS and p-
mercaptoethanol treated cystatin were mixed with 0.1ml of DTNB reagent 
(prepared by dissolving 40mg in 100ml of 0.05M Tris-EDTA buffer, pH 8.0) 
in a total volume of 3.1ml. The absorbance was read after 15 min at 412nm 
in Camspec spectrophotometer Model M330 B. Free thiol concentration was 
calculated from the absorbance using molar extinction coefficient of 13,600 
M"'cm'' for the released thionitrobenzoic acid. A standard plot was prepared 
using cysteine. 
Assay of Cystatin Inhibitory Activity 
Inhibitory assay of cystatin was performed as described by kunitz 
(1947). HPC was examined for its ability to prevent thiol proteinases from 
digesting casein. For determination of inhibitory activity, papain was 
activated in presence of 0.2 m EDTA and 0.5M cysteine for 10 min prior to 
incubation of papain cystatin complex for 30 min at 37°C in 20mM sodium 
phosphate buffer, pH 7.0. The enzyme inhibitor complex was further 
incubated with casein for 30 min at 37°C and the reaction was stopped by 
addition of 10% TCA. Acid insoluble material was removed by 
centrifugation at 2500rpm for 15 min. The supernatant was analyzed for acid 
soluble peptides with Folin's phenol reagent as described by Lowry et al 
(1951). Ficin inhibition was also assayed by similar method. 
Assay of Caseinolytic Activity of Bromelain 
The proteolytic activity of bromelain was measured according to the 
method of Murachi and Neurath (1960). The enzyme was activated at 37°C 
for 10 min in the presence of 20mM cysteine. Then the volume was made up 
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to 1ml by sodium phosphate buffer pH 6.0. One ml of 0.5 % casein was 
added and incubated for 30 min at ST^C. The reaction was stopped by 
addition of 1.0ml of 5% TCA. Acid insoluble material was removed by 
centrifugation at 2500rpm for 15min. The supernatant was analyzed for acid 
soluble peptides by Folin's phenol reagent by the method of Lowry et al 
(1951). 
3.3 SLAB GEL ELECTROPHORESIS 
Polyacrylamide Gel Electrophoresis (PAGE) 
Electrophoresis was performed by the method of Laemmli (1970) 
using the slab gel apparatus manufactured by Biotech, India. Concentrated 
stock solution of 30% acrylamide containing 0.8% N-N' methylene 
bisacrylamide and 1.5M Tris, pH 8.8 were mixed in appropriate portion to 
give the desired concentration of gel. It was then poured in to the mould 
formed by glass plates (8.5x10 cm) separated by 1.5mm thick spacers. 
Bubbles and leaks were avoided. A comb providing template for seven 
sample wells was inserted into the stacking gel solution before the 
polymerization began. The polymerization was complete in about 30 min 
after which the comb was removed and wells overlaid with running buffer. 
Routinely, a 12.5% acrylamide gel was used. Samples containing 40-60^g of 
protein mixed with equal volume of sample buffer (62.5mM Tris HCl pH 
6,8, 10% (v/v) glycerol and 0.001% bromophenol) as tracking dye was 
applied to the wells. Electrophoresis was performed at lOOV in the 
electrophoresis buffer containing 192mM glycine and 25mM Tris-HCl pH 
6.8 until the tracking dye reached the bottom of the gel. 
SDS Polyacrylamide Gel Electrophoresis (SDS-PAGE) 
Sodium dodecyl sulphate polyacrylamide gel electrophoresis was 
essentially performed by the Tris-glycine system of Laemmli (1970) using 
slab gel electrophoresis apparatus. Concentrated stock solution of 30% 
acrylamide containing 0.8% biscarylamide and 1.5M Tris, pH 8.8 were 
mixed in appropriate proportions to give the final required percentage. 
Protein samples were prepared in solution containing 62.5 mM Tris-HCl pH 
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6.8, 10% (v/v) glycerol, 2% (w/v) SDS, 5% (v/v) 2-mercaptoethanoI and 
0.001% (w/v) bromophenol blue. The samples were incubated at 100°C for 5 
min. Electrophoresis was performed at lOOV till the tracking dye reached the 
bottom of the gel. Running buffer used during electrophoresis contained 1% 
SDS in addition to 192 mM glycine and 25mM Tris-HCl, pH 6.8. 
Staining of the Gel 
Commassie Briliant Blue Staining 
After electrophoresis was complete the gels were removed and the 
protein bands were visualized by staining the gel with five gel volumes of 
0.25% commassie brilliant blue R-250 in 50% methanol and 10% acetic acid 
for atleast 4 hours. For destaining, the gels were incubated with shaking in 
5% methanol and 7.5% acetic acid at room temperature. 
3.4 MOLECULAR WEIGHT DETERMINATION 
The molecular weight of human placental cystatin was determined 
under native and denaturating conditions by gel filtration chromatography 
and SDS-PAGE, respectively. 
The molecular weight of native HPC was computed from its elution 
volume on a Sephadex G50-80 column (l.lx 100cm). The column was 
calibrated by determining the elution volume of some marker proteins-
Insulin (5.7KDa), Cytochrome C (12.7KDa), Ribonuclease (14KDa), 
Soyabean Trypsin Inhibitor (20.1 KDa) and Papain (23KDa). This data was 
analyzed according to the theoretical treatment by the method of Andrews 
(1964). The linear plot between Ve/Vo and logM was used for calculating the 
molecular v/eight of HPC where Ve is the elution volume of the protein and 
Vo is the void volume of the column determined by using blue dextran. 
Molecular weight of HPC under denaturating conditions was 
calculated by the procedure of Weber and Osborn (1969) using SDS-PAGE. 
The mobilities of marker proteins determined under identical conditions 
were plotted against the logarithms of molecular weight. The standard 
proteins used were Ovalbumin (43 KDa), Carbonic Anhydrase (29KDa), 
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Soyabean Trypsin Inhibitor (20.1KDa), Lysozyme (14,3 KDa) and Aprotinin 
(6.9KDa). The analysis of the data indicated a linear relationship between 
logM and relative mobility (Rm) and the plot was used in calculating the 
molecular weight of HPC. 
3.5 IMMUNOLOGICAL PROCEDURES 
Immunization of rabbits 
Antibodies against human placental cystatin were raised in healthy 
male albino rabbits. Purified inhibitor (300ngs/0.5 ml of normal saline) was 
emulsified with equal volume of Freund's complete adjuvant and injected 
subcutaneously. Two weeks later ISOngs of HPC was injected along with 
Freund's incomplete adjuvant. The injection was repeated every week and 
the rabbit was bled every second week. The blood collected was allowed to 
coagulate at 22°C for Bh.The antisera was decomplimented at 57°C for 30 
minutes and stored at -20°C in small aliquots. 
Direct binding ELISA 
The generation of antigen specific antibody was measured in the sera 
of HPC immunized rabbits by the technique of Direct binding ELISA as 
given by Voller et.al (1976). Ninety six wells of micro-titre plate (immulon 
2HB, Dynex, USA) were coated overnight with lOOul of antigen at 4°C. The 
plate was washed three times with TBS-T buffer (Tris buffered saline 
Tween-20, pH 7.4, 20mM Tris, 14.3 mM sodium chloride, 200mg potassium 
chloride and 5ml Tween 20 dissolved in IL of distilled water and pH 
adjusted to 7.4 by IN HCl). The unoccupied sites were saturated by 
incubation with 150ngs/200ml of 1.5% milk in TBS (Tris buffered saline pH 
7.4, 20 mM Tris, 150 mM sodium chloride) for 5-6 h at room temperature. 
Plates were washed twice with TBS-T. The test and the control wells were 
then loaded with I00|al of serially diluted serum. The plate was incubated 
for 2h at room temperature and then overnight at 4°C. lOO^ls of appropriate 
conjugate of anti-rabbit alkaline phosphatase (1: 3000) is coated in each well 
and kept for 2h at room temperature. After regular washing with TBS-T and 
distilled water, the substrate p-nitro phenyl phosphate (5ngs /100 ml of 
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bicarbonate buffer-pH 9.5, 50mM containing 0.02% sodium azide) was 
added in each well and incubated for 30-45 minutes. The reaction was 
stopped by addition of 100|il of 3M NaOH in each well. The absorbance of 
each well was monitored at 405nm on a Qualigens ELISA reader. 
Immunodiffusion 
Immunodiffusion was performed essentially by the method of 
Ouchterlony (1962). Agarose (1%) in normal saline containing 0.2% sodium 
azide was poured on glass plates and allowed to solidify at room 
temperature. Required number of wells was cut and the slides were stored at 
4°C. Fifteen microlitres of suitably diluted antiserum and required amount 
(60ngs) of antigen prepared in normal saline were added in different wells. 
The reaction was allowed to proceed for 12-24 h in a moist chamber at room 
temperature. The Sheep HMW Kininogen (Baba et al., 2005) and Phaseolus 
mungo cystatin (Sharma et al., 2005) used for immunodiffusion studies were 
purified in our laboratory. 
3.6 KINETICS OF INHIBITION 
Stoichiometry of Proteinase Inhibition 
Papain was used for the titration of HPC. The inhibitory activity of 
cystatin was assessed by its ability to inhibit caesinolytic activity of papain 
by the method of Kunitz (1947). The concentration of papain was varied 
from 0.01-0.06 |xM where as the inhibitor concentration was fixed at 
0.06nM. Papain was activated on incubation with 2mM EDTA and 50 mM 
cysteine for 10 min at 37°C. The inhibitor was added and the volume was 
diluted to 1 ml by 20 mM phosphate buffer, pH-7,0 and further incubated for 
30 min at 37°C. One ml of 2% caesin was added and again incubated for 30 
minutes at 37°C. The reaction was stopped by adding 1 ml of 10% 
trichloroacetic acid. After centrifugation (2500 rpm for 15 min) the acid 
soluble peptides were quantitated by the method of Lowry et al (1951). 
Identical experiments were carried out for the HPC with other proteinases, 
ficin and bromelain using casein as substrate (Kunitz, 1947; Murachi and 
Neurath, 1960). 
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Inhibiton Constant (Kj ) Determination 
Ki determination was carried out after lowering the enzyme and 
inhibitor concentration to obtain a non linearity of dose response curves. 
Thus papain was used at a concentration of 0.05 ^M to react with the 
inhibitor varying from 0.011 to 0.21 l|aM and measurement of residual 
activity was made as described by Kunitz (1947) using casein as substrate. 
Four different substrate concentrations were used that is, 0.5 Km, IKm, 
2Km and 3Km and with Km = 2.4mM and the results were analysed by the 
steady state equation of Krupka and Laidler (1959). The linear equation is 
presented as follows (Henderson, 1972). 
[I], 
1 - ^ 
V. 
" =K, 
Km 
Where [I]o, [E]o and [S]o are the initial concentration of Inhibitor, 
Enzyme and Substrate respectively. Vo is the velocity without Inhibitor. The 
plot of [I]o / (l-Vj/Vo) against Vo/Vi is a straight line, the slope of which 
gives. 
K,(app) = K, 
Km 
(2) 
True Kj was obtained from a replot of Kj (app) against [S]o . 
Determination of Association Rate Constant (K+i) 
K+i values were determined by monitoring the time-dependence of the 
association under second-order conditions. Equimolar amounts of enzyme 
and inhibitor (0.05 ^M) were mixed in a total volume of 1 ml of the same 
buffer, pH 7.5 at 37 °C and residual activity was assayed as a function of 
time after 0, 2, 5, 10, 15, 20, 25 and 30 minutes as described above using 
caesin as substrate for papain, ficin and bromelain. 
Association rate constant (K+i) was calculated assuming that Enzyme 
[E] and Inhibitor [I] react according to equation (3) and considering 
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dissociation constant (K.,) to be low enough to neglect the reverse reaction 
during the initial part of the process. 
E + l ^^L^ EI (3) 
Thus, when initial concentration of enzyme [E]o and inhibitor [I]o are 
identical the integrated form of the equation giving association rate 
becomes, 
True Ki was obtained from a replot of Ki (app) against [S]o. 
Determination of Dissociation Rate Constants (K.i) 
Conditions for maximal association between the protease and 
inhibitor were achieved before the reaction was shifted towards dissociation 
by adding either a2M which forms stable and enzymatically active complex 
with free enzymes or excess of substrate which also binds the entire free 
enzyme (Beith et al., 1980). Substrate induced dissociation was monitored 
with identical enzyme inhibitor complex incubated for 30 min at 37°C. 
Excess substrate (6% casein) was added to the mixture for different time 
periods and then assayed for their enzymatic activity. 
On the basis of eqn (3) the dissociation of EI complex obeys first 
order kinetics during the initial part of the reaction, ie, when there is almost 
complete association. In this case the integrated form of the dissociation rate 
equation is given by 
In [EI] = K.,t (5) 
.[EI]o 
From which half life of the complex may be calculated by rearranging 
the equation as follows 
ti/2= 0.693/K.1 
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Similar experiments for ki determination, association and 
dissociation rate constants were done for ficin and bromelain with HPC 
using their respective substrates. 
3.7 N-TERMINAL ANALYSIS 
The sequencing of 30 amino acid residues from N-terminal was 
carried out on Shimadzu ppsq-21 Sequencer which employs Edman 
degradation to sequentially cleave and identify amino acids starting from 
amino terminus of the protein (Edman and Begg, 1967). The highly purified 
protein was transferred to the PVDF membrane by western blotting before 
amino acid analysis. 
Western Blotting 
a. Buffers Used: CAPS buffer- 10 x stock (lOOmM, pH 11): 22.13g of 3-
[cyclohexylamino] 1-propane-sulphonic acid was dissolved in 980ml of 
deionized water and titrated with 2M NaOH (15ml) to pH 11. Deionized 
water was added to make final volume to 1 litre and the buffer was 
chilled at 4*'C before use. 
Transfer buffer- 2 litres of buffer were prepared by mixing 200ml of 
10 X stock buffer, 200ml Of methanol and 1600 ml of deionized water. 
b. Procedure: The PVDF membrane and the filter paper were cut according 
to the gel dimensions. The PVDF membrane was made wet in 100% 
methanol for 30 seconds, then soaked in distilled water for 5 min and 
then placed in a dish containing blotting buffer for 15 min. The gel, filter 
paper and fiber pads are allowed to equilibrate in transfer buffer for 15 
min to Ih depending on the gel thickness. The transblotting sand witch is 
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assembled as filter pad, filter paper, PVDF, gel, filter paper and then 
again fiber pad. After firmly closing the cassette it was locked properly 
taking care not to move the transblotting sandwitch. The cassette was 
placed in tank filled with transfer buffer completely. The lid was put and 
power supply plugged in. The blot was run at 30 V overnight. Upon 
completion of the run, the transblotting sandwitch was disassembled to 
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remove the PVDF membrane for development. The membrane was rinsed 
with distilled water and then stained with 0.1 % Comassie blue R-250 in 
10 % acetic acid and 50 % methanol for the minimum time necessary to 
visualize the band of interest. The PVDF membrane was destained for 
atleast 2h in 10 % acetic acid. After desatining, the PVDF membrane was 
rinsed in 100 % methanol and then soaked in distiller water for 15 min to 
remove the excess acetic acid and methanol. Finally the PVDF membrane 
was air dried and placed in a new sterile container till used for 
sequencing. 
Hydropathy Plot 
The hydropathy profiles were calculated using the mean segment 
approach, i.e. determining the average hydropathy with in a segment length 
of four residues, the segment being advanced one residue at a time from the 
sequence of N-terminal thirty residues (Kyte and Doolittle, 1982). 
3.8 SPECTRAL ANALYSIS 
Absorption Difference Spectra 
An ultraviolet absorption difference spectrum was measured for HPC 
(2.66^M) along with activated papian with a molar ratio of 1:1 at 25±2°C. 
Spectra were recorded by measuring the absorption between 200-350 nm on 
a Camspec spectrophotometer model M330 B in a cuvette of 1cm path 
length. Appropriate controls of the solvent buffer were run and corrections 
were made wherever necessary. 
Fluorescence Spectroscopy 
Fluorescence measurements of cystatin, papain and cystatin-papain 
complex were taken by measuring intrinsic fluorescence at 25±2°C in 
Shimadzu spectrofluorimeter model RF-540 equipped with a data recorder 
DR-3. The protein was excited at 280nm (Xex) and the emission range was 
300-400nm. l^M cystatin and 2nM of papain in a total volume of 1ml was 
used for the study. Cells with 1cm path length were used and samples were 
continuously stirred during measurements. Corrected emission spectra were 
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recorded with an excitation and emission band width of 5nm. Appropriate 
controls were run and corrections were made wherever necessary. 
Circular Dichroism (CD) Spectroscopy 
Circular Dichroism (CD) measurements were carried out at 25°C on a 
Jasco spectropolarimeter model J-720 using a SEKONIC XY plotter (model 
SPL-430 A) with thermostatically controlled cell holder attached to a 
NESLAB water bath model RTE 110 with an accuracy of ± 0.10°C. The 
instrument was calibrated with d-10-Camphorsulphonic acid. The spectra 
were recorded with a scan speed of 20nm min"' and with a response time of 
4 seconds. The concentration of inhibitor and papain for far UV-CD spectral 
analysis was SjiM and path length was 0.1 cm. Each spectrum was recorded 
as an average of five scans. The emission wavelength range was 210-250nm. 
Change in the secondary structure of HPC on interaction with activated 
papain (activated with 20mM EDTA and 50mM cysteine) at a molar ratio of 
1:1 was monitored. Commercially available papain was further purified by 
passing through Sepahadex G50.80 column (1.5x50cm. The a helical content 
of the cystatin was calculated from the MRE value at 222nm using the 
following equation (Chen et al., 1972) 
% helix = [(MRE222 - 2340)730300] x 100 
3.9 UNFOLDING AND REFOLDING STUDIES 
(A) DENATURANT INDUCED STRUCTURAL CHANGES 
Assay of Inhibitory Activity of HPC in presence of GdnHCi and Urea 
Under native conditions the inhibitory activity of HPC was assessed 
by its ability to inhibit caesinolytic activity of papain by the method of 
Kunitz, 1947. In the presence of denaturants the inhibitor (1.066nM) was 
incubated with increasing concentrations of GdnHCl (1-6 M) and urea (1-8 
M) at 25°C for 2 h before the activity was measured. Untreated HPC activity 
was taken as 100%. 
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Fluorescence Measurements in presence of GdnHCl and Urea 
The fluorescence was recorded in wavelength region 300-400 nm 
after exciting the protein solution at 280 nm for total protein fluorescence. 
The slits were set at 5nm for excitation and emission. The path length of the 
sample was 1cm. The protein concentration used in the measurement was 
2|aM. HPC in 20mM sodium phosphate buffer pH 6.0 was incubated in the 
presence of increasing GdnHCl (1-6 M) or urea concentration (1-8 M) for 2h 
at 25''C before the spectra were recorded. Appropriate controls containing 
the denaturants for the study were run and corrections were made wherever 
necessary. Each spectrum was an average of three scans. 
Refolding was also studied with the help of fluorescence 
spectroscopic measurements. HPC was completely unfolded in 6M GdnHCl 
or 8M urea for 24h and then allowed to refold by rapidly diluting the protein 
(1:50 fold) in the same buffer containing appropriate concentrations of 
GdnHCl and urea, vigorously vortexing the solution at the same time. The 
mixture was incubated for 24h before recording the spectra under same 
conditions set as above. 
Far UV-CD measurements of HPC in presence of GdnHCl and 
Urea 
Secondary structural changes of HPC on incubation with varying 
concentrations of GdnHCl (1-6M) and Urea (1-8M) was measured at 25°C. 
Each spectrum was recorded as an average of five scans. The concentration 
of HPC was 8^M and path length was 1mm. The spectra obtained were 
normalized by subtracting the base line recorded for the buffer having the 
same concentration of denaturants under similar conditions. 
(B) ACID INDUCED STRUCTURAL CHANGES 
The protein concentration was determined by the method of Lowry et 
al. 1951. ANS binding has been widely used to detect the molten globule 
states of different proteins (Stryer 1965, Engelhard and Evans 1995). A 
stock solution of ANS (10mg/5ml) in distilled water was prepared and its 
concentration was determined using an extinction ^coefficient of $(K)0M~ 
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cm ' at 350 mm (Mulqueen and Kronman 1982). The molar ratio of protein 
to ANS was 1:60. 
Conditions for acid induced denaturation 
HPC was allowed to undergo acid denaturation by subjecting it to 
buffers of varying pH range from pH 7.0 to pH 2.0. The buffers used were 
20mM solution of glycine/HCl (PH 2.0), sodium acetate (pH 3.0-5.0) and 
sodium phosphate (pH 6.0-7.0). pH measurements were carried on a Metzer 
Optical Instruments (Pvt. Ltd., India), pH meter model 603M with a least 
count of 0.01 pH unit. HPC was incubated with the respective buffer of 
desired pH at 4°C and allowed to equilibrate for 4 h before any 
spectrophotometric measurements were taken. For comparison of acid 
induced state and completely unfolded state, HPC was completely 
denaturated in presence of 6M GdnHCl, a stock solution of GdnHCl was 
made and required volume was added to the given sample of HPC to get 
final molar concentration of 6M GdnHCl. 
Spectrophotometric measurements 
Far and near UV-CD spectra of HPC at varying pH range and in 
presence of 6M GdnHCl was measured. The concentration of HPC was 23.2 
i^M for far UV-CD in the wavelength region 200-250nm in a 0.1cm path 
length cuvette and it was 80 i^M for near UV-CD in the wavelength region 
250-300 nm in a 1cm path length cuvette. 
Fluorescence measurements of HPC were taken at pH 6.0 (native 
state), at pH 2.0 (acid denatured state) and in presence of 6M GdnHCl at 
25*'C. The fluorescence was recorded in wavelength region 300-400nm after 
exciting the protein solution at 280nm for intrinsic fluorescence 
measurements. The slits were set at 5nm for excitation and emission and 
path length of the sample was 1cm. The protein concentration used was 
1 |iM. Binding of ANS to HPC in the above given conditions was studied by 
exciting the dye at 380nm and the emission spectra were recorded from 
400-600nm wavelength range with a 10 nm slit width for excitation and 
emission. ANS to protein molar ratio of 1:60 was used for each respective 
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measurement. Each fluorescence spectra was recorded as an average of five 
scans. 
Effects of alcohols, polyols and salts on the refolding of acid-
induced state of HPC 
Conditions for refolding of HPC 
The spectrophotometric analysis of refolding of acid denatured HPC 
was done under following set of conditions 
(I) HPC was allowed to refold in presence of increasing concentration 
(0-80 % v/v) of alcohols, TFE and methanol by adding requisite volume of 
each alcohol to study the stability effect of increasing concentration of 
alcohols on conformation of acid denatured HPC at pH 2.0. The effect of 
TFE and methanol was studied in 20mM glycine/HCl buffer, pH 2.0 and at 
25°C. The concentration of TFE and methanol used was 0-80% (v/v) and 0-
50% (v/v), respectively. 
(II) Polyols (glycerol and sorbitol) and salt solutions (magnesium 
sulphate, sodium sulphate and magnesium chloride) were freshly prepared 
for each study with a volumetric adjustment of concentrations. The effect of 
polyols (glycerol and sorbitol) and salts (magnesium sulphate, sodium 
sulphate, magnesium chloride) as a function of increasing concentration in 
20mM glycine/HCl buffer, pH 2.0 at 25°C was studied. Glycerol and sorbitol 
were used in the concentration range up to 80% (v/v) whereas salt 
concentrations used were restricted by the maximum stability of HPC in 
each salt solution. Sulphate salts were used up to concentration of 1.5 M 
whereas MgCh was used up to 3 M concentration for the respective protein 
stability studies. 
Spectrophotometric measurements 
Far and near UV-CD spectra of HPC at above mentioned conditions 
were measured. The concentration of HPC was 23.2 |iM for far UV-CD in 
the wavelength region 200-250nm in a 0.1cm path length cuvette and it was 
80 p,M for near UV-CD in the wavelength region 250-300 nm in a 1cm path 
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length cuvette. Each spectrum was recorded as an average of five scans. The 
spectra obtained were normalized by subtracting the base Hue recorded for 
the buffer having the same concentration of alcohols, polyols and salts under 
similar conditions. 
Refolding of acid denatured state of HPC was studied in terms of 
fluorescence measurements, at pH 6.0 (native state), at pH 2.0 (acid-induced 
state) and in the presence of alcohols (TFE, methanol), polyols (glycerol, 
sorbitol) and Salts (magnesium sulphate, sodium sulphate, magnesium 
chloride) as a function of increasing concentration of these components in 
20mM glycine/HCl buffer, pH 2.0 at 25°C. The conditions for fluorescence 
studies were same as given above for acid denaturation studies. 
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4. RESULTS 
SECTION I. 
4.1 PURIFICATION AND CHARACTERIZATION OF HUMAN 
PLACENTAL CYSTATIN (HPC) 
4.L1 PURIFICATION 
In the present study cystatin has been purified from human placenta 
by the method of Rashid et al (2004). As described in methods the procedure 
involved combination of acid treatment, ammonium sulphate fractionation 
and gel filtration chromatography. The proteins obtained after acid treatment 
were precipitated between 50-80% ammonium sulphate saturation. The 
precipitate thus obtained was dissolved in 20mM sodium phosphate buffer, 
pH 6.0 and then dialyzed against the same buffer containing 0.15 M NaCl. 
This resulted in 166.6 fold purification and 22.1 % yield (Table 4.0). 
4.L2 GEL FILTRATION 
The protein after dialysis was chromatographed on a column of Sephadex 
Gso-so (1.1>< 100cm) equilibrated with 20mM sodium phosphate buffer, pH 6.0 
containing 0.15M sodium chloride. Two protein peaks were obtained (Fig 4.0) 
Thiol proteinase inhibitory activity was checked in both the peaks. Peak II was 
the major peak with significant protein content and thiol proteinase inhibitory 
activity. This peak had 8913 fold purification and 14.8% yield (Table 4.0). 
Papain inhibitory fractions of peak II were pooled, concentrated and checked for 
purity. Peak I was not taken into consideration for further studies since it was 
found to have low protein content with minor inhibitory activity. 
4.L3 HOMOGENEITY 
Homogeineity of the protein, obtained from gel filtration as peak II 
was determined by electrophoretic techniques. The purified HPC gave a 
single band on native polyacryl amide gel electrophoresis (PAGE-12.5%) as 
shown in Fig 4.1. 
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Fig 4.0 Gel filtration chromatography on Sephadex G50.80 
The protein obtained by precipitation between 50-80% 
ammonium sulphate saturation was dissolved and dialyzed 
against several changes of 20mM sodium phosphate buffer, 
pH 6.0 containing 0.15M NaCl at 4°C. The sample was 
applied on Sephadex Gso-go column (1.1x100 cm) and 
fractions were eluted with the same buffer at the rate of 
30ml/h. Fractions of 5ml each were analyzed for their 
inhibitory activity against papain (•) and absorbance was 
taken at 660 nm (•). 
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Fig 4.1 Gel electrophoresis of HPC during various Stages of 
Purification 
Electrophoresis was performed on 12.5% acrylamide gel as 
described in methods section. Lane a; Human placenta 
homogenate, Lane b; dialyzed fraction after 50-80% 
ammonium sulphate fractionation and Lane c and d; purified 
protein obtained after gel filtration chromatography on 
Sephadex Gso-go- 50p,g of protein was loaded in lane c and d. 
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a b e d 
4.1.4 REDUCING AND NON-REDUCING SDS PAGE 
Purified human placental cystatin was analyzed by SDS-PAGE under 
non-reducing (in the absence of 6-mercaptoethanol) and reducing conditions 
(in the presence of P-mercaptoethanol). A single band was obtained in both 
the conditions (Fig 4.2). This indicates the presence of a single polypeptide 
chain. 
4.1.5 PROPERTIES OF PURIFIED HUMAN PLACENTAL CYSTATIN 
Molecular Weight Determination 
The molecular weight of human placental cystatin (HPC) was 
determined both under native as well as denaturating conditions. The 
molecular weight of native cystatin was determined using gel filtration 
chromatography on Sephadex Gso-so- The marker proteins insulin, 
cytochrome C, ribonuclease, soyabean trypsin inhibitor and papain were 
chromatographed on a column of Sephadex G50-80 (1.1^100 cm) equilibrated 
with 20mM sodium phosphate buffer, pH 6.0 and their elution volume was 
determined. Analysis of the data indicated linear relationship between log M 
and Vc/Vo, by the method of Andrews (1964) (Fig 4.3), where Vc is the 
elution volume of the protein and Vo is the void volume of the column. The 
Ve/Vo of the native cystatin corresponds to molecular weight of 12500 
(Fig 4.3). 
The molecular weight of cystatin under denaturating conditions was 
calculated from its mobility in SDS PAGE by the procedure of Weber and 
Obsorn (1969). The mobility's of marker proteins were plotted against the 
logarithm of their molecular weights (Fig 4.4). The least square analysis of 
the data indicated a linear relationship between log M and relative mobility 
(Rm). The position of migration of human placental cystatin corresponds to 
molecular weight of 12445 (Fig 4.4). 
Stokes Radius 
The stokes radius of a protein correlates well with its elution 
behaviour from gel filtration column. The stokes radius of human placental 
63 
Fig 4.2 SDS Polyacrylamide gel electrophoresis of purified HPC 
Electrophoresis was performed on 12.5 % gels as described in 
methods. SDS PAGE of the purified inhibitor was performed 
under non-reducing and reducing conditions Lane a; Non 
reducing condition in the absence of P-mercaptoethanol Lane 
b; Reducing condition in the presence of P-mercaptoethanol. 
Lanes a and b each contained 50^g of the inhibitor, 
respectively. 
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Fig 4.4 Molecular weight determination of HPC by SDS 
PAGE 
(A) Electrophoresis was performed on 12.5% acrylamide gel. The 
gel Lane a; contained the molecular weight standards: A-
Ovalbumin (43KDa), B-Carbonic Anhydrase (29KDa), C-
Soyabean Trypsin Inhibitor (20.1KDa), D-Lysozyme 
(14.3KDa) and E-Aprotinin (6.9 KDa). Lane b; contained 50^g 
of P-mercaptoethanol treated inhibitor respectively. 
(B) The Log M (Molecular weight) of the marker proteins were 
plotted against their relative mobility (Rm) using least square 
analysis. Molecular weight of HPC is indicated by an arrow. 
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Fig 4.3 Molecular weight estimation of the purified HPC 
using Sephadex G50.80 gel filtration chromatography 
Purified human placental cystatin was applied on a column of 
Sephadex G50.80 (1.1 >< 100cm) and eluted with 20mM sodium 
phosphate buffer, pH 6.0 at a flow rate of 30ml/h. The 
molecular weight markers used were A-Insulin (5.7KDa), B-
Cytochrome C (12.7KDa), C-Ribonuclease (HKDa), D-
Soyabean Trypsin Inhibitor (20.1 KDa) and E-Papain 
(23KDa). The position of elution of cystatin is indicated by an 
arrow. 
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cystatin was determined by its elution volume from a calibrated Sephadex 
G50.8O column (1.1x100cm) using 20mM sodium phosphate buffer, pH 6.0 
containing 0.15 M NaCl using marker proteins (Fig 4.5). The column was 
calibrated by determining the elution volume of several globular proteins 
with known stoke's radii such as insulin (12.3 A), cytochrome C (16.4 A), 
ribonuclease (19.2 A) and soyabean trypsin inhibitor (22.6 A). The data was 
analyzed according to the theoretical treatment of Laurent and Killander 
(1964). The equation is 
Kav = Ve-Vo/ Vt-Vo 
Where, Ve = elution volume, Vo = void volume and Vt = total 
volume. The linear plot between Stoke's radius and [-log Kav]''^ of the 
marker proteins was used for the calculation of stoke's radius of HPC and 
the value was found to be 14.5 A (Fig 4.5). 
Diffusion Coefficient 
The diffusion coefficient (D) of the HPC corresponding to the value 
of the stoke's radius was computed to be 1.53^10" cm /s with the help of 
equation 
D = KT/67iTir 
Where, K is the Boltzman's constant (1.386x10"'^ erg/deg), T is the 
absolute temperature (303 k) and TI is the coefficient of viscosity of the 
medium (0.01 OOP for water and dilute aqueous salt solutions at 20°C) 
(Friefelder, 1982). 
Carbohydrate Content 
Type 1 cystatins or stefins are known to be devoid of carbohydrate 
content (Barrett, 1986). Similar to this property of type 1 cystatins, human 
placental cystatin exhibited absence of carbohydrate content. 
Sulphydryl Groups 
The sulphydryl groups in HPC were titrated against DTNB. 
Colourless solution was obtained indicating that no free sulphydryl groups 
are present in the purified inhibitor. 
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Fig 4.5 Determination of stokes radius of purified HPC by 
Laurent and Killander plot 
Marker proteins and the purified cystatin were subjected to 
gel filtration on Sephadex G50-80 column (1.1 x 100cm). The 
Kav values were computed from the elution volume of marker 
proteins. Stokes radii of the marker proteins were A-Insulin 
(12.3 A), B-Cytochrome C (16.4 A), C-Ribonuclease (19.2 A) 
and D-Soyabean Trypsin Inhibitor (22.6 A). The stokes radii 
of purified inhibitor is indicated by an arrow 
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pH stability of HPC 
Effect of pH on the thiol proteinase inhibitory activity of of human 
placental cystatin was analyzed between a broad pH range (3.0-9.0). Fig 4.6 
shows that this inhibitor activity is stable in the pH range 3.0-9.0. 
Temperature stability of HPC 
The effect of exposure of HPC to varying temperature range (30-
95°C) on thiol proteinase activity of human placental cystatin is shown in 
Fig 4.7. HPC was found to be stable in the temperature range 40-100''C. 
Thermal denaturation 
Human placental cystatin was exposed to 90°C for different time 
intervals, rapidly cooled and inhibitory activity was determined. Results are 
shown in Fig 4.8. The inhibitor was found to be stable up to 120min at 90°C. 
4.1.6 IMMUNOGENIC PROPERTIES 
Antibody Titre 
As expected the placental cystatin being low molecular weight 
inhibitor the immunogenicity was moderate and led to the moderate titre of 
antibodies in rabbits. The titre of the antisera was determined by direct 
binding ELISA and the value obtained was 2238.73 (Fig 4.9). 
Cross Reactivity 
Placental cystatin was immunogenic and induced antibody formation 
in rabbits, however it has been found to be moderately immunogenic owing 
to its low molecular weight. Fig 5.0 shows that antisera raised against 
purified inhibitor showed cross reactivity with the inhibitor as indicated by a 
single precipitin line on immunodiffusion plate exhibiting immunogenic 
purity and homogeneity of the inhibitor preparation. This cystatin exhibited 
no immunogenic identity with sheep plasma HMW kininogen and 
phytocystatins purified from Phaseolus mungo(uTd), a plant sources (Fig 
5.1). 
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Fig 4.6 Effect of pH on the activity of purified HPC 
50|ig of the purified inhibitor was incubated with 20mM 
sodium acetate buffer pH 3.0-6.0, phosphate buffer pH 7.0-
8.0, tris-HCl buffer for 30 min at 37°C. After the incubation 
the pH of the mixture was neutralized and then 30|ig of 
activated papain was added and the mixture was further 
incubated for 60 min at 37°C. The following procedure was 
same as described in methods section for assaying the 
inhibitor using casein as substrate. 
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Fig 4.7 Effect of temperature on the purified HPC 
SO^ ig of purified thiol proteinase inhibitor in 20mM sodium 
phosphate buffer, pH 7.0, was incubated at various 
temperatures for 30 min and then rapidly cooled. 50^g of the 
activated papain was added and kept for 60 min at 37°C. The 
remaining procedure for determination of thiol proteinase 
inhibitory activity was same as described in methods section 
using casein as substrate. 
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Fig 4.8 Thermal denaturation of purified HPC 
50 i^g of the purified inhibitor was incubated at 90°C for 
different time intervals in 20mM sodium phosphate buffer, pH 
7.0 and then rapidly cooled. 50|xg of activated papain was 
added and incubated for 60 min at 37°C. Rest of the procedure 
was same as described in methods. 
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Fig 4.9 Direct binding ELISA 
Serially diluted antiserum and pre-immune serum were 
incubated with 0.5|ag/100)jl antigen. The procedure has been 
described in methods. The curve with solid circles is for post 
immunized sera where as the curve with hollow circles is for 
pre- immunized sera. 
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Fig 5.0 Ouchterlony Immunodiffusion 
Anti human placental cystatin antiserum was raised in albino 
rabbits. This anti HPC antiserum was allowed to react with the 
HPC (60|ag) on agarose plates as described in methods section. 
The central well contained the anti HPC antiserum where as the 
wells 1, 2 and 3 contain human placental cystatin. 
Fig 5.1 Immunodiffusion of HPC with sheep HMW kininogens 
and Phaseolus mungo cystatin. 
Anti human placental cystatin antiserum was allowed to react 
with sheep plasma HMW kininogens and Phaseolus mungo 
cystatin. The central well contains the anti HPC antiserum 
where as the well 1, 2, 3 and 4 contain human placental 
cystatin, sheep HMW kininogen, Phaseolus mungo (urd) 
cystatin and saline, respectively. 
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Inhibition of Proteinases by HPC 
The inhibitory activity of human placental cystatin towards thiol 
proteinases papain, ficin, bromelain and serine proteinases, trypsin and 
chymotrypsin was examined using casein as substrate. The thiol proteinases 
were inhibited in the order papain > ficin > bromelain, where as HPC did not 
inhibit serine proteinases trypsin and chymotrypsin (Fig 5.2). 
4.1.7 KINETICS OF INHIBITION 
Stoichiometry of inhibition 
Human placental cystatin is highly specific for thiol proteinases such 
as papain, ficin and bromelain with no specificity for serine proteases-
trypsin and chymotrypsin. The inhibition of the proteinases was studied by 
varying the molar concentration of proteases at a fixed molar concentration 
of cystatin. The remaining activity of proteinase showed that as the 
concentration of proteinase was increased from 0.01-0.06^M it is 
progressively inhibited by cystatin (0.06nM) showing a stoichiometric ratio 
of 1:1, therefore one molecule of cystatin inhibits one molecule of active 
protease. Stoichiometric ratios of 1:1 were also obtained for ficin and 
bromelain. 
Ki Determination 
Ki values have been determined after lowering the respective 
inhibitor and proteinase concentration, which favour the dissociation of the 
complex. Ki values were determined using the steady state equation derived 
by Krupka and Laidler (1959). 
1 - ^ 
V, 
= K. 
Km i.lBl J ' 0 
Fig 5.3, 5.4 and 5.5 showed that Ki (app) increases as a function of 
substrate concentration. The true Ki value may be obtained from a replot of 
Ki (app) against [S]. The Ki (app) values obtained from the plots (Fig. 5.3, 
5.4 and 5.5) were 5.5x10"^ for papain, 8.4x 10'* for ficin and 9.5x 10'* M for 
75 
Fig 5.2 Inhibitory activity of HPC with different proteinases 
30 ng of thiol proteinases papain, ficin, bromelain and serine 
proteinases, trypsin and chymotrypsin were incubated with 
varying concentrations of HPC (0-30ng) for 30 min, the 
inhibitory activity of HPC towards papain (•), ficin (A), 
bromelain (D), trypsin (o) and cymotrypsin (A) was measured 
by using 2% casein as substrate. 
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Fig 5.3 Determination of inhibition constant (Ki) with Papain 
Papain was used at final concentration of 0.05 i^M with 
increasing amounts of Inhibitor (0.011-0.21 l^iM). Measurement 
of residual activity was done as described in methods using 
casein as substrate. Four different substrate concentrations were 
used i.e. 0.5 Km, IKm, 2Km and 3Km with km = 2.4mM. For 
the sake of clarity the result obtained for [S] =0.5 Km are 
shown. The Inset shows the replot of experimental Kj (app) 
values versus [S]. Intercept on the ordinate gives the true Kj. 
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Fig 5.4 Determination of inhibition constant (Ki) with Ficin 
Ficin was used at final concentration of 0.05 i^M with increasing 
amounts of Inhibitor (0.011-0.21 IjiM). Measurement of residual 
activity was done as described in methods using caesin as 
substrate. Four different substrate concentrations were used i.e. 
0.5 Km, IKm, 2Km and 3Km with km = 2.4mM. For the sake of 
clarity the result obtained for [S] = 1 Km are shown. The Inset 
shows the replot of experimental Kj (app) values versus [S]. 
Intercept on the ordinate gives the true Kj. 
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Fig 5.5 Determination of inliibition constant (Ki) with 
Bromelain 
Bromelain was used at final concentration of 0.05 i^M with 
increasing amounts of Inhibitor (0.011-0.211^X1). Measurement 
of residual activity was done as described in methods using 
casein as substrate. Four different substrate concentrations were 
used i.e. 0.5 Km, IKm, 2Km and 3Km with km = 2.4mM. For the 
sake of clarity the result obtained for [S] = 1 Km are shown. The 
Inset shows the replot of experimental Ki (app) values versus [S]. 
Intercept on the ordinate gives the true Ki. 
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bromelain, respectively. The Ki(app) value is lowest for papain hence it has 
highest affinity for the inhibitor. 
ICso Value 
IC50 value is the concentration of the inhibitor at which 50% of the 
enzyme is inhibited. The IC50 values obtained with various thiol proteinases 
have been summarized in Table 4.1. The values obtained for the three thiol 
proteinases are comparable indicating that the affinities of the proteinases 
are in the order papain > ficin > bromelain. Papain has an IC50 value of 
0.05IfiM, ficin has 0.09IjiM where as bromelain has a value of O.lTl^iM 
respectively. 
Association Rate Constants K+i 
Association Rate Constants(K+i) were calculated for the three thiol 
proteinases assuming that the enzyme and inhibitor react in such a way that 
dissociation rate is low enough to neglect the reverse reaction during the 
initial part of the reaction. The equation obtained was:-
Figs 5.6, 5.7 and 5.8 show the plots of I/[E] versus time with papain, 
ficin and bromelain, respectively. The slope of the straight line obtained 
gives association rate constant K+i values which is equal to 3.4x10'' for 
papain (Fig 5.6), 2.9x10^ for ficin (Fig 5.7) whereas for bromelain the value 
is 8.6x10^ M-'S"'(Fig 5.8). 
Dissociation Rate Constants K.] 
The conditions for the dissociation were taken such that the enzyme-
inhibitor complex obeys first order kinetics during the initial part of the 
reaction. 
In this case the integrated form of the equation is given by 
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TABLE 4.1: Kinetic Constants obtained on Interaction of Human 
Placental Cystatin with proteinases - Papain, Ficin 
and Bromelain. 
KINETIC 
PARAMETERS 
Ki(M) 
K+, (M-'S-*) 
K., (S-') 
IC50 
VALUE((iM) 
HALF LIFE OF 
THE 
COMPLEX 
PAPAIN 
5.5±0.02xl0'' * 
3.4±0.01xl0^ 
2.3±0.02xl0"' 
0.051 
3.01x10" 
FICIN 
8.4±0.1xio-« 
2.9±0.3xl05 
2.6±0.3xl0-^ 
0.091 
2.6x10'* 
BROMELAIN 
9.5±0.2xl0"* 
8.6±0.1xl0^ 
2.1±0.1xl0-' 
0.171 
3.3x10^* 
Results represent the mean ± SEM calculated from three 
independent experiments. 
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Fig 5.6 Determination of association constant (Kg„) with 
Papain 
Equimolar concentration of Papain and Inhibitor (0.05 |xM) 
were incubated and residual activity was measured as a 
function of time as described in methods section. The 
fractional activity VJ/VQ is plotted against time. Inset 
represents a plot of data in accordance with equation (4). 
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Fig 5.7 Determination of association constant (Kass) with Ficin 
Equimolar concentration of Ficin and Inhibitor (0.05 ^M) 
were incubated and residual activity was measured as a 
function of time as described in methods section. The 
fractional activity Vj/Vo is plotted against time. Inset 
represents a plot of data in accordance with equation (4). 
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Fig 5.8 Determination of association constant (K s^s) witli 
Bromelain 
Equimolar concentration of Bromelain and Inhibitor (0.05 
}xM) were incubated and residual activity was measured as a 
function of time as described in methods section. The 
fractional activity Vi/Vo is plotted against time. Inset 
represents a plot of data in accordance with equation (4). 
84 
>° 
^^ ^ 
2 0.8 
S0.A 
—^  
•b 00, 
• 
1 1 
3 10' 
• ^ 
1 1 1 
20' 30' 
Time (min) 
J. j - j . 
10' 20' 30' 
Time (min) 
In 
log 
[EI] 
[EIJo 
[EI] 
= K_,t 
= K_,t/2.303 
.[EI]o 
Fig 5.9, 6.0, 6.1 shows the respective plots for papain, ficin and 
bromelain. K.i value obtained for papain was 2.3x10"^, for ficin it was 
2.6x10'* and for bromelain the value was 2.1xlO"*S"'. The kinetic 
parameters of HPC with papain, ficin and bromelain have been summarized 
in Table 4.1. 
Half life of the Complex 
It may be calculated by re-arranging the equation 
ty, =0.693/k.," 
The half life values for papain-cystatin complex was 3.01^10^ S, for 
ficin-cystatin complex it was 2.6x10'*S whereas for bromelain-cystatin 
complex the value was 3.3xl0*S. Among the three proteases the bromelain 
cystatin complex has highest half life time. 
4.1.8 N-TERMINAL ANALYSIS 
The sequence of the N-terminal 30 amino acid residues was obtained 
by automated Edman degradation method. Table 4.2 shows the amino 
terminal sequence of human placental cystatin and its sequence homology 
with other known mammalian cystatins. HPC has maximum (%) sequence 
homology with chicken cystatin as compared to other cystatins like bovine 
cystatin, human salivary cystatin SA, cystatin C, cystatin 87, rat cystatin, 
human stefin A and B and rat liver TPI- thiol proteinase inhibitor. 
Using the sequence of these N-terminal amino acid residues a 
hydropathy plot was made from the respective hydropathy index of each 
individual amino acid (Fig 6.2). It was observed that among the 30 residues 
sequenced the stretch of 4-8, 8-12 and 20-24 residues have maximum 
average hydropathy index. 
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Fig 5.9 Determination of dissociation constant (Kdus) with 
Papain 
Papain-placental cystatin complex (l|iM) was pre-incubated 
for 30min at 40°C before excess substrate was added to the 
mixture. Appearance of papain activity was recorded as a 
function of time. Inset shows plot of the data according to 
equation 5 as described in methods. 
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Fig 6.0 Determination of dissociation constant (Kdiss) with 
Ficin 
Ficin-placental cystatin complex (l^iM) was pre-incubated for 
30min at 40°C before excess substrate was added to the 
mixture. Appearance of ficin activity was recorded as a 
function of time. Inset shows plot of the data according to 
equation 5 as described in methods. 
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Fig 6.1 Determination of dissociation constant (Kdiss) with 
Bromelain 
Bromelain-placental cystatin complex (IjaM) was pre-
incubated for 30min at 40°C before excess substrate was 
added to the mixture. Appearance of bromelain activity was 
recorded as a function of time. Inset shows plot of the data 
according to equation 5 as described in methods. 
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Fig 6.2 Hydropathy Plot of the N-Terminal residues of HPC 
The already known hydropathy index of 30 amino acid 
residue was used. The average hydropathy index of four 
residues (window size) was plotted starting from residue 1-4, 
4-8, 8-12, 12-16, 16-20, 20-24, 24-28. 
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4.1.9 SPECTRAL ANALYSIS 
Changes in secondary and tertiary structure of human placental 
cystatin on binding with papain were studied by UV absorption difference 
spectra, fluorescence emission spectra and far UV-CD spectra. 
UV Difference Spectra of HPC with papain 
The interaction of cystatin and papain at its stoichiometric ratio was 
studied at pH-7.0 and ionic strength of 0.15M. Absorption difference spectra 
of the cystatin-papain complex showed significant changes in ultraviolet 
absorption in the aromatic wavelength region (Fig 6.3). The spectrum shows 
maxima at 295 nm and 255 nm and minima at 280 nm. 
Fluorescence Spectra of native HPC and in complex with papain 
The binding of cystatin to papain also resulted in a decrease of the 
wavelength of the maximum fluorescence emission spectrum (Fig 6.4). The 
fluorescence emission spectra of human placental cystatin gave emission 
maxima at 345nm, when excited at 280nm. The maxima of cystatin shifted 
from 345 nm to 340 nm for cystatin papain complex. This blue shift was 
accompanied by a small decrease in maximum emission intensity. 
Circular Dichroism Spectra of native HPC and in complex with 
Papain 
Far UV-CD spectroscopy shows that the placental cystatin has 
21.08% a helical content and a significant amount of P structure. The 
placental cystatin loses its native structure on formation of complex with 
papain (Fig 6.5). Human placental cystatin on interaction with papain 
exhibited slightly different pattern, the complex shows positive ellipticity in 
the range 215-240nm and small shoulders appear in 217-230 nm region. 
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Fig 6.3 UV-Absorption difference spectra measured for 
cystatin-papain complex 
HPC (2.66|iM) was incubated with activated papain for 30 
min and an absorbance difference spectrum was calculated 
between 245 nm to 305nm. HPC and papain were in a molar 
ratio of 1:1. Bandwidth was Inm on the 0.05 absorbance scale 
on a Camspec Spectrophotometer model M330 B. 
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Fig 6.4 Fluorescence spectra of HPC with papain 
Fluorescence spectra of inhibitor (I), papain (P) and papain-
inhibitor complex (PI) was measured at excitation 
wavelength (Xex) of 280 nm and emission wavelength (Xem) 
of 300-400nm. The concentration of HPC was l|i,M. The 
fluorescence of complex of HPC with papain was measured 
at a molar ratio of 1:1, The slit width was 5nm for both 
excitation and emission beams. 
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Fig 6.5 Far UV-CD spectra of HFC with papain 
Far UV-CD spectra of inhibitor (I), papain (p) and papain-
inhibitor complex (PI). The concentration of HPC was S^M 
and inhibitor to papain molar ratio was 1:1. The complex was 
obtained after incubation at 37°C for 30 min in 20mM sodium 
phosphate buffer pH 7.0. Cells of 1mm path length were used. 
The unit on the ordinate is millidegrees. 
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SECTION II. 
4.2 UNFOLDING AND REFOLDING STUDIES OF HPC 
(A) DENATURANT INDUCED STRUCTURAL CHANGES 
Effects of GdnHCl and urea on structural and functional properties of 
human placental cystatin have been studied. The maximum incubation time 
sufficient for achieving equilibrium under all conditions of denaturants were 
standardized in all the experiments, changes occurred with in a maximum of 
Ihr with no further alteration up to 12 hours. 
4.2.1 Functional Inactivation of HPC 
Thiol proteinase inhibitory activity of HPC was determined in the 
presence of varying concentrations of GdnHCl and Urea to get an estimate 
of conformational changes being induced in the enzyme as a result of 
progressive denaturation. The subtle readjustments as a result of various 
treatments in the functional site of a protein reflect changes in the overall 
conformation of protein. Fig 6.6 shows sigmoidal dependence of inhibitory 
activity of HPC on GdnHCl (1-6M) and urea (1-8M) concentrations. At 
0.5M of GdnHCl and urea no effect was observed on inhibitory activity of 
HPC, at IM concentration the activity in case of GdnHCl decreased to 80% 
where as for urea it was still 97%. Again at 1.5M and 2M concentration the 
inhibitory activity in the presence of GdnHCl was 55% and 35% and for urea 
it was 95% and 90% respectively. At 3M concentration the activity in case 
of urea was 52% while for GdnHCl it was only 10%. 
Further, Fig 6.6 shows that mid-point of inactivation of inhibitor or 
the mid-point of transition from native to denatured state is 1.5-2M for 
GdnHCl and 3M for urea, showing that GdnHCl is almost two fold more 
stronger denaturant than urea which is further supported by the 
spectroscopic studies given below. The activity at 4M GdnHCl is near equal 
to zero and the protein is completely inactivated in 4-6 M range whereas in 
case of urea complete inactivation is observed in 6-8 M concentration range. 
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Fig 6.6 GdnHCl and Urea inactivation of HPC 
Native HPC (1.066)aM) was incubated with increasing 
concentration of GdnHCl (1-6M) and Urea (1-8M) for 2h at 
room temperature. HPC was assayed for loss of antiproteinase 
activity by caesinolytic assay of Kunitz. Values are mean of 
four independent determinations. 
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4.2.2 Fluorescence Spectra of HPC in the presence GdnHCl and 
Urea 
The spectral parameters of fluorescence emission spectra such as 
position, shape and intensity are dependent on the electronic and dynamic 
properties of chromophore environment, hence fluorescence studies have 
been extensively used to obtain information on the structural and dynamic 
properties of a protein (Prajapati et al., 1998). The modification of 
microenvironment of aromatic residues of HPC due to denaturants has been 
studied by monitoring the changes in intensity and wavelength of emission 
maxima (Xmax) as a function of denaturant concentration. 
Fig 6.7 (A and B) show changes in fluorescence of HPC with 
increasing denaturant concentrations and Fig 6.7C shows the respective 
transition curves for the two denaturants. For native HPC the emission 
maximum (Xmax) was 345nm as reported earlier (Rashid et al., 2004) 
suggesting that aromatic residues are buried in the hydrophobic core of the 
protein. Fig. 6.7(A and C) shows that up to 1.5 M GdnHCl quenching of 
fluorescence is observed with no change in X,max. At 0.5M GdnHCl the 
maximum intensity decreased to 92%, at 1M concentration it further decreased 
to 90% however at 1.5M concentration of GdnHCl it slightly increased (the 
maximum intensity value of native HPC was taken as 100%). At 2M 
GdnHCl, the maximum % fluorescence intensity increased to 128 (Fig 6.7C) 
and a red shift in Xmax to 350nm was observed (Fig 6.7A). From 2.5-4.5M, 
the fluorescence intensity increases further (Fig 6.7C) and in the range 5-6M 
the fluorescence intensity remains almost constant. The transition curve for 
urea denaturation is different from that of GdnHCl (Fig 6.7C). There is very 
small increase in fluorescence up to 2M urea concentration as shown in Fig 
6.7B, at 3M urea the maximum intensity value increased to 138% (Fig 
6.7C). In the concentration range of 4-6 M urea the fluorescence intensity 
further increases and at 6 M concentration Xmax red shifts to 348nm. The 
fluorescence intensity in 6-8 M urea concentration shows little increase. 
Complete unfolding of HPC occurs at 4 M GdnHCl and at 6M urea 
97 
Fig 6.7 Intrinsic Fluorescence analysis of HPC on interaction 
with various concentrations of GdnHCl and Urea. 
The concentration of HPC was 2^M. HPC was pre-incubated 
for 2h at 25° C in 20mM sodium phosphate buffer (pH 6.0) 
containing the indicated concentrations of denaturants. 
Fluorescence was measured at an excitation wave length of 
280nm and the emission range was 300-400nm with a slit 
width of 5nm. 
(A) Fluorescence spectra of HPC were measured in different 
concentrations (1-6M) of GdnHCl at an interval of 0.5M. For 
the sake of clarity the spectra of only 0, 0.5, 1, 1.5, 2, 3, 4, 5, 
and 6M concentrations of GdnHCl are shown. 
(B) Fluorescence spectra of HPC were measured in different 
concentrations of urea (1-8M) at an interval of 0.5M. For the 
sake of clarity the spectra of only 0, 1, 2, 3, 4, 5, 6, 7 and 8 M 
concentrations of urea from bottom to top are shown with 
lowest trace being of OM and the top one of 8M (Traces for 7 
and 8 M overlap). 
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Fig 6.7 Intrinsic Fluorescence analysis of HPC on interaction 
with various concentrations of GdnHCI and Urea. 
The concentration of HPC was 2|iM. HPC was pre-incubated 
for 2h at 25° C in 20mM sodium phosphate buffer (pH 6.0) 
containing the indicated concentrations of denaturants. 
Fluorescence was measured at an excitation wave length of 
280nm and the emission range was 300-400nm with a slit 
width of 5nm. 
(C) Transition curves of HPC for GdnHCI and urea denaturation 
are shown as maximum fluorescence intensity % (with the 
peak value of native HPC taken as 100 %). (•) Values for 
GdnHCI in 1-6 M range and (o) for urea in 1-8 M range are 
shown at intervals of 0.5 M. The refolding of HPC was also 
determined in terms of fluorescence measurements. The (A) 
and (A) values show respective transition curves of refolding 
of HPC denatured in 6 M GdnHCI or 8 M urea for 24 h. For 
renaturation protein was diluted 1:50 fold in the same buffer 
containing appropriate concentrations of GdnHCI and urea. 
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concentration. The mid-point of transition is 1.5-2 M for GdnHCl and 3 M 
for urea. The refolding pattern of HPC was also monitored by observing 
fluorescence intensity (Fig 6.7C). The protein shows almost complete 
reversibility in case of urea where as for GdnHCl, in the concentration 
region 0.5 to IM the transition was not completely reversible and the values 
obtained are in between native and unfolded state. 
4.2.3 Secondary structure of HPC in GdnHCl and Urea solutions 
Far UV-CD studies on GdnHCl and urea induced unfolding of 
cystatin were carried out to investigate the effect of these denaturants on the 
secondary structure of the protein. In the far UV-region the CD spectrum of 
native HPC shows presence of 21.08% a-helical content determined by the 
method of Chen, et al (1975) and significant amount of P structure as has 
been reported earlier (Rashid et al., 2004). 
Fig 6.8A and 6.8B show the effects of increasing concentration of 
GdnHCl and urea on the ellipticity of native protein. Fig 6.8C shows the 
respective transition curves for the two denaturants in terms of ellipticity 
values at 222nm (6222 nm). The value of native protein in the absence of 
GdnHCl and urea at this wavelength was taken as 100%. In the range of 
0.5M to 1.5M GdnHCl there is an increase in ellipticity as compared to 
native protein whereas there is marked decrease in ellipticity from 2-4 M 
concentration of GdnHCl. At 5 and 6M of GdnHCl the protein is completely 
unfolded and the protein has a random coil conformation at 6M GdnHCl 
concentration. 
The transition curve for urea (Fig 6.8C) is simple as compared to that 
of GdnHCl. Fig 6.8 (B and C) shows that up to IM urea there was very small 
change in ellipticity whereas it decreased by 10% at 1.5M. There was further 
decrease in ellipticity as concentration of urea increased and at 3M 
concentration the value was reduced to almost half. Again ellipticity 
decreases in 4-6M concentration region and at 8M the protein is completely 
unfolded. From the transition curve (Fig 6.8C) the mid-points of transition 
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Fig 6.8 Secondary structure analysis of HPC in presence of 
GdnHCl and Urea 
The figure shov/s changes in far UV-CD spectra of HPC 
denatured in increasing concentrations of GdnHCl (1-6M) and 
urea (1-8M). The conditions were same as for Fig 6.7 except 
that the HPC concentration was 8nM. 
(A) CD spectra of HPC in 0, 0.5, 1, 1.5, 2, 3, 4, 5 and 6M 
GdnHCl. 
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Fig 6.8 Secondary structure analysis of HPC in presence of 
GdnHCl and Urea 
The figure shows changes in far UV-CD spectra of HPC 
denatured in increasing concentrations of GdnHCl (1-6M) and 
urea (1-8M). The conditions were same as for Fig 6.7 except 
that the HPC concentration was 8jiM. 
(B) CD spectra of HPC in 0, 1, 2, 3, 4, 5, 6, 7 and 8 M urea. 
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Fig 6.8 Secondary structure analysis of HPC in presence of 
GdnHCI and Urea 
The figure shows changes in far UV-CD spectra of HPC 
denatured in increasing concentrations of GdnHCI (1-6M) and 
urea (1-8M). The conditions were same as for Fig 6.7 except 
that the HPC concentration was 8|iM. 
(C) Transition curve of HPC denaturation in GdnHCI (•) and urea 
(0) determined in terms of % ellipticity values at wavelength 
of 222nm (with 6222 nm of native HPC taken as 100 %). 8222 
nm % values of curves corresponding to GdnHCI (1-6 M) and 
urea (1-8 M) were taken at an interval of 0.5 M. 
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are in accordance to earlier results showing that GdnHCl brings about 
protein denaturation at lesser concentration as compared to urea. 
(B) ACID INDUCED STRUCTURAL CHANGES 
The acid denaturation of HPC was studied over a pH range 1.0-7.0 in 
terms of far and near UV-CD, Intrinsic fluorescence and ANS binding 
measurements. Fig 6.9 shows that as the pH decreases from pH 7.0 to 1.0 
there is no major change in ellipticity value at 222nm up to pH of 4.5, 
however, at pH 4.0 and below there is marked decrease in ellipticity value 
reaching a minimum value at pH 2.0. From pH 2.0 to pH 1.0 there is some 
increase in ellipticity value. In the 1*' transition up to pH 2.0 there is loss of 
34.5% of secondary structure as compared to that of native conformation at 
pH 6.0 (taken to be having 100% secondary structure) where as in 2""* 
transition ie., from pH 2.0 to 1.0 there is regain of about 4% secondary 
structure compared to conformation at pH 2.0 which has only 65.5% residual 
structure left. ANS fluorescence measurements showed that as the pK of the 
sample decreases there is an increase in ANS fluorescence which reaches a 
maximum value at pH 2.0. There is no significant change in ANS 
fluorescence from pH 7,0 to pH 5.0, but as pH goes below 5.0 there is 
increase in ANS fluorescence from pH 5.0-2.0 with a maximum value at pH 
2.0. However, a further decrease of pH to 1.0 leads to decrease in ANS 
fluorescence value. 
4.2.4 Secondary and Tertiary structural analysis 
Fig 7.0 (A and B) show the far and near UV-CD spectra of HPC at pH 
6.0 (native state), at pH 2.0 and in GdnHCl denatured state. The curve for 
native state in Fig. 7.0A shows presence of minima at 208 and 222nm 
suggesting presence of a-helical structure. The curve for the acid denatured 
state retains most of the features of secondary structure, although there was 
some decrease in the ellipticity value compared to the native state indicating 
loss of about 34% of a-helical content. HPC in presence of 6M GdnHCl 
loses almost all the elements of secondary structure and forms a random coil 
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Fig 6.9 pH dependence of CD spectra and ANS fluorescence 
intensity of HPC at 25''C. 
Ellipticity values (•) were monitored at 222nm and ANS 
fluorescence intensity (A) at 480nm after excitation at 
380nm. Experimental details are given in methods section. 
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Fig 7.0 Secondary and tertiary structure analysis of HPC at 
pH 6.0, pH 2.0 and in the presence of 6M GdnHCl 
(A) Far UV-CD spectra of HPC at pH 6.0 (native state) (1) and at 
pH 2.0 (acid-induced state) (2) and in presence of 6M 
GdnHCl (3). The concentration of HPC was 23.2 ^M and path 
length was 0.1 cm. 
(B) Near UV-CD spectra of HPC at pH 6.0 (1), at pH 2.0 (2) and 
in presence of 6M GdnHCl (3). The concentration of HPC for 
near UV-CD was 80 i^M and path length was 1cm. 
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as reported earlier (Rashid et al., 2005). Near UV-CD spectra were used to 
probe the asymmetry of the proteins aromatic amino acids environment. The 
near UV-CD spectra of HPC (Fig. 7.0 B) shows that in native state at pH 
6.0, it is characterized by a positive peak aroxmd 280 nm showing significant 
amount of tertiary structure. Interestingly the near UV-CD of acid induced 
state is almost similar as that of the native state with slight decrease in 
ellipticity value. There is greater decrease in band intensity of HPC in the 
presence of 6M GdnHCl suggesting the formation of random coil, 
4.2.5 Fluorescence Measurements 
Fig 7.1 shows the intrinsic fluorescence emission spectra of HPC in 
different conditions. In the native state HPC is characterized by a peak at 
345 nm (Rashid et al., 2004, 2005). The acid induced state (pH 2.0) has 
decreased fluorescence and the X^ ax is 335 nm. HPC in presence of 6M 
GdnHCl shows increase in fluorescence accompanied by a red shift of 
emission maxima to 350 nm. 
4.2.6 ANS Binding 
Fig 7.2 shows the binding of ANS dye to different states of HPC. 
Binding of ANS to the hydrophobic regions of proteins results in increase in 
fluorescence intensity which has been widely used to detect the molten 
globule states of different proteins (Stryer, 1965; Engelhard and Evans 
1995). As can be seen from this figure there is large increase in ANS 
binding at pH 2.0 state as compared to that of native state accompanied by a 
blue shift from 500nm to 480nm indicating exposure of hydrophobic regions 
of the protein on acidification. 
(C) EFFECT OF TFE AND METHANOL ON ACID INDUCED 
STATE OF HPC 
4.2.7 Secondary and Tertiary structural analysis 
Fig 7.3 (A and B) show the effect of increasing concentration of 
TFE on far UV-CD spectra of acid denatured state of HPC. Fig. 7.3A shows 
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Fig 7.1 Intrinsic Fluorescence analysis of HPC at pH 6.0, pH 
2.0 alone, in presence of 6M GdnHCl and at pH 2.0 in 
presence of 80% TFE 
Fluorescence Spectra of HPC at pH 6.0 (1), at pH 2.0 (2), in the 
presence of 6M GdnHCl (3) and at pH 2.0 in presence of 80% 
TFE (4). The concentration of HPC was l^iM. HPC was 
preincubated for 4h at 25°C in buffers of pH 6.0 and pH 2.0 
containing the indicated concentrations of GdnHCl and TFE for 
the respective fluorescence measurements. Fluorescence was 
measured at an excitation wavelength of 280 nm in the emission 
range (300-400 nm) with a slit width of 5nm. 
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Fig 7.2 Fluorescence emission spectra of ANS bound to HPC 
at pH 6.0, pH 2.0 alone, in presence of 6M GdnHCl 
and at pH 2.0 in presence of 80% TFE 
Figure shows spectra of ANS bound to HPC at pH 6.0 (1), at 
pH 2.0 (2), in presence of 6M GdnHCl (3) and at pH 2.0 in 
presence of 80% TFE (4). The ANS to protein molar ratio was 
1:60. HPC was preincubated for 4h at 25°C in buffers of pH 
6.0 and pH 2.0 containing the indicated concentrations of 
GdnHCl, TFE and ANS for the respective fluorescence 
measurements. ANS Fluorescence was measured at an 
excitation wavelength of 380 nm in the emission range (400-
60 nm) with a slit width of 5nm. 
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Fig 7.3 Effect of TFE on secondary structure of HPC 
(A) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as a function of TFE concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
TFE from top to bottom starting from the curve below curve 1 is 
10%, 20%. 30%, 40%, 50%, 60%, 70% and 80% (v/v). The 
concentration of HPC was 23.2 |xM and path length was 0.1 cm. 
(B) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 in absence (2) and presence of 40% TFE (3). Rest of the 
conditions was same as Fig. 7.3A. 
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that as TFE concentration (% v/v) increases there is increase in the helical 
content of protein indicated by increase in the ellipticity values. At 40% 
TFE the spectral characteristics of protein are similar to that of native state 
at pH 6.0 (Fig.7.3 A and B). Further increase in TFE concentration leads to 
increase in helical structure more than that of native state. The maximum 
helical content was obtained at 80% TFE. Near UV-CD spectra in Fig. 7.4 
shows that the curve corresponding to 40% TFE lies between acid denatured 
and native state where as the curve for 80% TFE shows much decreased 
ellipticity value showing denaturating effect of the alcohol at higher 
concentrations. 
Fig 7.5 shows the far UV-CD spectra of acid induced state at pH 2.0 
in the presence of increasing concentration of methanol (% v/v). It can be 
seen that at 10% methanol concentration there is an increase in the helical 
content of protein as shown by increased ellipticity value compared to acid 
induced state, however this was much less when compared to that of TFE. 
The respective transition curves showing effects of TFE and methanol on 
acid-induced state of HPC are shown in Fig 7.6 where 8222 nm has been 
plotted against increasing concentrations of alcohol. As the concentration of 
ethanol increases up to 50% there was not much variation in induction of 
helical content with an increase in the concentration of alcohol. 
4.2.8 ANS Binding and Intrinsic Fluorescence measurements 
Relative changes in ANS binding of protein at 480nm against increasing 
alcohol concentration are shown in Fig 7.7. Increase in alcohol concentration 
leads to decrease in ANS fluorescence showing non-availability of hydrophobic 
regions for binding in presence of alcohols. Furthermore, from Fig 7.7, it can 
be observed that TFE is again more effective in decreasing ANS 
fluorescence as compared to methanol. Intrinsic fluorescence measurements 
also showed a decrease in fluorescence of acid induced HPC as compared to 
the native state in presence of increasing concentration of alcohols. In Fig 
7.1, the curve representing 80% TFE shows significant decrease in 
fluorescence and emission maxima of 370nm. Again ANS fluorescence 
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Fig 7.4 Tertiary structure analysis of HPC at pH 6.0, pH 2.0 
alone, in presence of 6M GdnHCl and at pH 2.0 in 
presence of 40% and 80% TFE 
Figure shows near UV-CD spectra of HPC at pH 6.0 (1), at 
pH 2.0 (2), in presence of 6M GdnHCl (3) and at pH 2.0 in 
presence of 40% TFE (4) and 80% TFE (5). The 
concentration of HPC for near UV-CD was 80 ^M and path 
length was 1cm. Further experimental details are given in 
methods section. 
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Fig 7.5 Secondary structure analysis of HPC at pH 6.0, pH 2.0 
alone and at pH 2.0 in presence of increasing 
concentrations of methanol 
Spectra of HPC were recorded as a function of methanol 
concentration in 20mM glycine/HCl buffer at pH 2.0 and at 
25°C. Figure shows far UV- CD spectra of HPC at pH 6.0 (1), 
at pH 2.0 in absence (2), and presence of 10% (3), 20%(4), 
30%(5), 40% (6) and 50% (7) methanol concentration (v/v). 
The concentration of HPC for far UV-CD was 23.2 i^M and 
path length was 0.1cm. 
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Fig 7.6 Alcohol induced conformational transitions of HPC in 
terms of ellipticity values at 222nm 
The respective ellipticity values at 222nm of HPC at pH 2.0 
in presence of TFE and methanol were plotted against 
increasing concentration of these alcohols. Experimental 
conditions are same as that in Fig 7.3 and 7.5. The traces in 
figure represent alcohol induced transition curves in terms of 
ellipticity values of HPC at pH 2.0 in presence of TFE 
(—•—) and Methanol (—A—). 
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Fig 7.7 Alcohol induced conformational transitions of HPC in 
terms of ANS fluorescence 
The respective fluorescence values at wavelength of 480nm of 
ANS bound to HPC at pH 2.0 in presence of TFE and 
methanol were plotted against increasing concentration of 
these alcohols. Experimental conditions are same as that in 
Fig 7.3 and 7.5. The traces in figure represent alcohol induced 
transition curves in terms of ANS fluorescence bound to HPC 
in presence of TFE (—•—) and Methanol (—•—). 
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emission (Fig 7.2) shows that at 80% TFE the emission is very less with 
Xmax of 510nm which is characteristic of free ANS in water suggesting 
absence of any hydrophobic clusters under these conditions. 
D. EFFECT OF POLYOLS AND SALTS ON ACID INDUCED 
STATE OF HPC 
The effect of polyols, glycerol and sorbitol and salts, MgS04, 
Na2S04, and MgCb was studied on HPC at pH 2.0. 
(I) POLYOL INDUCED REFOLDING OF ACID DENATURED HPC 
4.2.9 Secondary structural analysis 
Fig. 7.8A shows the far-UV CD spectra of HPC in native state (pH 
6.0), acid induced state (pH 2.0) in the absence and presence of increasing 
concentration of glycerol 0-80% (v/v). The native state of HPC has 
significant amount of secondary structure and shows minima at 222nm and 
208nm. The acid-induced state has 65% of native secondary structure with 
decreased ellipticity compared to that of native conformation. As the 
glycerol concentration increases up to 80% there is an increase in the 
ellipticity values compared to that of acid-induced state. At 20% glycerol 
there is no marked change in ellipticity and the stabilization or the structure 
inducing effect is very less. As the concentration of glycerol increases from 
40-80% there is large increase in ellipticity values and at 80% glycerol 
concentration the structure is almost similar to that of native state. This 
glycerol induced state has 98% of a-helical content resemblance to native 
state. 
Fig 7.8B shows the effect of increasing concentration of sorbitol on 
the acid induced state of HPC. As can be seen from the figure, although 
there is an increase in ellipticity values of protein with the increase in 
sorbitol concentration from 20-80%, the effect is less as compared to that of 
glycerol. Fig 7.8C shows the comparing effect of two polyols on the acid-
induced state of HPC where 6222 
nm values of HPC at pH 2.0 in presence of 
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Fig 7.8 Effect of Polyols on the secondary structure of HPC 
(A) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as a function of glycerol concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
glycerol was 20% (3), 40% (4), 60% (5) and 80% (v/v) (6) 
respectively. The concentration of HPC was 23.2 i^M and path 
length was 0.1cm. 
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Fig 7.8 Effect of Polyols on the secondary structure of HPC 
(B) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as a function of sorbitol concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
sorbitol was 20% (3), 40% (4), 60% (5) and 80% (v/v) (6) 
respectively. The rest of conditions are same as in Fig. 7.8 A. 
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Fig 7.8 Effect of Polyols on the secondary structure of HPC 
(C) Polyol induced conformational transition of HPC studied in 
20mM glycine/HCl buffer, pH 2.0 at 25°C, by measuring 
ellipticity at 222nm, (—•—)Glycerol and (—A—) Sorbitol. 
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increasing concentration of polyols (glycerol and sorbitol) shows different 
helical content inducing ability of these polyols. 
4.3.0 Fluorescence Measurements 
Fig 7.9 shows the fluorescence emission spectra of HPC in the native 
state and in the acid-induced state in the absence and presence of 80% 
concentration of both glycerol and sorbitol. The fluorescence emission 
spectrum of HPC in native conditions (pH 6.0) has a Xmax of 345nm as has 
been reported earlier (Rashid et al., 2004; 2005). The acid induced state has 
a slightly decreased fluorescence and shows blue shift of 10 nm. The 
fluorescence spectra of glycerol-induced state at 80% concentration shows 
intensity almost same as that of native state but with a lOnm blue shift, 
where as when 80% sorbitol was added to acid-induced state it showed 
decreased intensity compared to that of pH 2.0 state. 
4.3.1 ANS Binding 
Fig 8.0 shows ANS binding to various states of HPC in absence and 
presence of polyols. The acid-induced state at pH 2.0 shows the maximum 
binding of ANS suggesting maximum exposure of hydrophobic clusters. The 
glycerol-induced state at 80% (v/v) glycerol concentration also shows ANS 
binding but to a lesser extent compared to that of acid-induced state. Both 
have emission maxima of 480nm where as at 80% sorbitol concentration 
ANS fluorescence is very low. 
(II) SALT INDUCED REFOLDING OF ACID DENATURED HPC 
In the present study three salts- MgS04, Na2S04, and MgCb are 
considered for their protein stability effects. 
4.3.2 Secondary structural analysis 
Fig 8.1 A shows far-UV CD spectra of HPC in native state, acid 
induced state, in the presence of IM and 1.5M MgS04 at pH 2.0. It can be 
seen from the figure that these salt concentrations have no profound effect 
on the refolding of HPC denatured at pH 2.0. As the concentration of MgS04 
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Fig 7.9 Intrinsic Fluorescence analysis of HPC at pH 6.0, pH 
2.0 alone and at pH 2.0 in presence of 80% glycerol 
and sorbitol 
Figure shows fluorescence spectra of HPC at pH 6.0 (1), at 
pH 2.0 alone (2) and at pH 2.0 in presence of 80% (v/v) 
glycerol (3) and 80% (v/v) sorbitol (4). The concentration of 
HPC was l|iM. HPC was pre-incubated for 4h at 25°C in 
buffer of pH 6.0 for native and pH 2.0 for acid-induced state 
and at pH 2.0 in presence of polyols for the respective 
fluorescence measurements. Fluorescence was measured at an 
excitation wavelength of 280nm in the emission range of 300-
400nm with a slit width of 5nm. 
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Fig 8.0 Fluorescence emission spectra of ANS bound to HPC 
at pH 6.0, pH 2.0 alone and at pH 2.0 in presence of 
80% glycerol and sorbitol 
Figure shows fluorescence spectra of ANS bound to HPC at 
pH 6.0 (1), at pH 2.0 alone(2) and at pH 2.0 in presence of 
80% glycerol (3) and 80% sorbitol (4). The ANS to protein 
molar ratio was 1:60. HPC was pre- incubated for 4h at 25°C 
in buffer of pH 6.0(for native state), pH 2.0 and ANS (for 
acid-induced state) and pH 2.0 containing the indicated 
concentrations of polyols and ANS for the respective 
fluorescence measurements. ANS fluorescence was measured 
at an excitation wavelength of 380nm in the emission range of 
400-600nm with a slit width of lOnm. 
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Fig 8.1 Effect of Salts on the secondary structure of HPC 
(A) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as function of MgS04 concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
MgS04 used is IM (3) and 1.5 M (4). The concentration of 
HPC was 23.2 ^M and path length was 0.1cm. 
(B) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as function of Na2S04 concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
Na2S04 used is IM (3) and 1,5 M (4). The rest of conditions 
were same as in Fig 8.1 A. 
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increases there is decrease in ellipticity values although the spectra shows 
some secondary structural features in the form of minima at 208 nm and 
222nm for 1M salt concentration where as at 1.5M salt concentration the 
peak at 208nm is absent. It should be noted that maximum concentration of 
salt used in this study to monitor ellipticity was the one in which the 
solutions were clear and higher concentrations of salt led to precipitation of 
protein. Fig 8.1 B shows effect of other sulphate salt - Na2S04 on the far 
UV-CD spectra of acid-induced state of HPC. At both 1 and 1.5 M 
concentrations of this salt HPC shows decreased ellipticity and loss of 
minima at 208nm, with broad peak at 222nm. The third salt used in this 
study-MgCl2 has increased protein stabilizing effect as shown in Fig 8.1C. 
The figure indicates that the ellipticity values in the presence of both 2 and 
3M salt concentrations are increased as compared to that of acid induced 
state of HPC. At 3M salt concentration the spectral features have 
resemblance to that of native state. Fig 8.1 D shows the respective salt 
induced conformational transitions for the three salts studied where the 
ellipticity values at 222nm of HPC at pH 2.0 in presence of these salts 
plotted against increasing concentration of salts shows differences in their 
helix inducing ability. 
4.3.3 Fluorescence measurements 
Fluorescence emission measurements in Fig 8.2 show that the 
fluorescence intensity in the presence of both the sulphate salts is increased 
as compared to that of the native and acid-induced states. The spectra for 
MgCb has same intensity as that of acid-induced state but shows red shift of 
5nm which indicates the changed tertiary structural features when compared 
with acid-induced state. ANS binding experiments in Fig 8.3 show that these 
salts have different effects on the ANS binding properties of HPC at pH 2.0. 
The MgCb induced state shows increased binding of ANS than the native 
state at pH 6.0 however the Xmax at 510nm showed a red shift of 30nm 
compared to acid-induced state. The ANS binding in case of both sulphate 
salts is less than that of the native state showing least presence of 
hydrophobic clusters. 
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Fig 8.1 Effect of Salts on the secondary structure of HPC 
(C) Figure shows far UV-CD spectra of HPC at pH 6.0 (1), at pH 
2.0 (2) and as function of MgCl: concentration in 20mM 
glycine/HCl buffer, pH 2.0 and at 25°C. The concentration of 
MgCl2 used is 2M (3) and 3 M (4). The rest of conditions 
were same as in Fig 8.1 A. 
(D) Salt induced conformational transition of HPC studied in 
20mM glycine/HCl buffer, pH 2.0 at 25°C, by measuring 
ellipticity at 222nm. (—•—; MgS04 and (—A—) Na2S04 and 
(—•—) MgCb. 
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Fig 8.2 Intrinsic Fluorescence analysis of HPC at pH 6.0, pH 2.0 
alone and at pH 2.0 in presence of sulphate and 
chloride salts 
Figure shows fluorescence spectra of HPC at pH 6.0 (1), at 
pH 2.0 alone (2) and at pH 2.0 in presence of 1.5M MgS04 
(3), 1.5M Na2S04 (4) and 3M MgCb (5). The concentration of 
HPC was luM. HPC was pre-incubated for 4h at 25°C in 
buffer of pH 6.0 for native state and pH 2.0 for acid-induced 
state and at pH 2.0 in presence of salts for the respective 
fluorescence measurements. Fluorescence was measured at an 
excitation wavelength of 280nm in the emission range of 300-
400 nm with a slit width of 5nm. 
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Fig 8.3 Fluorescence emission spectra of ANS bound to HPC 
at pH 6.0, pH 2.0 alone and at pH 2.0 in presence of 
sulphate and chloride salts 
Figure shows spectra of HPC at pH 6.0 (1), at pH 2.0 alone (2) 
and at pH 2.0 in presence of 3M MgCb (3), 1.5M MgS04 (4) 
and 1.5M Na2S04 (5) and. The ANS to protein molar ratio was 
1:60. HPC was pre- incubated for 4h at 25°C in buffer of pH 
6.0(for native), pH 2.0 and ANS (for acid-induced state) and pH 
2.0 containing the indicated concentrations of salts and ANS for 
the respective fluorescence measurements. ANS fluorescence 
was measured at an excitation wavelength of 380 nm in the 
emission range of 400-600nm with a slit width of lOnm. 
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4.3.4 Tertiary structural analysis 
Fig 8.4 shows the near UV-CD spectra in the 250-300nm range of 
native and acid-denatured HPC both in the absence and presence of 80% 
(v/v) glycerol and 3M MgCi2. As can be seen from the figure, near-UV CD 
spectra of native HPC is characterized by a peak at 280nm suggesting 
presence of tertiary structure in the protein. Near UV-CD spectra of acid-
induced state of HPC also showed these characteristics but the ellipticity 
values are reduced showing change in proteins tertiary structure at pH 2.0. 
In the presence of 80% glycerol and 3M MgCla there was increase in 
ellipticity value compzu-ed to that of acid-induced state, the effect being 
more significant for glycerol. 
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Fig 8.4 Tertiary structure analysis of HPC at pH 6.0, pH 2.0 
alone and at pH 2.0 in presence of 80% glycerol and 
3M MgCl2 
Figure shows near UV-CD spectra of HPC at pH 6.0 (1), at 
pH 2.0 alone (2) and at pH 2.0 in presence of 80% (v/v) 
glycerol (3) and 3M MgCh (4). The concentration of HPC for 
near UV-CD was SO-^ M and path length was 1cm. 
129 
10-
3 -
0) 
• D -
Q 
O " 
n -
U 
-3-
x/^S. 
^ ^ ^ ^ 2 ' 
, 
1 
3 ^ ^ % ^ ^ 
1 1 
260 280 300 320 
V\^velength (nm) 

5. DISCUSSION 
I. Purification and characterization of Human Placental 
Cystatin 
Natural inhibitors of cysteine proteinases are called as cystatins. They 
constitute a powerful regulatory system for endogenous cysteine proteinases, 
which may otherwise lead to uncontrolled proteolysis and tissue damage. 
Cystatin are the Superfamily of evolutionary, structurally and functionally 
related proteins involved in the inhibition of papain and related cysteine 
proteinases, cathepsins B, H, L, ficin and bromelain (Barrett 1981; 
Abrahamson 1994). All cystatins form a single superfamily within which all 
the members can be shown to have a statistically significant relation with 
each other or with papain but they do not resemble members of other 
superfamilies (Dayhoff et al., 1979 a,b). Members of the superfamily may be 
divided in to three families namely stefins, cystatins and kininogens on the 
basis of sub-cellular localization, disulphide bonds, number of amino acid 
residues and sequence homology, (Barrett et al., 1986a). 
The unique properties and wide range of physiological function of 
thiol proteinases are remarkable and demand attention. A proteinase 
inhibitor is of physiological importance because inhibition is achieved at 
physiological concentration of the inhibitor in a sufficiently short time with 
negligible dissociation of the complex (Beith 1980). They are associated 
with several pathological conditions such as rheumatoid arthritis (Trabandt 
et al., 1991), renal failure (Kabanda et al., 1995), septic shock (Assfalg-
Machleidt et al., 1988), osteoporosis (Delaisse et al., 1991), metastasizing 
cancer (Koppel et al., 1994), purulent bronchiectasis (Buttle et al., 1990) and 
peridontitis (Cox and Eley, 1989) resulting due to imbalance of endogenous 
cysteine proteinase inhibitors (CPI's) and the proteinases. Extensive work 
has been carried out for the purification and characterization of these 
inhibitors using various isolation procedures. Purification of CPI's have 
been reported from various mammalian tissues like bovine muscle (Zabari et 
al., 1993), chicken egg white (Barrett 1986), rat submandibular cystatin 
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(Bedi 1989) and rabbit skeletal muscle (Matsuishi and Okitani, 2003), 
epidermis (Ohtani et al., 1982a), various squamous epithelia (Hopsu-Havu et 
al., 1983; Ohtani et al., 1982b), liver (Green et al., 1984) and spleen 
(Jarvinen and Rinne, 1982). 
In the present study thiol proteinase inhibitor has been purified from 
human placenta an organ of special importance in human system. In normal 
pregnancy and various pregnancy associated disorders, placenta plays highly 
significant role (Lin et al., 1976). Lysosomes present in the cells of placenta 
take part in the intracellular degradation of proteins (Bohley et al., 1978). 
The activity of lysosomal enzymes (cathepsins B, H, L and C) is controlled 
by cystatins present in the placenta. Since lacuna exists in the isolation and 
physicochemical characterization of cystatin from this tissue it was 
envisaged that a thorough and systematic study will be useful in 
understanding in depth about the cystatins of human placenta and to 
compare its properties with other known cystatins. 
The cystatin was purified from human placenta using a simple 
procedure which involved ammonium sulphate precipitation and gel 
filtration chromatography (Fig 4.0) (Rashid et al., 2004). The procedure is 
rapid with a 14.8% yield and 8913 fold enrichment in specific activity of the 
protein (Table 4.0). The purification scheme gave a better yield as compared 
to the method of Warwas and Sawicki (1989) which is a multistep procedure 
with 13% yield and lower specific activity. Purification of CPI from other 
sources has been reported using affinity chromatography, 
chromatofocussing, gel filtration and ion exchange chromatography 
(Anastasi et al., 1983; Evans and Barrett, 1987; Cimermann et al., 1996). 
The purified inhibitor was found to be homogenous on the basis of 
charge and molecular weight as shown by native-?AGE (Fig 4.1) and SDS-
PAGE in non-reducing and reducing conditions (Fig 4.2). The results 
suggest that the purified protein is a single polypeptide. The molecular 
weight obtained by passing marker proteins through Sephadex G50-80 column 
was calculated to be 12500 (Fig 4.3). It was further confirmed by SDS-
PAGE and the value obtained was 12445 (Fig 4.4). Cystatins type 1 and type 
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2 have been classified on the basis of molecular weight and presence of 
disulphide bonds (Abrahamson 1994). Cystatins from tissues are usually 
small inhibitors having molecular mass in the range of 11 to 25 KDa (Barrett 
1984). Molecular weights of 11400 and 12000 have been reported for 
cysteine proteinases inhibitors isolated from Human spleen (Jarvinen and 
Rinne, 1982), 14000 and 14300 for cystatins from bovine muscle (Zabari et 
al., 1993), 14200 from human liver (Green et al., 1984). For type 1 cystatins 
(Stefins A and B) molecular weights of 11100 and 12000 have been reported 
(Turk et al., 1995). Hence, the molecular weight of cystatin obtained in the 
present study suggests it to be a type 1 cystatin. 
Hydrodynamic parameters for the HPC as determined from gel 
filtration behaviour suggested a stokes radius of 14.5 A (Fig 4.5) and 
diffusion coefficient of 1.53x10"'^  cmVsec. Diffusion coefficient depends 
on the size and shape of the molecule. The stokes radius of cytochrome C is 
16.4 A, it is a compact and globular protein. Thus as indicated by the 
hydrodynamic properties human placental cystatin has a compact globular 
structure. 
Generally, cystatin type 1 and type 2 which are isolated from tissues 
lack carbohydrate content (Barrett et al., 1984) where as presence of 
carbohydrate content is a distinguishing property of type 3 cystatins, the 
kininogens (Salvesen et al., 1986). However, presence of carbohydrate has 
been reported in some type 2 cystatins for example, rat cystatin C isolated 
from urine is slightly glycosylated (Esnard et al., 1988). Ni et al (1997) 
found carbohydrate attachments in cystatin E. Glycosylation has also been 
demonstrated in cystatin F and cystatin M which are all type 2 cystatins (Ni 
et al., 1998; Sotiropoulou et al., 1997). Human Placental cystatin is devoid 
of any carbohydrate content and disulphide bonds are also absent which is 
again a characteristic similar to type 1 cystatins (Barrett et al., 1984). 
Effect of pH on human placental cystatin activity showed that the 
inhibitor has stable activity in the pH range 3.0-9.0 (Fig 4.6). Further, this 
inhibitor was found to be stable in the temperature range 40°C to 100°C (Fig 
4.7). The inhibitor was stable for 120 minutes at 90°C (Fig 4.8). These 
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properties are in accordance with other cystatins, from bovine muscle (Beige 
et al., 1985) and Chicken cystatin (Saxena and Tayyab 1997), Zerovnik et al 
(1997) have shown high thermal stability of chicken cystatin and stefin A 
and B. Barrett et al (1986b) reported similar stability for LMW-CPI up to 
lOO C^ for 5 min. 
The placental cystatin showed moderate immime response and gave a 
low titre of antibodies in rabbits owing to its low molecular weight. The titre 
of antibodies determined by direct binding ELISA in rabbit serum was 
2238.73(Fig 4.9). The low antibody titre suggests that the inhibitor used as 
antigen here is of low molecular weight range. The antibodies raised against 
purified inhibitor gave a reaction of identity with the inhibitor as indicated 
by a single precipitin line on immunodiffusion indicating that HPC has 
immunogenic purity and homogeneity (Fig 5.0). The antisera exhibited no 
immunogenic identity with sheep plasma HMW kininogen and phytocystatin 
purified from Phaseolus mungo (Urd-a commonly used Indian legume) (Fig 
5.1). This indicates that the human placental cystatin has no immunogenic 
identity or similarity in structure and composition to high molecular weight 
mammalian kininogens (type 3 cystatins) and to phytocystatins. 
Stoichiometry of the binding of human placental cystatin with papain, 
ficin and bromelain was determined by the titration of the proteases with the 
inhibitor. A stoichiometric ratio of 1:1 was obtained for HPC with papain, 
ficin and bromelain. This suggests that human placental cystatin is a tight 
binding inhibitor of these proteases. Anastasi et al (1983) and Nicklin and 
Barrett (1984) reported equimolar complexes of cystatin with cysteine 
proteinase. Abrahamson et al (1987) also reported the rapid formation of 1:1 
complex between cystatin C and papain. The human placental cystatin 
(HPC) strongly inhibits thiol proteinases- papain, ficin and bromelain but 
does not inhibit serine proteinases like trypsin and chymotrypsin (Fig 5.2). 
This has also been reported for many other cystatins along with the thiol 
proteinase inhibitor isoforms purified from human spleen (Jarvinen and 
Rinne, 1982). 
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The inhibitory activity of HPC towards above mentioned thiol 
proteinases and serine proteinases were examined using casein as substrate. 
Accurate Ki values were determined by working at lower enzyme 
concentrations and using equations derived by Krupka and Laidler (1959) 
and Henderson (1972). Ki values were calculated from the slope of curve 
obtained for the inhibition of caesinolytic activity of papain, ficin and 
bromelain (Table 4.1). HPC is a potent inhibitor of thiol proteinases as is 
evident by their Ki values. It was readily apparent that the degree of 
inhibition varied with the absolute concentration of the inhibitor as is 
expected for tight binding reversible inhibition. The data shows that HPC 
inhibited papain, ficin and bromelain with Ki values of 5.5x10 M, 8.4x10' 
M and 9.5x10*' M respectively, under conditions of routine assay system 
(Fig 5.3, 5.4 and 5.5). The Ki value is lowest for papain hence it has the 
highest affinity for the inhibitor. These values are in good comparison with 
other thiol proteinase inhibitors, for example inhibition constant (Ki) for 
chicken cystatin and cystatin C has been reported to be 5x10''^ M with 
papain, Ki values of nanomolar range have been reported for cathepsin B, H 
and L with cystatin A (Barrett et al., 1984), cystatin C (Machleidt et al., 
1986), chicken cystatin (Salvesen et al., 1986) and cystatin D (Balbin et al., 
1994). The increasing value of Ki with an increase in substrate concentration 
suggests the inhibition to be competitive. This finding is supported by the 
apparent results of Nicklin and Barrett (1984) for the inhibition of human 
cathepsin B by chicken cystatin. They obtained Ki (app) values of 1.85 and 
3.68 nM with the substrate concentration of 0.05 and 0.39 mM, respectively. 
IC50 value is the concentration of the inhibitor at which 50% of the 
enzyme activity is inhibited. IC50 values of the human placental cystatin for 
the three proteinases papain, ficin and bromelain were 0.051 nM, 0.09 luM 
and 0.131^M respectively (Table 4.1). Lesser IC50 value suggests a greater 
affinity of the inhibitor towards the enzyme. Thus, these values indicate that 
the affinity of HPC for these proteinases are in order of papain> ficin> 
bromelain. Katunuma and Kominami (1985) have found the IC50 value of 
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0.16 \Lg of the inhibitor isolated from rat liver for papain and 0.46 jxg for 
ficin and IC50 value of 4.2 ^g for cathepsin B and 0A4\ig for cathepsin H. 
The kinetics of association was determined assuming that the 
enzymes and the inhibitor react in such a way that dissociation rate is low 
enough to neglect the reverse reaction during the initial part of the reaction. 
The slope of the straight line obtained by plotting 1/ [E] versus time for 
papain, ficin and bromelain gave a k+i values of 3.4x10'*, 2.9x10 and 
8.6x10^ (M"'S'') respectively (Fig 5.6, 5.7 and 5.8). Again the affinity was 
in the order of papain > ficin> bromelain. The dissociation constant values 
(k-i) for the enzyme-inhibitor complex was determined by displacement 
procedure, in which the inhibitor released from the complex was trapped by 
excess substrate (casein) with the increase in time. The amount of enzyme 
released from the complex was monitored by continuous measurement of 
enzyme activity. The respective k.i values of HPC obtained for papain, ficin 
and bromelain were 2.3xl0•^ 2.6x10'^ and 2.1xlO"'(S'') respectively (Fig 
5.9, 6.0 and 6.1). The values of k.i are consistent with k.i values obtained 
for chicken cystatin, 5x10'^ S"' with papain and 2.3x10'^ S"' with cathepsin B 
(Nicklin and Barrett, 1984). The calculated half life values of enzyme-HPC 
complex using these k.i values for papain, ficin and bromelain were 
3.01x10" S, 2.6x10" S and 3.3xlO"S respectively (Table 4.1). The above data 
gives comprehensive information about the kinetics of inhibition of purified 
cystatin with papain, ficin and bromelain and the overall comparison showed 
that HPC inhibits papain more effectively compared to other two 
proteinases. 
The sequence of N-terminal 30 amino acid residues gave some 
interesting results. As reported for other human cystatins, the human 
placental cystatin has Gly residue at position 11 rather than the conserved 
position 9 in various species (Brzin et al., 1984) however, maximum 
sequence homology was observed with chicken cystatin (Schwabe et al., 
1984). Sequence homology of HPC has also been observed with Bovine 
cystatin (Zabari et al., 1993), human-salivary cystatin SN, cystatin S7, 
cystatin C (Turk et al., 1995), rat cystatin (Bedi 1989), human-stefin A 
135 
(Machleidt et al., 1983) stefin B (Ritonja et al., 1985) and Rat liver TPI 
(thiol proteinases inhibitor) (Takio et al., 1983), the details are given in 
Table 4.2. Using the sequence of these N-tenninal amino acid residues a 
hydropathy plot was made using the respective hydropathy index of each 
individual amino acid (Fig 6.2). It was observed that among the 30 residues 
sequenced the stretch of 4-8, 8-12 and 20-24 residues have maximum 
average hydropathy index indicating that these residues are present inside 
the hydrophobic core of the protein. 
The interaction between papain and human placental cystatin was 
studied using various spectroscopic techniques. UV absorption difference 
spectra between the HPC-papain complex showed a pattern of changes in 
ultraviolet absorption in the aromatic wavelength region (Fig 6.3). The 
spectrum shows maxima at 295 nm and 255 nm and minima at 280 nm. The 
peak at 295 nm suggests that aromatic residues are involved in binding with 
papain where as the peak at 280 nm is indicative of changes around tyrosine 
residues (Donovan 1969; 1973a; 1973b), The peak around 255nm may be 
partly due to phenyalanine or cysteine residues and may also contain 
contribution from aromatic residues (Donovan 1973a). Our results are 
comparable to positive absorption difference spectrum throughout the 
aromatic wavelength region reported earlier for rat cystatin-papain 
interaction (Takeda et al., 1986). These results suggest that the environment 
of several aromatic amino acids has been perturbed by this interaction. 
Fluorescence studies showed a decrease in wavelength of the 
maximum fluorescence emission spectrum of cystatin on binding with 
papain (Fig 6.4). The maxima of cystatin shifted from 345 nm to 340 nm for 
cystatin papain complex. This blue shift was accompanied by a small 
decrease of maximum emission intensity. The fluorescence changes induced 
by the binding further shows that the environment of one or more aromatic 
side chains is perturbed (Friefelder 1982). These changes may have arisen 
due to altered conformation of either or both the proteins induced by their 
binding to form the complex (Rashid et al., 2004). 
CD spectra in the far UV region depict the contribution of the 
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secondary structure of the protein (Jiregensons 1970). The a-helical 
structure of the protein in the far UV region is characterized by negative 
peaks at 208-210 nm and 222 nm and a positive peak between 190-192 nm 
(Jirgensons 1970, Chen et ai., 1972). HPC has a-helical content of 21.08% 
and also shows presence of significant amount of p structure (Fig 6.5). The 
a-helical content was calculated from the ellipticity values at 222nm using 
equation given by Chen et al (1972). This type of structure has also been 
reported for chicken cystatin which has a-helical content of about 20% with 
substantial amount of P-structure (Schwabe et al., 1984). Structurally, the 
resemblance between chicken cystatin which is a type 2 cystatin and steflns 
A and B which are type 1 cystatins has been reported earlier (Martin et al., 
1995; Stubbs et al., 1990). Stefm A and stefm B have an a-helical content of 
22% and 20% respectively, however, chicken cystatin has disulphide bonds 
which are absent in case of HPC as well as in the steflns A and B, in 
addition there are differences in amino acid sequence (Staniforth et al., 
2001). 
The placental cystatin loses its native structure on formation of 
complex with papain (Fig 6.5). The complex show's positive ellipticity in 
the range of 215-240nm's and small shoulders appear in 217-230 nm region 
which is a feature of random coil structure (Chen et al., 1972). Far UV-CD 
spectroscopic changes shown here on binding of human placental cystatin to 
papain are appreciably different from those reported earlier for the 
interaction of chicken cystatin with papain (Lindahl et al., 1988). The results 
reported by Lindahl et al (1988) showed small changes in far UV-CD 
spectrum of the complex of chicken cystatin and papain. Complex 
spectroscopic changes in the far UV-region accompanying the binding of 
human placental cystatin to papain indicates that the environment of several 
aromatic amino acids in one or both the proteins is perturbed by the 
interaction resulting in conformational changes in the constituent proteins. 
The results indicate that the UV absorption, fluorescence emission 
and far UV-CD changes are more due to conformational changes in proteins 
rather than any local interaction affecting chromophoric groups of the two 
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constituent proteins of the complex. The positive ellipticity observed for PI 
(protein-inhibitor) complex in far-UV CD region further confirms that 
cystatin and papain both lose their native structures on forming complex. 
The conformation of this complex resembles neither of the constituent 
proteins, rather indicates attainment of random coil structure due to this 
interaction. The kinetics studies also suggest formation of tight complex on 
interaction of inhibitor with papain (Rashid et al., 2004). 
Thus, owing to absence of any carbohydrate content and disulphide 
bonds and all other results taken together, HPC can be placed in type 1 
cystatin family with resemblance to chicken cystatin which is a type 2 
cystatin showing no structural similarity with type 3 cystatins (kininogens). 
II A. GdnHCl and Urea induced Unfolding of HPC 
GdnHCl and Urea are the most common chemical denaturants, used 
for probing the protein conformation, stability and unfolding studies. These 
denaturants show different behaviour towards different proteins, for 
example, prostaglandin D-Synthase in presence of urea and GdnHCl show an 
increase in enzyme activity at lower concentrations which is a dej'iation 
from classical behavior of denaturants (Inui et al., 2003). In case of protein 
matrilysin (recombinant human matrix metalloproteinase 7) half of the 
fluorescence change was observed at 2.2-2.7 M GdnHCl, where as no change 
was observed even with 8M urea and half inactivation of protein was 
induced at 0.8 M GdnHCl and at 2 M urea (Inouye et al., 2000). It is 
generally recognized that protein denaturation is a highly cooperative 
process, which for small globular proteins may be approximated by a two-
state model and no significant intermediates are present during the transition 
N —» D (Aune and Tanford, 1969). However, recently reported results show 
that some intermediates exist during the unfolding of proteins. The 
intermediates between native and unfolded states have been referred to as 
molten globules in some cases (Ptitsyn, 1995). Such intermediates have been 
found for many proteins in mild denaturating conditions. 
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The protein molecule in the molten globule state (MG) is almost as 
compact as in the native state (Dolgikh et al., 1981; Gast et al., 1986; 
Uversky et al., 1993) and has a loosely packed non-polar core. It is usually 
characterized by intense far-UV CD spectra, which suggests existence of 
pronounced secondary structure (Kuwajima, 1989). In case of o-lactalbumin 
the amplitude of CD spectrum increases in the molten globule state 
compared to that of native conformation (Vassilenko and Uversky, 2002). 
For several proteins (Shortle, 1996; Mork et al., 1999) when NMR data has 
been combined with hydrodynamic and small angle scattering data the 
picture emerges that the protein chains are relatively compact under mild 
denaturating conditions, forming intermediates (Shortle, 1996; Mork et al., 
1999). As conditions are made less favorable for structure formation 
generally by adding chemical denaturants like GdnHCl and urea, the 
denatured state gradually loses its residual structure and increases in size 
(Dill and Shortle, 1991). At the highest concentration of denaturant, the 
conformation is expected to converge towards that of a random coil (Shortle 
and Ackerman, 2001). 
Differences in the behaviour of HPC have been observed from 
classical behaviour towards GdnHCl and urea. Activity measurements show 
that at 1.5M GdnHCl concentration the enzyme is already inactivated by 
45% suggesting a change in conformation of protein compared to fully 
active native form (Fig 6.6). Two different effects are displayed by GdnHCl 
on the unfolding pattern of HPC. At low concentrations (0.5 to 1.5M) the 
protein shows increased ellipticity as compared to the native state and 
quenching of fluorescence in this concentration region compared to that of 
zero denaturant concentration. The decrease in fluorescence intensity 
observed up to 1.5M may be caused by tertiary structural rearrangement 
involving aromatic residues or because of the increased mobility of the local 
environment of the aromatic residues. It could be due to aggregation which 
quite often occurs in non native states, even a combination of these factors 
may also be responsible for this decrease. Normally exposed aromatic 
residues in the unfolded protein show emission maxima between 348-356nm 
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(Lakowicz, 1983). Treatment of HPC with higher concentration of GdnHCl 
and urea has resulted in exposure of buried residues present in the native 
protein to the solvent as Xmax in case of GdnHCl red shifts to 350nm and in 
case of urea to 348nm, suggesting induction of unfolding of HPC by these 
denaturants (Fig 6.7 A and B). 
GdnHCl starts behaving as a classical denaturant at higher 
concentrations where it leads to extreme unfolding of the enzyme. However, 
in case of urea the transition ciu^es of unfolding are sigmoidal in shape 
where the protein inactivates and loses its conformation as the concentration 
of denaturant increases giving a mid-point of transition at 3M, where as in 
case of GdnHCl there is tendency of forming intermediates at low 
concentration regions with mid-point of transition in the range 1.5 —• 2M 
(Fig 6.7 C and 6.8 C). The increased ellipticity at lower concentrations of 
GdnHCl may be due to transformation of native form to some intermediate 
state which is different from both native and completely denatured states 
(Fig 6.8 A) where as in case of urea denaturation there is gradual decrease in 
ellipticity of protein with increase in urea concentration without formation 
of any intermediate states (Fig 6.8 B). This formation of intermediates can 
have several explanations. It may be due to micro-environmental changes in 
the aromatic region of the protein, small local rearrangements of the native 
state (Ferreon and Bolen, 2004) or the stabilizing effects of GdnHCl at low 
concentrations (Mayr and Schmid, 1993; Smith and Schlotz, 1996). The data 
obtained for HPC denaturation is supported by several other reports on 
GdnHCl and urea providing different estimates for the conformational 
stability of proteins (Pace, 1975; Yao and Bolen, 1995; Park et al., 2003; 
Deshpande et al., 2003; Wang et al., 2000; Inui et al., 2003; Inouye et al., 
2000). 
The difference in behavior of GdnHCl and urea towards HPC 
denaturation may also be explained on the following basis. Although, urea 
and GdnHCl have similar modes of action, urea has only chaotropic effects 
where as GdnHCl is a monovalent salt having both ionic and chaotropic 
effects. Guanidine is an electrolyte with pKa of 11, which means that at pH 
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values below this it will be present in a fully protonated form as Gdn^. The 
presence of Gdn* and CI" influence the stability properties of proteins and 
enzymes. The effect of GdnHCl and NaCl has been reported on RNase Tl 
(Mayr and Schmid, 1993) where compaction of native enzyme is interpreted 
in terms of stabilization by cation (Gdn^ and Na"^ ) binding to the negatively 
charged moieties of protein. There is stabilization of enzyme by affinity 
binding of these cations at one or more sites, this effect has also been 
demonstrated for glucose oxidase (Ahmad et al, 2001). 
In the present case also, HPC may be stabilized by low concentration 
of cation binding to the negatively charged sites of the inhibitor. Hence at 
low concentration of GdnHCl, stabilization by Gdn"^  cation binding to 
negatively charged sites in protein dominates and at higher concentrations it 
acts as a classical denaturant leading to unfolding of protein chain. As 
protein contain ion-binding sites of varying affinity and specifity degree of 
stabilization of proteins by denaturants could vary from protein to protein. 
The unfolding of human placental cystatin suggests different unfolding 
pathways and mechanisms for the two denaturants. The urea unfolding 
corresponds to a two-state mechanism where N—• D transition takes place in 
a single step and no intermediate states are observed. It has been recently 
reported for lysozyme, that urea induced unfolding follows a two state 
model of equilibrium unfolding with no intermediate states in between the 
N—^  D transition (Bonincontro et al, 2004). The following scheme represents 
the two possible unfolding pathways in GdnHCl and urea solutions for 
human placental cystatin. 
Native (N) 0.5-1.5M GdnHCl Non-Native 
HPC Intermediate state (I) 
Urea 8M GdnHCl 6M 
Denatured state (D) 
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The refolding transitions determined by fluorescence measurements 
show that both urea and GdnHCl unfolding are greatly reversible, however, 
in case of GdnHCl at low concentrations the renatured protein has changed 
intensity compared to native and denatured forms, indicative of an 
intermediate state (Fig 6.7 C). The observed results could be due to 
combined effect of all the factors mentioned above. These different 
stabilizing and destabilizing effects of GdnHCl are apparently additive and 
lead to the complex dependence of GdnHCl concentration and the stability 
of protein (Rashid et al., 2005). 
Understanding the conformational changes that result in a protein by 
various treatments would provide a powerful tool for drug design and for 
comprehension of cellular organization at molecular level. Cysiatins have 
important roles to play in normal body processes owing to their cysteine 
proteinase inhibitory activities and it is of utmost consequence that their 
conformation should be stable for maximum functional activity. Thus the 
above observations have shed some light on the structural alterations and 
loss of function which result due to exposure of denaturants and thus effect 
the normal functioning of the protein. 
II B. Acid Induced unfolding of HPC 
The acid duration of HPC was studied to obtain information about the 
behavior of this protein at low pH conditions. The spectral parameters of 
fluorescence such as position, shape and intensity are dependent on the 
dynamic and electronic properties of the chromophore environment, hence 
fluorescence measurements have been extensively used to obtain information 
on the structural and dynamic properties of the proteins (Ghisla et al. 1974). 
The CD spectra of a protein in the far-UV region gives information about 
the conformation of polypeptide back bone and the hydrophobic dye ANS 
which binds to exposed hydrophobic regions of partially folded proteins is 
used in protein conformational studies to monitor these hydrophobic regions 
(Johnson and Fersht 1995, Stryer 1965). 
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Far UV-CD studies of acid denaturation of HPC showed no major 
change in ellipticity value at 222nm up to pH of 4.5, however, at pH 4.0 and 
below there is marked decrease in ellipticity value and a minimum value was 
obtained at pH 2.0. From pH 2.0 to pH 1.0 there is some increase in 
ellipticity value and the ANS fluorescence was increased at lower pH values 
with a maximum value at pH 2.0 (Fig 6.9). These two results taken together, 
that is, decrease in ellipticity and increase in ANS binding with decreasing 
pH suggest exposure of hydrophobic regions of the HPC and their 
availability in binding to ANS. Both ellipticity measurements at 222nm in 
the far UV region and ANS fluorescence show co-operative transition 
without formation of any intermediate states. Increase in secondary structure 
of HPC at pH 1.0 can be explained on the basis of anion induced folding 
where anions bind to the positively charged protein and decreases the 
number of hydrophobic patches resulting in less binding of ANS (Goto et al. 
1990). 
The far UV-CD spectra of human placental cystatin at pH 2.0 has 
almost all the features of secondary structure same as that of spectra at pH 
6.0 which is the native state of protein (Fig 7.0 A), but the ellipticity value 
is decreased and having an a helical content of about 65% (the helical 
content of native state (pH 6.0) being taken as 100%). For comparison 
unfolding of HPC was also achieved in presence of 6M GdnHCl (Fig 7.0 A) 
which shows loss of secondary and tertiary structure forming a random coil 
structure (Rashid et al., 2005). The near UV-CD spectra of human placental 
cystatin is characterized by a positive peak around 280nm (Fig 7.0 B) 
showing significant amount of tertiary structure in this inhibitor. The 
absence of positive peaks in the region 250nm indicate that disulphide bonds 
are absent in the protein (Ramasarma et al., 1995) which supports our earlier 
mentioned observation of absence of any free thiol groups in this inhibitor. 
HPC at pH 2.0 in the near UV region has native like topology with slight 
decrease in ellipticity value (Fig 7.0 B), A comparison of near UV and far 
UV-CD spectra of acid induced state with native state shows that HPC at pH 
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2.0 retains lot of secondary structure as well as significant amount of tertiary 
structure which is close to that of native state. 
The native state of HPC has fluorescence emission maxima of 345nm 
(Rashid et al., 2004) where as the HPC at pH 2.0 (the acid induced state) has 
decreased fluorescence with X^ ax at 335 nm (Fig 7.1). This blue shift of 
lOnm and decreased fluorescence indicates that the protein conformation is 
altered and microenvironment of aromatic amino acid has become more 
nonpolar. When these results are compared with the fluorescence emission 
spectra of HPC in presence of 6M GdnHCl which shows increase in 
fluorescence accompanied by a red shift of emission maxima to 350 nm 
compared to native state (Rashid et al. 2005), it suggested that the 
conformation of acid-induced state of HPC is different from both the native 
state at pH 6.0 and unfolded state in presence of 6M GdnHCl. 
ANS binding has been widely used to detect the molten globule states 
of different proteins (Stryer 1965, Engelhard and Evans 1995). HPC shows 
large binding of ANS at PH 2.0 compared to native state accompanied by a 
blue shift of 30nm (Fig 7.2). The marked blue shift observed is an indication 
of exposed hydrophobic regions of protein present at lower pH values. 
Therefore, il as compared to native state at pH 6.0 or the 
denatured state in presence of 6M GdnHCl the conformation of acid induced 
state with increased ANS fluorescence than native is different. 
These results suggest that acid induced state in addition to retaining 
secondary and tertiary structural features also has sizeable amount of 
exposed hydrophobic regions. Thus there is an accumulation of a compact 
molten globule like intermediate at low pH possessing persistent tertiary as 
well as secondary structure. In the light of molten globule theory, the molten 
globule state of HPC at low pH conditions has similar characteristics as 
reported for molten globule state of other proteins (Bychkova et al. 1992) 
and in addition has stable native like tertiary structure. The resemblance of 
MG state and native state has significant bearing in understanding protein 
folding problems (Kataoka et al. 1993). It is important to determine the 
extent of tertiary structure present in MG state to understand the role of 
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specific side chain packing in stabilizing and specifying the MG structure. It 
has been shown for proteins cytochrome C, apomyoglobin and 
staphylococcal nuclease that small degree of side chain packing stabilizes 
MG states (Shiraki et al., 1995). Tertiary interactions have been reported for 
MG sates of a-lactalbumin (Shulman et al., 1997), ubiquitin 
(Khorasanizadeh 1996), myoglobin (Kay and Baldwin 1996) and RNase H 
(Raschke and Marqusse 1997). Thus it can be concluded that native like 
packing of core amino acids help in stabilization of molten globule state of 
HPC at pH 2.0 which thus has secondary and tertiary structures resembling 
the native state. 
l i e . Effect of TF£ and Methanol on refolding of acid induced 
state of HPC 
The stabilizing effect of TFE and methanol on the acid induced 
molten globule state of HPC was studied to investigate its structural stability 
of HPC. Far UV CD showed that there is increase in ellipticity value of HPC 
in presence of TFE at pH 2.0. At 40 % (v/v) TFE the helical content of 
protein is almost same as that of the native state (at pH 6.0) (Fig 7.3A and 
7.3B). The increased a-helical content induced by low (20%) and moderate 
(50%) concentrations of TFE in denatured proteins have been reported 
earlier for cardiotoxin analogue I and peptide fragments of hen egg white 
lysozyme (Arunkumar et al. 1997, Yang et al. 1995). In case of lysozyme the 
helical structure induced in presence of 50% TFE was very much similar to 
the native state of protein. In case of HPC as the concentration of TFE 
increased helical content increased and maximum value was obtained at 80% 
concentration of TFE. The results in presence of 40% TFE state showed near 
UV-CD spectral features in between acid denatured state and native state 
however, the curve for 80% TFE shows much decreased ellipticity value 
indicating the denaturating effect of the alcohol at higher concentrations 
(Fig 7.4), Disruption of tertiary structure of protein in presence of alcohol 
has also been reported earlier (Kamatari et al., 1996). 
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Different alcohols have different helix stabilizing potential (Hirota et 
al. 1997, Konno et al. 2000). Thus for comparison in addition to TFE, 
methanol was also used to study the transition from acid denatured state to 
the alcohol induced state. Compared to TFE the helix inducing effect of 
methanol was much less as can be seen in Fig 7.5 and Fig 7.6. The 
respective alcohol induced transition curves of HPC for TFE and methanol 
showed that in case of TFE there is marked increase in the ellipticity as 
shown in far UV-CD spectra of HPC (at pH 2.0) with the increase in 
concentration of these alcohols whereas same effect is not observed in 
presence of methanol. As the concentration of methanol increases to 50 % 
there is not much variation in far UV-CD intensity and with further increase 
in concentration of methanol the intensity remained constant. Therefore it 
can be concluded that TFE has much higher helix inducing ability as 
compared to Methanol. 
Effect of TFE on acid-induced state of HPC shows that alcohols do 
not induce major structural changes but significantly modify the unfolded 
protein by inducing a-helical structures (Fig 7.3, 7.4 and 7.5). Thus, TFE 
while inducing secondary structural features leads to the disruption of 
tertiary structure (Fig 7.4). Therefore, TFE induced state at higher 
concentrations (80%) with significant helical structure and disrupted tertiary 
structure has some molten globule like characteristics but it is significantly 
different from the compact molten globule state at pH 2.0 which has stable 
hydrophobic interactions and more resemblance to native state in terms of 
secondary and tertiary structural features. 
The TFE induced molten globule like state can be referred to as non-
interacting open helical structure as reported elsewhere (Thomas and Dill 
1993, Hagihara et al. 1994, Nishii et al. 1994) in which the interactions 
between the helical segments are weak. The decreased hydrophobic 
interactions among helical segments explain the presence of disrupted 
tertiary structure in TFE induced state of HPC, although this conformation 
has high secondary structural content (or increased helicity) due to 
stabilization of polar interactions or hydrogen bonds in the presence of TFE. 
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The transition curves in Fig 7.7 showed that increase in alcohol 
concentration leads to decrease in ANS fluorescence showing non 
availability of hydrophobic clusters for binding in presence of alcohols. The 
decrease in ANS fluorescence is more in presence of TFE than methanol. 
Decrease in ANS fluorescence has also been reported earlier (Kamatari et al. 
1996). The acid induced state of HPC in the presence of 80 % TFE showed 
decreased fluorescence emission as compared to native state with an 
emission maxima of 370nm (Fig 7.1). This red shift suggests disordered 
tertiary structure in the presence of increasing alcohol concentration. The 
fluorescence intensity shown by ANS bound to HPC at pH 2,0 in the 
presence of 80% TFE is very less with Xmax of 510nm which is 
characteristic of free ANS in water suggesting absence of any hydrophobic 
clusters under these conditions (Fig 7.2). 
From these results it may be inferred that the additon of alcohol to the 
acid denatured HPC induces a state characterized by more helical structure 
and highly internalized hydrophobic regions. Halogeneted alcohol, that is, 
TFE has strong effectiveness in conversion of acid denatured state to alcohol 
induced state, suggesting that fluorine-atom is important for enhancing the 
effect of alcohol. It has been shown earlier that co-operative a helix 
formation in a lactalbumin and melittin induced by hexa fluoroisopropanol, 
a compound with six fluorine atoms is more rapid in inducing this type of 
change than TFE which contains only three fluorine atoms (Hirota and Goto 
1999). 
Our results in the present study may be summarized as (a) formation 
of acid induced molten globule (MG) state at pH 2.0 having signiflcant 
secondary and tertiary interactions which have resemblance to native state 
and has exposed hydrophobic regions (b) effect of TFE compared to 
methanol is more pronounced in conversion of acid denatured state of HPC 
to alcohol induced state, which is characterized by increased helical content, 
disrupted tertiary structure and absence of hydrophobic clusters. 
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II D. Effect of polyols and salts on refolding of acid induced 
state of HPC 
Both polyols and salts have stabilizing effect on proteins. The ability 
of co-solvents to stabilize proteins has been attributed to the preferential 
hydration of proteins (Nolting et al., 1995; Privalov 1996), which means that 
co-solvents do not interact directly with the protein molecule, i.e. they 
preferentially solubilizes in the bulk water. In a triphasic system consisting 
of water, protein and co-solvent (a stabilizer) - the stabilizer is excluded 
from the vicinal water that composes the solvent layer of protein. As a result 
the protein becomes preferentially hydrated, but the radius of the solvation 
layer and the apparent volume of the protein decreases in a phenomenon that 
leads to more stable conformation (Felix et al., 1999; Lopes et al., 1999). 
Kamiyama et al., (1999) has reported molten globule formation in presence 
of polyols for horse Cytochrome C. In the present study polyols, glycerol 
and sorbitol showed different degree of stabilizing effects on acid denatured 
state of HPC. There was a considerable increase in ellipticity values of HPC 
with the increase in glycerol concentration as shown by far UV-CD 
measurements (Fig 7.8). At 80 % (v/v) glycerol the far UV-CD spectra of 
HPC at pH 2.0 showed that the protein has gained highly stabilized structure 
like that of native state. This glycerol induced state has 98% of a helical 
content compared to the value of 65% for acid induced state of HPC (a 
helical content of native state at pH 6.0 taken as 100%). Another polyol used 
in the study that is sorbitol had less structure stabilizing effect on acid 
induced state of HPC as compared to that of glycerol (Fig 7.8 B and C). This 
clearly shows that glycerol has higher protein stabilizing potential. 
The polyol induced transition which was more effective for glycerol 
than sorbitol can be explained on the basis that HPC is preferentially 
hydrated as indicated above, predominantly due to unfavorable interaction of 
polyols with non-polar amino acid residues resulting in exclusion of polyols 
from the protein surface while being retained in the bulk. Thus glycerol 
stabilizes the protein structure by strengthening hydrophobic interactions 
and by overcoming the electrostatic interactions between the charged 
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residues (Kamiyama et al., 1999; Gekko and Ito 1990; Mason et al., 2003). 
In case of glycerol-induced state at 80% concentration fluorescence intensity 
is almost same as that of native state but with a lOnm blue shift indicating 
that the aromatic amino acid residues still have non-polar environment 
where as for 80% sorbitol-induced state fluorescence intensity was 
decreased compared to that of pH 2.0 state suggesting the presence of lesser 
amounts of tertiary folds in the protein (Fig 7.9). 
The acid induced state of HPC in presence of 80% glycerol also 
showed ANS fluorescence with emission maxima of 480nm indicating the 
presence of sizeable amount of hydrophobic clusters but ANS binding was 
less than that of the pH 2.0 state where ANS binding is maximum (Fig 8.0). 
These results show that glycerol induced state has different conformation as 
compared to that of sorbitol induced state which showed minimal ANS 
binding. The glycerol induced state showed conformation close to the 
tertiary structure of protein in the native state as there is some ordering of 
hydrophobic regions indicated by decreased ANS binding as compared to the 
acid-induced state alone. 
In the present study in addition to polyols, three salts (MgS04, 
Na2S04, and MgCb) are considered for their protein stability effects. The far 
UV CD studies of acid induced state of HPC in the presence of these salts 
showed that both the sulphate salts are less effective in stabilizing the 
protein (Fig 8.1 A and B). However, presence of MgCh showed more 
pronounced stabilizing effect on HPC at pH 2.0 as compared to that of 
sulphate salts. At 3M MgCb concentration spectral features showed 
resemblance to the native state of protein (Fig 8.1 C and D). The maximum 
fluorescence emission of HPC at pH 2.0 is increased in presence of both the 
sulphate salts (Fig. 8.2) when compared to that of native (pH .60) and acid-
induced states (pH 2.0) alone. The large increase in fluorescence observed 
for MgS04 than Na2S04 suggests a change in the environment of aromatic 
amino acid residues with a decreased tertiary structure. The spectra for 
MgCl2 has same intensity as that of acid-induced state but shows red shift of 
5nm which indicates the changed tertiary structural features when compared 
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to acid-induced state. The ANS binding studies show least ANS binding in 
the presence of sulphate salts whereas in presence of MgCla ANS binding is 
more than that of native state at pH 6.0 although being less than the acid 
induced state with a 30nm red shift (Fig 8.3). The ANS binding in case of 
both sulphate salts is less than that of the native state showing least presence 
of hydrophobic clusters. The intrinsic fluorescence and ANS binding studies 
show that MgCb-induced state has more stable conformation as compared to 
the structures induced by sulphate salts and it lies somewhere in between the 
native and acid-induced state. 
The CD spectrum in the near UV region has been used to probe the 
asymmetry in the environment of proteins aromatic amino acid residues 
(Kuwajima 1989; Dryden and Weir 1991). The near UV-CD spectral studies 
show that HPC at pH 2.0 in presence of 80% glycerol and 3M MgCb has 
ellipticity values higher than that of acid induced state alone, however less 
than that of the native state of protein at pH 6.0 (Fig 8.4). The increase in 
tertiary structure as shown by near UV-CD spectra is more for glycerol 
induced state than the MgCh state. Although the ellipticity values obtained 
in the presence of 80% glycerol was less than the ellipticity of native HPC, 
it certainly shows the attainment of tertiary structure close to native state in 
presence of glycerol. 
The protein stability in the presence of salts and increased induction 
of helical structure can be explained on the basis of 'Salting out' effects of 
these salts as reported earlier (Arakawa and Timasheff 1984; Arakawa et al., 
1990 (a), 1990 (b)). In order to explain further the differential effects of 
salts on protein stabilization, experiments in the wide concentration range 
are necessary to discriminate the 'Salting out' effect from the preferential 
salt binding (salting in) effects. The MgCb induced refolding of HPC is 
accompanied by induction of significant secondary and tertiary structure and 
overall increased compactness of the protein molecule compared to the 
sulphate salts. At low pH conditions there is net positive charge on the 
proteins, it is more likely that it is the anions that are the key components in 
the action of salts. One indication that the effects involve a significant direct 
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ion interaction with the protein is that although both sulphate and chloride 
have stabilizing effects on the protein, sulphate is a known Kosmotropic 
(stabilizing) agent for protein, however, chloride is neutral in this regard 
(Collins and Washabaugh 1985). Thus, it is most likely that the effects are 
due to specific interaction of ions with the protein, in addition to preferential 
hydration of protein in the presence of salts. Thus chloride ions at high 
concentration, 3M used in this case, binds to the positively charged HPC (at 
pH 2.0) and stabilizes the protein on account of specific ion interactions. 
The ion-induced effects on the water structure at high salt concentration 
could in turn effect the hydrophobic interactions within the protein (Kella 
and Kinsella 1988). All these effects taken together explain differential 
effects of salts in protein stabilization. 
The overall results suggest that the acid denatured state of HPC in 
presence of polyois and salts refolds in to a structure which lies in between 
the native and acid denatured conformation. Among polyois, glycerol 
showed more protein stabilizing effect as compared to sorbitol. The 
glycerol-induced state at 80% concentration has some molten globule like 
characteristics Tt has o<^ en been claimed that the stability of molten globule 
state is determined by balancing between the hydrophobic interactions and 
the electrostatic repulsive forces since studies on the amino acid solubility 
and preferential solvent interaction of protein in polyol-water mixtures 
clearly demonstrated that the main driving force of protein stabilization by 
polyois is the enhancement of hydrophobic interactions overcoming the 
electrostatic repulsion between the charged residues (Kamiyama et al., 1999; 
Goto et al., 1990). Figs. 7.8A, 7.9 and 8.0 reveal following features of HPC 
at pH 2.0 in presence of glycerol (80%), native like secondary structural 
features as shown by far UV-CD, increased binding of ANS compared to 
native state (pH 6.0) although less than that of acid denatured state (pH 2.0), 
blue shift of intrinsic fluorescence measurement indicating apolar 
environment of aromatic amino acid residues, slightly increased ellipticity as 
compared to acid denatured state in near UV region as shown in Fig 8.4. 
Thus, with these features glycerol induced state (80% concentration) is 
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different from acid denatured state which has a molten globule 
conformation. On the basis of above considerations this glycerol induced 
state can be regarded as a state in between native and MG state at pH 2.0. 
The decreased binding of ANS observed in the glycerol induced state can be 
explained as decrease of ANS binding sites or an increased ordering of 
tertiary structure making ANS binding sites more inaccessible. 
ANS binds to hydrophobic patches on protein (Stryer 1965). In native 
state ANS binding sites are buried deep in the protein interior, increased 
accessibility of ANS to these sites in the molten globule states results from 
the loose packing of residues in this conformation (Semisotnov et al., 1991). 
Since both intrinsic fluorescence and near UV-CD show glycerol-induced 
state resembling to native state, it suggests ordering of tertiary structure. 
Similar is the case in the presence of MgCb (3M) where HPC has 
conformation in between the native and acid induced state as can be seen in 
Fig 8.1C, Fig 8.2, Fig 8.3 and Fig 8.4. Thus, on the basis of these studies it 
can be concluded that both polyol (80% glycerol) and salt (3M MgCh) 
induced states are different from molten globule states at pH 2.0 and have 
compactness lying in between native and MG state. As the degree of 
preferential exclusion «f a cc colvent is directly proportional to the protein 
surface area, the system under a particular set of conditions favors the 
protein state with the smallest area (Kendrick et al., 1997) and preferential 
exclusion of co-solvents leads to increased compactness of protein compared 
to native state, especially in view of the unfavorable interactions between 
water and the polypeptide backbone (Liu and Bolen 1995). This explains the 
mid-way conformation lying in between the native and molten globule state 
(at pH 2.0), of the co-solvent induced states of HPC. 
In conclusion our results showed that human placental cystatin (HPC) 
is a type 1 cystatin similar in some properties to type 2 mammalian 
cystatins. The investigations have shed some light on the structure of this 
inhibitor from an important human tissue, which certainly will add to the 
scientific information available about these inhibitors and it will help in 
understanding cystatins in a wider perspective. 
152 

6. BIBLIOGRAPHY 
Abrahamson M, Barrett AJ, Salvesen G and Grubb A (1986) J.Biol.Chem., 
261:11282-11289. 
Abrahamson M, Grubb A, Olafsson I and Lundwall A (1987) FEES Lett., 
216:229-233. 
Abrahamson M (1994) Methods Enzymology., 244: 685-700. 
Abrahamson M (2001) International Symp. Protemase Inhibitors Biol. 
Control, Brdo, Slovenia. Book of Abstracts: 29. 
Adam A, Albert A, Calay G, Closset J, Damas J and Franchiomont P (1985) 
Clin. Chem., 31(3): 423-426. 
Agarwala KL, Kawabat S, Hirata M, Miyagi M, Tsuriasawa S and Iwanaga S 
(1996) J. Biochem., 119(1): 85-94. 
Aghajanyan HG, Arzumanyan AM, Arutunyan AA and Akopyan JN (1996) 
Neurochem. Res., 13(8): 721-727. 
Ahmad A, Akhtar Md.S and Bhakuni V (2001) Biochemistry, 
40:1945-55. 
Alavaikko M, Aine R, Rinnie A, Jarvinen M and Blanco G (1985) Int. J. 
Cancer., 35: 319-325. 
Anastasi A, Brown MA, Kembhavi AA, Nicklin MJH, Sayers CA, Sunter 
DC and Barret AJ (1983) Biochem. J., 211: 129-138. 
Andrews P (1964) Biochem. J., 91:222-227. 
Anfmsen CB (1973) Science, 181:223-230. 
Arakawa T and Timasheff SN (1984) Biochemistry, 23: 5912-5923. 
Arakawa T, Bhat R and Timasheff SN (1990a) Biochemistry, 29: 
1914-1923. 
153 
Arakawa T, Bhat R and Timasheff SN (1990b) Biochemistry, 29: 
1924-1931. 
Arakawa T and Timasheff SN (1982) Biochemistry, 21: 6545-6552. 
Arunkumar AI, Kumar TKS and Yu C (1997) Biochem. Biophys. 
Acta, 1338: 69-76. 
Asboth B, Mayer Z and Polgar L (1988) FEBS Lett., 233: 339-341. 
Assfalg-Machleidt I, Jochun M, Klaubert W, Inthom D and Machleidt W 
(1988) Biol.Chem. Hoppe-Seyler, 369: 263-269. 
Aune KC and Tanford C (1969) Biochemistry, 8: 4586-4590. 
Baba SP, Zehra S and Bano B. (2005) The Prot. J.,( In press) 
Babu KR and Bhakuni V (1997) Eur. J. Biochem., 245: 781-789. 
Bai P, Song J, Luo L and Peng ZY (2001) Protein. Sci., 10:53-62. 
Balbin M, Hall A, Grubb A, Mason RW, Lopez-Otin C and Abrahamson M 
(1994) J. Biol. Chem., 269(37): 23156-23162. 
Ballery N, Desmadril M, Minard P and Yon JM (1993) Biochemistry, 
32: 707-714. 
Barker WC and Dayhoff MO (1972) Atlas of Protein Sequence and 
Structure. Vol. 5. National Biomedical Research Foundation, Washington 
DC: 101-110. 
Barrett AJ (1981) Methods Enzymol., 80: 771-778. 
Barrett AJ, Davies ME and Grubb A (1984) Biochem. Biophys. Res. 
Commun., 120:631-636. 
Barrett AJ (1985) Litracellular Protein Catabolism; A.R.Liss, New York: 
105-116. 
Barrett AJ, Rawlings ND, Davies ME, Machleidt W, Salesen G and Turk V 
(1986a) In Proteinase Inhibitors (Barrett AJ, Salvesen G. eds): 515-569. 
154 
• 
• 
• 
Barrett AJ, Fritz H, Grubb A, Isemura S (1986b) Biochem. J., 236: 311-312. 
Barrett AJ (1987) Trends Biochem. Sci., 12: 193-196. 
Barrett AJ, Rawlings ND and Woessner JF (1998) Handbook of Proteolytic 
En2ymes, Academic Press, San Diego, London. 
Barrick D and Baldwin RL (1993) Biochemistry, 32: 3790-3796. 
Barrick D, Hughson FM and Baldwin RL (1994) J. Mol .Biol., 237: 
588-601. 
Bedi GS (1989a) Arch. Biochem. Biophys., 270:335-343. 
Bedi GS (1989b) Aich. Biochem. Biophys., 273: 245-253. 
Bever CT and Garver DW (1995) J. Neurol. Sci., 131: 71-73. 
Beith J (1980) Bull. Eur. Physiopathol. Respir., 16(suppl): 183-195. 
Bige L, Ouali A and Valin C (1985) Biochim. Biophys. Acta, 843: 269-275. 
Bjork I, Alriksson E and Ylinenjarvi K (1989) Biochemistry, 28:1568-1573. 
Bode W, Engh R, Musil D, Thiele U, Huber R, Karshikov A, Brzin J, Kos J 
and Turk V (1988) EMBO.J., 7:2593-2599. 
Bohley P, Kirschke H, Langer J, Riemanim S, Wiederanders B, Ansorge S 
and Hanson H (1978) in Protein turnover and lysosomal function (Segal, HL 
and Doyle, D. eds) pp. 379-391, Academic Press, New York. 
Bohn H (1976) Peeters, H. (ed) Oxford Pergamon Press, pp. 117-124. 
Bonincontro A, Cinelli S, Comaschi T and Onori G (2004) Phys. 
Chem. Chem. Phys., 6, 1039-1042. 
Booth DR, Sunde M, Bellotti V, Robinson CV, Hutchinson WL, 
Fraser PE, Howkins PN, Dobson CM, Radford SE, Blake CCF and 
Pepys MB (1997) Nature, 385: 787-793. 
Brems DN, Plaisted SM, Havel HA, Kauffman EW, Stodola JD, Eaton 
LC and White RD (1985) Biochemistry, 24: 7662-7668. 
155 
Brems DN, Brown PL and Becker GW (1990) J. Biol. Chem., 265, 
5504-5511. 
Brzin J, Kopitar M, Locnikar P and Turk V (1982) FEBS Lett., 138: 193-
197. 
Brzin J, Kopitar M, Turk V and Machleidt W (1983) Hoppe-Seyler's Z. 
Physiol. Chem., 364:1475-1480. 
Brzin J, Popovic T, Perk V, Borchart U and Machleidt W (1984) Biochem. 
Biophys. Res. Commun., 118:103-109. 
Butler EA and Flynn FV (1961) J. Clin. Pathol., 14:172-178. 
Buttle DJ, Burnett D and Abrahamson M (1990) Scand. J. Clin. Lab. Invest., 
50: 509-516. 
Bychkova VE, Bemi R, Rossi GL, Kutyshenko VP and Ptitsyn OB 
(1992) Biochemistry, 31: 7566-7571. 
Cejka J and Fleischmann LE (1973) Arch. Biochem. Biophys., 157: 
168-176. 
Chamberlain AK and Marqusee S (2000) Adv. Protein. Chem., 53: 
283. 
Chen YH, Yang JT and Martinez HM (1972) Biochemistry, 13: 3350. 
Choi SJ, Reddy SV and Devlin RD (1994) Cell Death Differ., 6: 1028-1042. 
Christensen H and Pain RH (1991) Eur. Biophys. J., 19: 221-229. 
Cimerman N, Kosorok MD, Korant BD, Turk B and Turk V (1996) Biol. 
Chem. Hoppe-Seyler, 377:19-23. 
Cole T, Inglis AS, Roxburg CM, Howlett GJ and Schreiber G (1985) FEBS 
Lett., 182:57-61. 
CoUe A, Guinet R, Leclerecq M and Manuel Y (1976) Clin. Chem. Acta., 
67: 93-97. 
156 
• Collins AR and Grubb A (1991) Antimicrob. Agents. Chemother., 35: 2444-
2446. 
• Collins KD and Washabaugh MW (1985) Q. Rev. Biophys. 18, 323-
422. 
• 
• 
• 
Cox SW and Eley BM (1989) J. Peridontal. Res., 24: 353-361. 
Davies KJ (1987) J. Biol. Chem., 262: 9895-9901. 
Davies ME and Barrett J (1984) Histochemistry, 80: 373-377. 
DayhofiF MO, Hunt L, Barker WC, Schwartz RM and Orcitt BC (1979a) 
Protein Segment Dictionary 78, National Biomedical Research Foundation, 
Georgetown University Medical Centre, Washington DC, 2007. 
DayhofiF MO, Barker WC and Hunt LT (1979b) Atlas of Protein Sequence 
and Structure, Vol 5, suppl., 3. National Biomedical Research Foundation, 
Washington DC: 9-20. 
Delaisse JM, Ledent P and Vaes G (1991) Biochem. J., 279, 167-174. 
Deshpande RA, Khan MI and Shankar V (2003) Biochem. Biophys. 
Acta, 1648(1-2), 184-194. 
Dice FJ, Walker CD, Bryne B and Cardiel A (1978) Proc. Natl. Acad. Sci. 
USA, 75: 2093-2097. 
Diekmann T, Mitschang L, Hofinann M, Kos J, Turk V, Auerswald EA, 
Jaenicke R and Oschkinat H (1992) J. Mol. Biol., 234: 1314-1321. 
Diekmann T, Mitschang L, Hofinann M, Kos J, Turk V, Auerswald EA, 
Jaenicke R and Oschkinat H (1993) J. Mol. Biol., 234:1048-1059. 
Dill KA and Shortle D (1991) Annu. Rev. Biochem., 60, 795-825. 
Dill KA, Bromberg S, Yue K, Fiebig KM, Yee DP, Thomas PD and 
Chan HS (1995) Protein. Sci., 4: 561-602. 
Dobson CM (1994) Curr. Biol., 4: 663-640. 
157 
Dolgikh DA, Gilmanshin RI, Brazhnikov EV, Bychkova VE, 
Semisotnov GV, Venyaminov SYu and Ptitsyn OB (1981) FEBS 
Lett., 136, 311-315. 
Donovan JW (1969) in Physical Principles and Techniques of Protein 
Chemistry, Part A. (Leach SJ Ed.) pp 101-170, Academic Press, New 
York. 
Donovan JW (1973a) Methods EnzymoL, 27:497-525. 
Donovan JW (1973b) Methods EnzymoL, 27: 525-548. 
Drenth, Kalk KM and Swen HM (1976) Biochemistry, 15:3731-3738. 
Dryden D and Weir MP (1991) Biochim. Biophys. Acta, 1078: 94-96. 
Dubois MK, Gilles A, Hamilton JK, Rebers PA and Smith F (1956) Anal. 
Biochem., 28: 350-354. 
Duffy MJ (1996) Clin. Cancer. Res., 2:613-618. 
Edman P and Begg G (1967) Eur. J. Biochem., 1: 80-91. 
Ekiel I, Abrahamson M, Fulton DB, Lindahl P (1997) J. Mol. Biol., 271: 
266-271. 
Eliman GB (1959) Arch. Biochem. Biophys., 82: 70-77. 
Engelhard M and Evans PA (1995) Proteins. Sci., 4:1553-1562. 
Esnard A, Esnard F, Faucher D and Gauthier F (1988) FEBS Lett., 236: 475-
480. 
Estrada S and Bjork I (2000) Protein Science, 9(11): 2218-2224. 
Estrada S, Nycander M, Hill NJ, Craven CJ, Waltho JP and Bjork I (1998) 
Biochemistry, 37(2): 7551-7560. 
Etherington DJ (1976) Biochem J., 153: 199-209. 
Evans HJ and Barrett AJ (1987) Biochem. J., 246: 795-797. 
158 
Felix CF, Moreira CC, Oliveira MS, Sola-Penna M, Meyer-Fernandes 
JR, Scofano HM and Ferreira-Pereira A (1999) Eur. J, Biochem., 266: 
660-664. 
Ferreon AC and Bolen DW (2004) Biochemistry, 43(42), 13357-
13369. 
Fink AL, Calciano LJ, Goto Y, Kurotsu T and Palleros DR (1994) 
Biochemistry, 33: 12504-12511. 
Finkelstadt JT (1957) Proc. Soc. Exp. Biol. Med., 95: 302-304. 
Fossum WM and Whitaker JR (1968) Arch. Biochem. Biophys., 125: 367-
375. 
Fraki JE (1976) Arch. Dennatol. Res. 255: 317-330. 
Freiji JP, Abrahamson M, Olafsson I, Velasco G, Gnibb A and Lopez-Otin C 
(1991) J. Biol. Chem., 266:20538-20543. 
Friefelder D (1982) Physical Biochemistry, 2"** Ed. WH Freeman and 
Company, New York. 
Fukuyama K, Ohtani O, Hibino T and Epstein WL (1982) Cell Tissue Res., 
233:313-323. 
Gabrejeleic D, Annan Prah A, Rodie B, Rozman B (1990) J. Clin. Chem. 
Clin. Biochem., 28: 149-153. 
Gast K, Zirver D, Welfl, H, Bychkova VE, Ptitsyn OB (1986). Int. J. 
Biol. Macromol., 8, 231-236. 
Gekko K and Timasheff SN (1981) Biochemistry, 20: 4667-4676. 
Gekko K and Ito H (1990) J. Biochem., 107(4): 572-577. 
Ghisla S, Massey V, Lhoste JM and Mayhew S (1974) Biochemistry, 
13:589-597. 
Goto Y and Fink L (1989) Biochemistry, 28: 945-952. 
159 
Goto Y, Takahishi M and Fink AL (1990) Biochemistry, 29: 3480-
3488. 
Goto Y, Hagihara Y, Hamada D, Hoshino M, Nishii I (1993) 
Biochemistry, 32, 11878-85. 
Gounaris AD, Brown MA and Barrett AJ (1984) Biochem. J., 218:939-946. 
Green GDJ, Kembhavi AA, Davies ME and Barrett AJ (1984) Biochem. J., 
218: 939-946. 
Grubb A, Weiber H and Lofberg H (1983) Scand. J. Clin. Lab. Invest., 43: 
421-425. 
Grubb A, Lofberg H and Barrett AJ (1984) FEBS Lett., 170: 370-374. 
Grubb A, Abrahamson M, Olafsson I, Tronjar J and Grzonka Z (1990) Biol. 
Chem. Hoppe-Seyler, 371:137-144. 
Hagihara Y, Tan Y and Goto Y (1994) J. Mol. Biol., 237: 336-348. 
Hamada D, Kuroda Y, Tanaka T and Goto Y (1995) J. Mol. Biol., 
254: 737-746. 
Hayashi H (1975) Int. Rev. Cytol., 40:101-151. 
Henderson PJF (1972) Biochem. J., 127: 321-333. 
Hibino T, Fukuyama K and Epstein WL (1980) Biochim. Biophys. Acta, 
632: 214-226. 
Hirado M, Niiobi M and Fujii S (1984) J. Biochem., 96: 51-58. 
Hirado M, Tsunasawa S, Sakiyama F, Niiobe M and Fujii S (1985) FEBS 
Lett., 186: 41-45. 
Hirota N, Mizuno K and Goto Y (1997) Protein. Sci., 6: 416-421. 
Hirota-Nakaoka N and Goto Y (1999) Biorg. Med. Chem., 1:67-73. 
Hochwald GM and Thorbecke GJ (1962) Proc. Soc. Exp. Biol. Med., 
109: 91-95. 
160 
Hopsu-Havu VK, Kalimo K and Jarvinen M (1981) Br. J. Dermatol., 104: 
621-625. 
Hopsu-Havu VK, Joronen I, Jarvinen M and Rinne A (1982) Eur. Rev. Med. 
Phama. Sci., IV: 389-394. 
Hopsu-Havu VK, Jarvinen M and Rinne A (1983a) Br. J. Dermato., 109: 77-
85. 
Hopsu-Havu VK, Joronen I, Jarvinen M and Rinne A (1983b) Eur. Rev. 
Med. Phann. Sci., IV, 1-4. 
Hopsu-Havu VK, Joronen I, Jarvinen M and Rinne A (1985a) Arc. Dermatol. 
Res., 277:452-456. 
Hopsu-Havu VK, Joronen I, Havu S, Rinne A, Jarvinen M and Forsstrom J., 
(1985b) Scan. J. Clin. Lab. Invest., 45:11-16. 
Inouye K, Tanaka H and Oneda H (2000) J. Biochem., (Tokyo) 
128(3): 363-9. 
Inui T, Okhubo T, Emi M, Irikura D, Hayaishi O and Urade Y (2003) 
J. Biol. Chem., 278 (5), 2845-52. 
Isemura S, Saitoh E and Sanada K (1984a) J. Biochem., 96: 489-498. 
Isemura S, Saitoh E, Ito S, Isemura M and Sanada K (1984b) J. Biochem., 
96:1311-1314. 
Isemura S, Saitoh E, Sanada K, Isemura M and Ito S (1986) In V.Turk (Ed). 
Cysteine Proteinase and their inhibitors, Walter de Gruyter, Berlin. 
Isemura S, Saitoh E, Ito S, Sanada K and Minakata K (1991) J. Biochem., 
110: 648-654. 
Jagannadham MV and Balasubramanian D (1985) FEBS Letts., 188: 
326. 
Janowski R, Kozak M, Jankowska E, Grzonka Z, Grubb A, Abrahamson M 
and Jaskolski M (2001) Nat. Struct. Biol., 5(4): 316-320. 
161 
Jarvinen M and Hopsu-Havu VK (1975) Acta. Chem. Scand. B., 29: 772-
780. 
Jarvinen M (1976) Acta. Chem. Scand. B., 30: 933-940. 
Jarvinen M (1978) J. Invest. Dermatol, 71:114-118. 
Jarvinen M, Rasanen O and Rinnie A (1978) J. Invest. Dermatol., 71: 119-
121. 
Jarvinen M (1979) FEBS Lett., 108:461-464. 
Jarvinen M and Rinnie A (1982) Biochim. Biophys. Acta, 708:210-217. 
Jarvinen M, Pemu H, Rinnie A, Hopsu-Havu VK and Altonen M (1983) 
Acta. Histochem., 73:279-282. 
Jenko S, Skarabot M, kenig M, Guncar G, Musevic I, Turk D and Zerovnik 
E (2004) Prot. Struct. Funct. Bioinform., 55:417-425. 
Jirgensons B (1970) Biochim. Biophys. Acta, 200: 9-17. 
Johnson CM and Fersht AR (1995) Biochemistry, 34: 6795-6808. 
Johnson P, Parkes C and Barrett AJ (1984) Biochem. Soc. Trans., 12: 1106-
1107. 
Kabanda A, Goffin E, Bernard A, Lauwerys R and Van Yperseie de Strihou 
C (1995) Kidney Int. 48: 1946-1952. 
Kamatari YO, Konno T, Kataoka M and Akasaka K (1996) J. Mol. 
Biol., 259:512-523. 
Kamiyama T, Sadahide Y, Nogusa Y and Gekko K (1999) Biochim 
Biophys Acta, 1434: 44-57. 
Kataoka M, Hagihara Y, Mihara K and Goto Y (1993) J. Mol. Biol., 
229:591-596. 
Kato H, Nagasav^ a^ S and Iwanaga S (1981) Methods Enzymol., 80:172-198, 
Katunuma N and Kominami E (1985) Curr. Topics Cell Reg., 345-360. 
162 
• Katunuma N, Kominami E and Hashida S (1982) Adv. Enzyme Regul, 20: 
337-350. 
• Kasprzykowski F, Schalen C, Kasprzykowska R, Jastrzebska B and Grubb A 
(2000) APIMS, 108: 473-481. 
• Kay MS and Baldwin RL (1996) Nat. Struct. Biol., 3: 439-445. 
• Keil-Dlouha V and Planchenault J (1986) Proc. Natl. Acad. Sci. USA, 
83:5377-5381. 
• Keilova H and Tomasek V (1975) Coll. Czech. Chem. Commun., 40: 218-
224. 
• Kella NK and Kinsella JE (1988) Int. J. Pept. Protein. Res., 32: 396-
405. 
• Kendrick BS, Chang BS, Arakawa T, Peterson B, Randolph TW, 
Manning MC, Carpenter JF (1997) Proc. Natl. Acad. Sci. USA. 94: 
11917-11922. 
• Khorasanizadeh S, Peters ID and Roder H (1996) Nat. Struct. Biol., 3: 
193-205. 
• Kim PS and Baldwin RL (1990) Annu. Rev. Biochem., 59: 631-660. 
• Kitamura N, Kitagawa H, Fukushima D, Takagaki Y, Miyate T and 
Nakanishi S (1985) J. Biol. Chem., 260: 8610-8617. 
• Knight CG (1980) Biochem. J., 189:447-453. 
• Koh JT, Cornish VW and Schultz PG (1997) Biochemistry, 36: 1314. 
• Kominami E, Wakamatsu N and Katunuma N (1981) Biochem. Biophys. 
Res. Commun., 99: 568-575. 
• Kominami E, Wakamatsu N and Katunuma N (1982a) Acta. Biol. Med. Ger., 
41: 69-74. 
163 
Kominami E, Wakamatsu N and Katunuma N (1982b) J. Biol. Chem., 257: 
14648-14652. 
Kominami E, Tsukahar T, li K, Hizaura K and Katunuma N (1984) 
Biochem. Biophys. Res. Commun., 123: 816-821. 
Konno T, Iwashita J and Nagayama K (2000) Protein. Sci., 
9(3):564-569. 
Koppel P, Baici A, Keist R, Matzku S and Keller R (1994) Exp. Cell Biol, 
52: 293-299. 
Kopitar M, Stem F and Marks N (1983) Biochem. Biophys. Res. Commun., 
112: 1000-1006. 
Korant BD, Brzin J and Turic V (1985) Biochem. Biophys. Res. Commun., 
127:1072-1076. 
Kos J, Stabuc B, Schweiger A, Krasovec M, Cimerman N, Kopitar-Jerala N 
and Vrhovec I (1997) Clin. Cancer Res., 3:1815-1822. 
Kotyza J and Krepela E (2002) Biomarkers and Environment, 5:1. 
Krupka RM and Laidler KJ (1959) Can. J. Chem., 51: 1268-1271. 
Kunitz M (1947) J. Gen. Physiol., 30: 291-295. 
Kuwajima K (1989) Proteins, 6: 87-93. 
Kyte J and Doolittle RF. (1982) J. Mol. Biol., 157: 105-132. 
Lakowicz JR (1983). Principles of fluorescence spectroscopy. Plenum 
Press, New York. 
Laemmli UK (1970) Nature, 227: 680-687. 
Lah TT, Kokalj-Kunovar M and Turk V (1990) Biol. Chem. Hoppe-Seyler, 
371: 199-203. 
Lah TT, Babnik J, Schiffman E, Turk V and Skaleric U (1993) J. Peridontal., 
64:485-491. 
164 
Lakowski M Jr and Kato J (1980) Ann. Rev. Biochem., 49: 593-626. 
Lalioti MD, Mirotsu M, Buresi C, Peitsch MC, Rossier C, Ouazzani R et al., 
(1997) Am. J. Hum. Genet., 60: 342-351. 
Laurent TC and Killander J (1964) J. Chromatography, 140: 317-325. 
Lenney JF, Tolan JR, Sugai WJ and Lee AG (1979) Eur. J. Biochem., 101: 
153-161. 
Li JB and Goldberg AL (1976) Am. J. Physiol., 231:441-448. 
Lin Chi-wei, Kirley SD (1976a) Peeters H. (ed) Oxford Pergamon Press, pp. 
103-108. 
Lin TM, Halbert SP, Spellacy WN and Gall S (1976b) Am. J. Obstet. 
Gynecol., 124: 382-387. 
Lindahl P, Alriksson E, Jomvall M and Bjork I (1988) Biochemistry, 27: 
5074-5082. 
Liu Y and Bolen DW (1995) Biochemistry, 34:12884-12891. 
Lofberg H and Grubb AO (1979) Scad. J. Clin. Lab. Invest., 39: 619-626. 
Lofberg H, Grubb AO and Brun A (1981a) Biomed. Res., 2: 298-306. 
Lofberg H, Stromblad LG, Grubb AO and Olson SA (1981b) Biomed. Res., 
2: 527-535. 
Lofberg H, Grubb AO, Jomvau H, Moller CA, Stromblad LG and Olsson SO 
(1982) Acat Endocrinol., 100: 595-598. 
Lofberg H, Grubb A, Davidsson J, Kjellander B, Stromblad LG, Tibblin S 
and Olsson SO (1983) Acat Endocrinol., 104: 69-76. 
Lopes DH, Meyer-Fernandes JR and Sola-Penna M (1999) Z. 
Naturforsch. 54C: 186-190. 
Lottspeich F, Kellermann J, Henschen A, Foertsch B and Muller-Esteri W 
(1985) Eur. J. Biochem., 152: 307-314. 
165 
• 
• 
Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) J. Biol. Chem., 
193: 265-270. 
Machleidt W, Borchart U, Fritz H, Brzin J, Ritonja A and Turk V (1983) 
Hoppe-Seyler's Z. Physiol. Chem., 364:1481-1486. 
Machleidt W, Machleidt I, Muller-Esteri I, Brzm J, Kotnik M, Popovic T and 
Turk V (1986) In V. Turk (Ed), Cysteine Proteinase and their Inhibitors, 
Walter de Gruyter, Berlin. 
Manoury B, Hewitt EW, Morrice N (1998) Nature, 396:695-699. 
Manoury B, Gregory WF, Maizels RM and Watts C (2001) Curr. Biol., 11: 
447-451. 
Martin JR, Jerala R, Kroon-Zitko L, Zerovnik E, Turk V and Waltho JP 
(1994) Eur. J. Biochem., 225:1181-119. 
Martin JR, Craven CJ, Jerala R, Kroon-Zitko L, Zerovnik E, Turk V and 
Waltho JP (1995) Mol. Biol., 246: 231-343. 
Mason PE, Neilson GW, Dempsey CE, Barnes AC and Cruickshank 
JM (2003) Proc. Natl. Acad. Sci., 100(8): 4557-4561. 
Matsuishi M and Okitani A (2003) Comp. Biochem. Phys., 136: 309-
316. 
Mayr LM and Schmid FX (1993) Biochemistry, 32: 7994-7998. 
McDonald JK and Elis S (1975) Life Sci., 17:1269-1276. 
Minakata K and Asano M (1985) Biol. Chem. Hoppe-Seyler, 366: 15-18. 
Mirny LA and Shakhnovich EI (1999) J. Mol. Biol., 291:177. 
Mitchinson C and Pain RH (1985) J. Mol. Biol., 184: 335. 
Moller CA, Lofberg H, Grubb AO, Olsson SO, Davies ME and Barrett AJ 
(1985) Neuroendocrinology, 41:400-404. 
Monteiro ACS, Abrahamson M, Vannier MAS and Scharfstein J (2001) J. 
Cell Sci., 114: 3933-3942. 
166 
• Mork YK, Kay CM, Kay LE and Forman-Kay J (1999) J. Mol. Biol. 
289: 619-638. 
• Mort JS, Becklies AD and Poold AR (1984) Biochim. Biophys. Acta, 
614: 134-143. 
• Muller-Esterl W, Vohletimmennann M, Boos B and Dittmann B (1982) 
Biochim. Biophys. Acta, 706: 145-152. 
• Muller-Esterl W, Fritz H, Kellermann J, Lottspeich F, Machleidt W and Turk 
V (1985) FEBS Utt., 191(2): 221-226. 
• Muller-Esterl W, Iwanaga S and Nakanishi S (1986) UBS, 11: 336-339. 
• Mulqueen PM and Kronman MJ (1982) Arch. Biochem. Biophys., 
215: 28-39. 
• Murachi T and Neurath H (1960) J. Biol. Chem., 235:99-102. 
• Nagai A, Murukama Y, Terashima et al., (2000) Neurology, 55: 1828-1832. 
• Nakamura Y, Takeda M, Suzuki H, Tada K, Hariguchi S, Hashimoto S and 
Nishimura T (1991) Neurosci. Lett., 130:195-199. 
Newman DJ, Thakkar H, Edwards RD, Wilkie M, White I, Gnibb AO and 
Price CP (1995) Kidney Int., 47(1): 312-318. 
• Ni J, Abrahamson M, Zhang M and Fernandez MM (1997) J. Biol. Chem., 
272(16): 10853-10858. 
• Ni J, Fernandez MA and Danielsson L (1998) J. Biol. Chem., 273(38): 
24797-24804. 
• Nicholson DW (1999) Cell Death Differ., 6: 1028-1042. 
• Nicklin MJH and Barrett AJ (1984) Biochem. J., 223:245-253. 
• Nishida Y, Sumi H and Mihara H (1984) Cancer Res., 44: 3324-3329. 
» Nishii I, Kataoka M, Tokunaga F and Goto Y (1994) Biochemistry, 
33:4905-4909. 
167 
Noda T, Isogai K, Hayashi H and Katumima N (1981) J. Biochem., 90: 371-
379. 
Nolting B, Golbik R and Fersht AR (1995) Proc. Natl. Acad. Sci., 
USA. 92: 10668-10672. 
North MJ (1982) Microbiol. Rev., 46: 308-340. 
North NK, Mottram JC and Coombs GH (1990) Parasitology Today, 6: 270-
275. 
Nycander M and Bjork I (1990) Biochem. J., 271:281-284. 
Nycander M, Estrada S, Mort JS, Abrahamson M and Bjork I (1998) FEBS 
Lett., 422: 61-62. 
Obiekwe B, Grudzinskas JG, Gardon YB, Bohn H and Chard T (1978) 
Proceedings of the 6"* meetings international research group for Carcino 
embryonic proteins 152. 
Ohtani 0, Fukuyama K, Epstein WL (1982a) Biochim. Biophys. Acta. 
707:21. 
Ohtani O, Fukuyama K, Epstein WL (1982b) J. Invest. Dermatol., 82: 280. 
Okamoto H and Greenbaum LM (1983) Biochem. Biophys. Res. Commun., 
112: 701-708. 
Ouchterlony 0 (1962) Process m Allergy (P. Kallos and B.H.Waksman, ed) 
Basel Karger 6,30. 
Pace CN (1975) Crit. Rev. Biochem., 3, 1-43. 
Pace CN (1986) Methods Enzymol., 131, 266-280. 
Pagano M and Engler R (1982) FEBS Letts., 138: 307-310. 
Park YD, Jung JY, Kim DW, Kim WS, Hahn MJ and Yang JM (2003) 
J. Protein. Chemistry, 22(5), 463-471. 
168 
Pennacchio lA, Lehesjoki AE, Stone NF, Willour VL, Faham M, Cox DR 
and Myers DR (1996) Science, 271: 1731-1734. 
Pennacchio LA, Bouley DM and Higgins KM (1998) Nat. Genet., 20: 251-
258. 
Peterson EA and Sober HA (1962) Methods in Enzymol. Colowick, S.P. and 
Kaplan, N.O. eds) Academic Press, New York. 5,3. 
Plafr AW, Schulz-Key H, Soboslay PT, Taylor DW, Maclenan K and 
Hof&nan WH (2002) Int. J. Parasitol., 32(2): 171-178. 
Plaxo KW and Dobson CM (1996) Curr. Opin. Struct. Biol., 6: 630-
636. 
Pol E and Bjork I (2001) Protein Science, 10: 1729-1738. 
Pontremoli S, Melloni E, Salamino F, Sparator B, Michetti M and Horecker 
BL (1983) Proc. Natl. Acad. Sci., USA, 80:1261-1264. 
Popovic T, Brzin J, Ritonja A and Turk V (1990) Biol. Chem. Hoppe-Seyler, 
371: 575-580. 
Poulik MD, Schinnick CS and Smithies 0 (1981) Mol. Immunol., 18: 
569-572. 
Prajapati S, Bhakuni V, Babu KR and Jain SK (1998) Eur. J. 
Biochem., 255, 178. 
Privalov PL (1979) Adv. Protein. Chem., 33:167. 
Privalov PL (1996) J. Mol. Biol., 258: 707-725. 
Ptitsyn OB, Pain RH, Semisotnov GV, Zerovnik E and Razgulyaev 01 
1990) FEBS Lett., 262: 20-24. 
Ptitsyn OB (1994) Protein Eng., 7: 593-596. 
Ptitsyn OB (1995) Curr. Opin. Struct. Biol., 5: 74-78. 
Ptitsyn OB (1995) Adv. Protein Chem., 47: 83- 229. 
169 
Quinn PS and Judah (1978) Biochem. J., 172: 301-309. 
Radford SE and Dobson CM (1995) Phil Trans R Soc Lond B. 348: 
17-25. 
Ramasarma PR, Appu Rao AG and Rao DR. (1995) Biochim. 
Biophys. Acta. 1248: 35-42. 
Raschke TM and Marqusee S (1997) Nat. Struct. Biol., 4:298-304. 
Rashid F, Baba SP, Sharma S and Bano.B (2004) Prot. Peptide Lett., 
11(6), 583-591. 
Rashid F, Sharma S and Bano B (2005) The. Prot. J (In Press). 
Rawlings ND and Barrett AJ (1990) J. Mol. Evol., 30:60 
Rawlings ND and Barrett AJ (1994) Methods Enzymol., 244, ed by Barrett 
AJ. Acad Press: 461-486. 
Redfield C, Smith RA and Dobson CM (1994) Nat. Structl. Biol., 1: 
23-29. 
Rinnie A, Jarvinen M and Rasanen O (1978) Acta Histochem., 63: 183-192. 
Rinnie A, Alavaikko M, Jarvinen M, Martikinen J, Kartunen T and Hopsu-
Havu V (1983) Virchows Arch. Cell Pathol., 43: 121-126. 
Rinnie A, Rasanen O, Jarvinen M, Dammert K, Kallioinen M and Hopsu-
Havu V (1984) Acta Histochem., 74: 75-79. 
Ritonja A, Machleidt W and Barrett AJ. (1985) Biochem. Biophys. Res. 
Commun., 131: 1107. 
Rohrlich ST, Levy H and Rifkin DB (1985) Biol. Chem. Hoppe-Seyler, 366: 
147-155. 
Roughley PJ, Murphy G and Barrett AJ (1978) Biochem. J., 169: 721-724. 
Ryan SN, Laing WA and Mcmanus MT (1998) Phytochemistry, 
49(40): 957. 
170 
Ryley HC (1979) Biochem. Biophys. Res. Commun., 89: 871-878. 
Salvesen G, Parkes C, Abrahamson M, Grubb A and Barrett AJ (1985) 
Biochem. J., 241: 476-479. 
Salvesen G, Parkes C, Rawlings ND, Brown MA, Barrett AJ, Abrahamson 
M and Grubb A (1986) hi V.Turk (Ed), Cysteme Proteinase and their 
Inhibitors, Walter de Gruyter, Berlin. 
Saxena I and Tayyab S (1997) Cell Mol. Life Sci., 53: 13-23. 
Saxena VP and Wetlaufer DB (1971) Proc. Natl. Acad. Sci., USA. 68: 969-
975. 
Schonbruimer N, Wey J, Engels J, Geortge H and Kiefhaber T (1996) 
J. Mol. Biol., 260: 432-445. 
Schnittger S, Gopal Rao WN, Abrahamson M and Hansmann I (1993) 
Genomics, 16: 50-55. 
Schreiber G and Fersht AR (1995) J. Mol. Biol., 248:478. 
Schwabe C, Anastasi A, Crow H, McDonald JK and Barrett AJ (1984) 
Biochem. J., 217: 813-817. 
Sekine T and Poulik MD (1982) Clin. Chim. Acta, 120: 225-235. 
Semisotnov GV, Rodionova NA, Razgulyaev 01, Uversky VN, Gripas 
AF and Gilmanshin RI (1991) Biopolymers, 31: 119-128. 
Sen LC and Whitaker JR (1973) Arch. Biochem. Biophys., 158: 623-
632. 
Sharma S, Rashid F and Bano B (2005) J. Agri. Food Chem., 53(15): 
6027-6034. 
Shiraki K, Nishikawa K and Goto Y (1995) J. Mol Biol., 245: 
180-194. 
Shortle D (1996) Curr. Opin. Struct. Biol., 6, 24-30. 
171 
Shortle D and Ackerman MS (2001) Science, 293: 487-489. 
Shulman BA, Kim PS, Dobson CM and Redfield C (1997) Nat.Struct. 
Biol., 4:630-634. 
Singh H and Kalnitsky G (1978) J. Biol. Chem., 253: 4319-4326. 
Sloanne BF and Honn KV (1984) Cancer Metastasis Rev., 3: 249-263. 
Sloane BF, Moin K and Lah TT (1994) In: TG Pretlow and TP Pretlow (eds), 
Biomedical and Molecular Aspects of Selected Cancers, Academic Press, 
New York: 411-472. 
Smith JS and Scholtz JM (1996) Biochemistry, 35: 7292-7297. 
Sohar I, Laszlo A, Gaal K and Mechler F (1988) Biol. Chem. Hoppe-
Seyler, 369: 277-284. 
Sola-Penna M and Meyer-Femandes JR (1996) Z. Naturforsch. 51C: 
160-164. 
Sola-Penna M, Ferreira-Pareira A, Lemos AP and Meyer-Fernandes 
JR (1997) Eur. J. Biochem., 248: 24-29. 
Sola-Penna M and Meyer-Fernandes JR (1998) Arch. Biochem. 
Biophys., 360: 10-14. 
Solan M, Rawson C, Lindburg K and Burnes D (1990) Biochem. 
Biophys. Res. Commun., 172: 945-951. 
Song J, Bai P, Luo L and Peng ZY (1998) J. Mol. Biol., 280: 
167-174. 
Sotiropoulou G, Anisowics A and Sager R (1997) J. Biol. Chem., 272: 903-
910. 
Spanier AM and Bird JWC (1982) Muscle Nerve, 5: 313-320. 
Staniforth RA, Giannini S, Higgins LD, Conroy MJ, Hoimslow AM, Jerala 
M, Craven CJ and Waltho JP. (2001) EMBO J. 20: 4774-4781. 
172 
Stenman G, Astrom AK, Roitjer E, Sotiropoulou G, Zhang M and Sager R 
(1997) Cytogenet. Cell Genet., 76:45-46. 
Stennicke HR and Salvesen GS (1999) Cell Death Dififer., 6:1054-1059. 
Stennicke HR and Salvesen GS (2000) Biochim. Biophys. Acat, 1477: 299-
306. 
Stoka V, Turk B, Schendel SL and Kim TH (2001) J. Biol. Chem., 276: 
3149-3157. 
Strauli P, Barrett AJ and Baici A (Eds) (1980) Proteinases and Tumor 
Invasion. Raven Press, New York. 
Stryer, L (1965) J. Mol. Biol., 13: 482-495. 
Stubbs MT, Laber B, Bode W, Ruber R, Jerala R, Lenarcic B and Turk V 
(1990) EMBO J., 9: 1939-1948. 
Sugo T, Ikari N, Kato H, Iwanaga S and Fujii S (1980) Biochemistry, 19: 
3215-3220. 
Suhar A and Marks N (1979) Eur. J. Biochem., 101: 23-30. 
Swanson AA, Martin BJ and Spicer SS (1974) Biochem. J., 137: 223-228. 
Tanford C (1968) In Advances in Protein Chemistry, Academic Press, 
New York, 121-128. 
Takeda A, Kobayashi S, Kaji H, Aoki Y and Samejima T (1986) J. 
Biochem., 99: 785-791. 
Takio K, Kominami E, Wakamatsu N, Katunuma N and Titani K. (1983) 
Biochem. Biophys. Res. Commun., 115: 902. 
Taniguchi K, Ito J and Sasaki M (1981) J. Biochem., 89: 179-184. 
Timasheff SN and Arakawa T in: T.E.Creighton (Ed.) (1989) Protein 
Structure, a practical approach. IRL Press. Oxford, pp. 331-345. 
Thomas PD and Dill KA (1993) Protein Sci., 2: 2050-2065. 
173 
Trabandt A, Gay RE, Fassbender HG and Gay S (1991) Arthritis Rheum., 
34: 1444-1449. 
Tsai YJ, Chang GD, Chang YS and Huang FL (1996) Comp. Biochem. 
Physiol. B. (Biochem. Mol.Biol.,) 113(3): 573-580. 
Tsushima H (1993) Arch. Dermatol Res., 285(7): 418-422. 
Tsushima H, Higashiyama K and Mine H (1996) Arch. Dermatol. Res., 
288(8): 484-488. 
Turk V, Brzin J, Lenarcic B, Locnikar P, Popovic T, Ritonja A, Babnik J, 
Bode W and Machleidt W (1985) In Intracellular Protein Catabolism: 91-
103, Alam R. Liss, New York. 
Turk B, Krizaj I, Kralj B, Dolenc I, Popovic T, Beith JG and Turk V (1993) 
J. Biol. Chem., 268: 7323-7329. 
Turk B, Ritonja A, Bjork I, Stoka V, Dolenc I and Turk V (1995) FEBS 
Lett., 360: 101-105. 
Turk B, Turk D and Turk V (1997) Biol. Chem., 387: 141-150. 
Turk B, Turk D and Turk V (2000) Biochim. Biophys. Acta, 1477: 98-111. 
Turk B, Stoka V, Rozman J et al (2001). International Symp. Proteinase 
Inhibitors. Biol. Control, Brdo, Slovenia, Book of Abstracts: 13. 
Uversky VN (1993) Biochemistry, 32: 13288-13298. 
Vassilenko KS and Uversky VN (2002) Biochim. Biophys. Acta, 
1594: 168-177. 
Voller A, Bidwell DE and Bartlett A. (1976) Bull World Health Org., 
53: 55-65. 
Von Heijne G (1985) J. Mol. Biol., 184: 99-105. 
Von Hippie PH and Wong KY (1965) J. Biol. Chem., 240: 3909-3923. 
174 
Wang GF, Cao ZF, Zhou HM and Zhao YF (2000) Int. J. Biochem. 
Cell Biol., 32: 873-878. 
Warwas M and Sawicki G (1985) Placenta, 6(5): 455-463. 
Weber K and Osbom M (1969) J. Biol. Chem., 244:4406-4412. 
Williams J (1982) Trends Biochem. Sci., 7:394-397. 
Wood L, Yorke G, Roisen F and Bird JWC (1985) Progr. Clin. Biol. Res., 
180:81-90. . 
Wong KP and Tanford C (1973) J. Biol .Chem., 248, 8518. 
Wu LC and Kim PS (1998) J. Mol Biol., 280: 175-182. 
Wuthrich K (1994) Curr. Opin. Struct. Biol., 4: 93. 
Yajima Y and Kawashuma S (2001) Int. Symp. Proteinase Inhibitors Biol. 
Control, Brdo, Slovenis, Book of Abstracts: 32. 
Yamamoto Y, Watanabe S, Kageyama T and Takahashi SY (1999) Insect. 
Biochem. Physiol., 41: 119-129. 
Yamashita M and Konagawa S (1996) J. Biol. Chem., 271(3): 1282-1284. 
Yang JJ, Buck M, Pitkeathly M, Kotik M, Hayne DT, Dobson CM and 
Radford SE (1995) J. Mol. Biol., 252:483-491. 
Yao M and Bolen DW (1995) Biochemistry, 34: 3771-3781. 
Zabari M, Bern M, Rouchon P, Zamora F, Tassy C, Ribadeau Dumas B and 
Ouali A (1993) Biochimie, 75(10): 937-945. 
Zerovnik E, Cimermann N, Kos J, Turk V and Lohner K (1997) Biol. Chem., 
378:1199-1203. 
Zhang B and Peng ZY (1996) J. Biol. Chem., 271: 28734-28737. 
175 
7. BIOGRAPHY 
(1) RashidF, Baba SP, Sharma S and Bano B. 
Studies on Interaction of Papain with Human Placental Cystatin by UV, 
Fluorescence and CD Spectroscopy. 2004 11(6) 583-591 Protein and Peptide 
Letters. 
(2) Rashid F, Sharma S and Bano B 
Comparison of Guanidine Hydrochloride (GdnHCl) and Urea denaturation 
on inactivation and unfolding of Human Placental Cystatin (HPC). 2005 The 
Protein Journal (Accepted). 
(3) Rashid F, Kaleem M, Sheema and Bano B 
Comparative studies on effect of olive oil and fish oil supplementation in 
combating gentamicin induced nephrotoxicity in rats. 2005 20(1) 108-133 
Indian Journal of Clinical Biochemistry. 
(4) Sharma S, Rashid F and Bano B 
Biochemical and Biophysical changes induced by fungicide Sodium 
diethyl dithiocarbamate (SDD), in Phytocystatin obtained from 
Phaseolus mungo (Urd)- a commonly used Indian legume. 2005 J 
Agric Food Chem. 53(15) 6027-6034. 
(5) Rashid F, Sharma S and Bano B 
Detailed Biochemical Characterization of Human Placental Cystatin (HPC) 
(Communicated). 
(6) Rashid F, Sharma S, Baig MA and Bano B 
Molten Globule state of Human Placental Cystatin (HPC) at low pH 
conditions, effects of Trifluoroethanol (TFE) and Methanol 
(Communicated). 
(7) Rashid F, Sharma S, Baig MA and Bano B 
Effect of Polyols and Salts on the molten globule state of Human Placental 
Cystatin (HPC) at low pH conditions (Communicated). 
ABSTRACTS AND PROCEEDINGS PUBLISHED 
(1) Rashid F, Sharma S and Bano B 
Effect offish oil and olive oil treatment on gentamicin nephrotoxicity in 
rats. 
Proceedings of the 6* International Scientific Conference of molecular 
Biology, Chemistry and Physics of non-equilibrium systems at Ivano-Ples 
ISCUT 27 May-2 June 2002 Russia. 
(2) Rashid F and Bano B 
Studies on Interaction of papain with human placental cystatin by UV, 
Fluorescence and CD Spectroscopy. 
Proceedings of the 6* International Conference of Human Ecology and 
Nature at Moscow-Pies, July 5-11,2004 Russia 
(3) Rashid F and Bano B 
Effect of olive oil on gentamicin induced nephrotoxicity in rats. 
Abstract m te 71^ Annual general Body Meeting of the Society of Biological 
Chemists (India) held at the Department of Biochemistry and Chemistry, 
College of Basic Sciences and Humanities, Punjab Agricultural University, 
Ludhiana, Pimjab , India Nov 14-16 2002. 

Protein and PtptUe Utun, Vol. U. No. 6. pp. 583-591. 2004 
Bcathain Science Publishers Ltd. 
0929-«6ti5AM S 45.00 * .00 
STUDffiS ON THE INTERACTION OF PAPAIN WITH 
HUMAN PLACENTAL CYSTATIN BY UV, 
FLUORESCENCE AND CD SPECTROSCOPY 
FouzM Rasbid, S.P. Baba, Sandeep Sharma and B. Bano* 
Department of Biochemistry, Faculty of Life Sciences, Aligarii Muslim University, Aligarh 202002, India 
E-mail : fouzia_bc@yahoo.com, Fax:+91-571-2702587 
Abstract: The interaction of activated papain with low molecular weight cystatin (Mr 12500) purified from 
human placenU has been studied. Analysis of inhibition of caesinolytic activity of papain by ^ystatin 
showed stoichiometiy of 1:1. Kinetic studies gave an inhibition constant (K,) value of 5.5 x 10 M and 
association rate constant (K*i) value of 3.4 x 10* (M"' s'). All spectroscopic studies showed conformational 
changes in both papain and nystatin on formation of complex. The data suggest perturbation of 
environment of aromatic residues and change of their native structure and conformation thereby shedding 
light on the behaviour of cystatins, especially interaction of placental cystatin with thiol protease 
inhibitors. 
Keywords: cystatin, far XN-CD spectroscopy, fluorescence emission, human placenta, papain, UV-
absorption. 
INTRODUCTION 
Cysteine proteinase inhibitors of the cystatin superfamily are present in a variety of tissues and 
body fluids of human beings and animals. Their presence has also been reported in micro-organisms and 
plants [I, 2]. Cystatins arc non-covalent competitive inhibitors of cysteine proteinases such as cathepsins 
B, H. L and S [3, 4]- Structurally cystatins constitute a single superfamily of evolutionary related proteins 
[5]. On the basis of structural diflerences. the members ofcvstatm superfamily have been grouped mto three 
families (Families 1. 2 and 3) (3] FamiK 1 cNstatin.s lack disulphidc bridges and arc found mainly 
intracclluiarly. Family 2 cystatins contain tuo disulphidc bonds and are present in tissues and biological 
fluids Family 3 cystatins are found in plasma onl> and arc named as kininogcns Cystatins have an 
important regulator)' role in normal bod} processcb m\ohing c\stcinc proteinase actnit\ such as bone 
resorption [6] and control of unwanted protcol>sis in cells They are also associated with several 
pathological conditions such as rheumatoid arthrms [7]. renal failure [8]. septic shock [9]. osteoporosis 
[10] resulting due to imbalance between endogenous inhibitors and c>stcinc proteinases Cystatins have 
been purified from several mammalian sources including bovine muscle [I Ij. human spleen (I2J. li\cr [13]. 
blood polymorphonuclear granulocytes |I4. 15], urine (16). am\loid fibrils [17]. sali\a (18-20] and 
amniotic fluid [21] 
The interaction of chicken cystatin with papain has been studied in detail as a model for other 
reactions between cystatins and cysteine proteinases The inhibitor forms a tight equimolar complex with 
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papain after which ihc reactnc c>;>tcinc of the cn/>me is macccNsible lo ilic bubblratcs and to thiol groii| 
reagents (22, 23] 
Given the significance of placenta in human svitem and lack ol informanan regarding the 
chemical structure and function of cystatin from this source, the aim ol thi.s \sork was lo purify c> statin 
from human placenta This was then subjected to a comprehensive anal>sis ot both its kinetic properties 
and spectroscopic behaviour of the interaction between this cystatin and papain to determine the changes in 
Secondary structure ol this inhibitor on interaction with papain 
MATERIALS AND METHODS 
Materials 
Papain and Sephade\ G^ o-so were from Sigma Chemical Companv All other (.hemicals were ot 
analytical grade 
Purification of the Inhibitor 
Purification of cystatin from human placenta was achieved by a modification of the method of 
Warwas and Sawicki [24J Fresh placental tissue after homogcnization was subjected to pH and heat 
treatment and later fractionated between 50-80% ammonium sulphate saturation The precipitated protein 
after dialysis was applied on Sephadex GSO-M column The fractions of protein peak having maximum 
cysteine proteinase inhibitory activity were pooled and concentrated for this study. 
Protein Estimation: 
The protein content was quantitatcd by Folm's phenol reagent by the method of Lowry [25] 
Stoichiometry of Cystatin-Papain Complex 
The inhibitory activity of cystatin was assessed by its ability to inhibit caseinolytic activity of 
papain by the method of Kunitz [26]. The concentration of papain was varied from 0 01-0 06 jxM where as 
the inhibitor concentration was fixed at 0.06 ^M. 
KINETICS OF INHIBITION 
Inhibition Constant (Ki) Determination 
K, determination was carried out after lowering enzyme and inhibitor concentration to obtain a 
non linearity of dose response curves. Thus papain was used at a concentration of 0 05 jxM to react with 
inhibitor varying from 0.011 to 0.211 \iM and measurement of residual activity was made as described by 
Kunitz [26] using casein as substrate. Four different substrate concentrations were used, i.e, 0 5 Km, 1 Km, 2 
Km and 3 Km with Km " 2.4 mM and the results were analysed by the steady state equation of Krupka and 
Laidler [27] and Henderson's method [ZH]. 
Determination of Association Rate Constant (K+i) 
K+i values were determined by monitoring the time-dependence of the association under second-
order conditions. Association rate constant (K+i) was calculated assuming that enzyme [E] and inhibitor fl| 
